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Abstract 
This PhD has focussed on characterising two proteins key to fungal infections; Als and 
BEC1054. 
The Als (agglutinin-like sequence) family of surface adhesins are critical virulence factors 
from Candida albicans, contributing to biofilm formation and colonisation of a range of 
tissues in the human host. The broad tissue tropism of Als has been linked to a broadly 
specific peptide binding cavity (pbc) identified in crystal structures of Als N-terminal 
domains (NTs). 
Questions remained regarding the relative roles of the pbc and Als aggregative mechanisms 
in host cell binding. A series of targeted mutants generated in Als3 were characterised in vitro 
via NMR and in vivo (collaborator’s work) to delineate these adhesion mechanisms and 
demonstrate that the pbc alone mediates host binding. It was further demonstrated that 
sequence differences in the pbcs of Als1 and 3 underlie differences in Als substrate binding 
specificities. Solution based assays showed that Als3 binds to a wider range of peptide 
sequences; correlating with a larger pbc and additional interactions with peptides formed in 
Als-peptide co-crystal structures. We hypothesise that the broader binding specificity of Als3 
correlates with the protein’s increased contribution to C. albicans adhesion and virulence in 
infection. Binding assays provided new insights into the peptide binding mechanism, and a 
robust system for future development of novel Als inhibitors.  
Following infection of barley, Blumeria graminis delivers effector proteins such as BEC1054 
into the plant to perturb host immunity. The crystal structure of BEC1054 was solved, 
revealing an RNAse fold that lacks catalytic residues required for hydrolysis. Binding to 
nucleic acid has been demonstrated, and the binding site localised via mapping of chemical 
shift perturbations (CSPs) in NMR. Preliminary data have been acquired to test the theory 
that BEC could associate with ribosomes. Understanding the role of BEC1054 could provide 
important insights into effector-based modulation of plant immunity, an area that is currently 
poorly understood. 
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FAM: 5, 6- carboxyfluorescein 
FP: Fluoresence polarisation 
FPLC: Fast performance liquid chromatography 
Gp96: Glycoprotein96 
GPI: Glycosyl phosphotidyl-inositol 
HBEC:  Human buccal epithelial cells 
HER2: Human epidermal growth factor receptor 2 
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HI: Haustorial index 
HIGS: Host-induced genome silencing 
HSQC: Heteronuclear single-quantum coherence 
HUVEC: Human umbilical vein epithelial cells 
ICU: Intensive care unit 
Ig: Immunoglobulin 
ITC: Isothermal titration calorimetry 
JA: Jasmonic acid 
KD: Dissociation constant 
koff: On-rate 
kon: Off-rate 
LB: Lysogeny broth 
LIC: Ligation independent cloning 
LLG: Log-likelihood gain 
MALs: Multi-angle laser scattering 
MCL: Markov Cluster algorithm 
MSCRAMM: Microbial Surface components recognising adhesive matrix molecules 
MST: Microscale thermophoresis 
NEB: New England Biolabs 
NI-NTA: Nickel- Nitriloacetic acid  
NMR: Nuclear magnetic resonance spectroscopy 
NOE: Nuclear Overhauser effect 
NTD or NT: N-terminal domain 
Pbc: Peptide binding cavity 
PCR: Polymerase chain reaction 
PEG: Polyethylene glycol 
PolyT: Polythreonine peptide (heptathreonine) 
PRR: Pathogen-associated molecular pattern recognition receptors 
PTI: PAMP-triggered immunity 
(Q)RT-PCR: (Quantitative) Reverse transcriptase PCR 
R protein: Resistance protein 
RHE: Reconstituted human endothelial cells 
RIP: Ribosome inactivating protein 
RMSD: Root-mean squared deviation 
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RNA: Ribonucleic acid 
RNAse: Ribonuclease 
SA: Salicylic acid 
SAD: Single-wavelength anomalous diffraction 
SAG1:  Saccharomyces alpha-agglutinin1 
SAPs: Secreted aspartyl proteases 
SDS-PAGE: Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SEC: Size-exclusion chromatography 
sNT: Short N-terminal domain construct 
SOC: Super optimal broth  
SPR: Surface plasmon resonance 
SRS: Stable reversible, sensistive 
SSEs: Secondary structural elements 
TANGO: A protein aggregation prediction server 
TBS-T: Tris- buffered saline with Tween20 
TEV: Tobacco Etch Virus  
TLR: Toll-like receptor 
TLS: Translation Libration Screw-motion 
TROSY: Transverse relaxation optimised spectroscopy 
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Chapter One: Research context, hypotheses and 
aims 
 
Chapter summary 
Blumeria graminis and Candida albicans are highly important fungal pathogens, and major 
sources of life-threatening infections in barley plants and humans respectively. This thesis 
focusses on structurally characterising proteins key to infection establishment in these fungi; 
BEC1054 from B. graminis and the Als adhesin family from C. albicans.  
This introductory chapter will provide some biological and clinical context to the research 
conducted during the PhD. This will begin with a discussion of the threat posed by fungal 
infections, examining specifically the impact of C. albicans and B. graminis infections as 
examples of pathogens afflicting human and plant hosts respectively. The infection cycles of 
these pathogens are subsequently compared, with a discussion of the roles of the Als adhesins 
and BEC1054 in infection establishment and maintenance (Section One). Finally, in Sections 
Two and Three the known molecular details governing the roles of these proteins in 
pathogenesis will be discussed in detail, and the research questions and aims for the PhD 
presented. 
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1.1 Fungal infection in C. albicans and B. graminis 
1.1.1 An introduction to fungal infections 
Fungal pathogens are increasingly recognised as a major threat to human health, food security 
and the economy. Ubiquitous in nature and highly diverse, fungi have the ability to infect the 
widest range of eukaryotic hosts for any class of pathogen (Fisher et al., 2012). They are the 
leading source of infection in plants, underlying major annual crop losses and some of the 
most serious famines in history (Scholthof, 2003). Fungal pathogens are also emerging as an 
important source of disease in humans, causing infections that range from benign to fatal.  
This thesis discusses the structural and functional characterisation of two proteins critical to 
fungal pathogenesis; the Als family of adhesins from Candida albicans, an important human 
pathogen, and BEC1054 from Blumeria graminis f. sp. hordei, a fungal pathogen of barley.  
 
 
 
 
 
 
 
Figure 1.1: Examples of fungal cellular morphology. Fungi may be multicellular, and composed of 
coenocytoic or sepate hyphal cells as in A and B, or can be unicellular, as in C. Major cellular organelles are 
labelled. 
Fungi are heterotrophic eukaryotes possessing a chitin cell wall and cellular features typical 
to other eukaryotes, such as membrane bound nuclei and organelles and 80S ribosomes 
(Figure 1.1). Forming one of the taxonomic kingdoms of life, fungi are extremely 
morphologically diverse. The fungal kingdom encompasses unicellular yeasts and 
multicellular filamentous moulds, rusts and mushrooms, with pleomorphic fungi having the 
ability to interconvert between the different forms. Multicellular fungi are composed of 
elongated filamentous cells termed hyphae; typically multinucleate and containing a large 
vacuole. Hyphae may lack divisions between individual cells (coenocytic) as in the chytrids 
A                                                                                              C 
 
 
 
B 
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and zygomycetes, or contain septate cell walls as in the ascomycetes and basidiomycetes. The 
body of hyphal filaments forms a diffuse higher order structure termed a mycelium. Hyphae 
are critical to the fungal life cycle, reproduction, and infection; mediating adhesion to host 
cells and subsequent invasion (Fu, Ibrahim et al., 2002).  
Whilst the Mycobank fungal database suggests that around 365,000 species of fungi have 
been identified to date (Mycobank Database, 2015), it is estimated that only approximately 
10% have adapted to a parasitic mode of existence. 
1.1.2 The significance of fungal infections in humans; C. albicans as a case 
study 
Fungal pathogens that cause infections in a human host may be classified as primary or 
opportunistic according to the nature of their infection strategy (Walsh and Dixon, 1996). 
Whilst primary fungal pathogens are able to infect a host irrespective of the host’s immune 
status, opportunistic pathogens are natural commensals of the human body that become 
pathogenic under conditions favouring infection. Risk factors can be linked to impaired 
immunity (generally as a result of chemotherapy, immunodeficiency disorders, neutropenia, 
use of immunosuppressive drugs, severe burns or extremes in age), changes to the host 
microbiotic flora, (typically following administration of broad spectrum antibiotics) or use of 
medical implants (Jarvis, 1995; Ostrosky-Zeichner and Pappas, 2006; Rex and Sobel, 2001); 
(Hsueh et al., 2009; Paphitou et al., 2005). 
C. albicans is the second leading source of fungal opportunistic infections (Pfaller and 
Diekema, 2007), and a natural commensal of the human vagina, nasopharyngeal cavity and 
gastrointestinal tract (Lipman and Saadia, 1997). However, if growth of the fungus is left 
unchecked due to any of the risk factors cited above, the fungus can become pathogenic. 
Candidiasis infections can be classified as superficial, disseminated or invasive, according to 
the degree of tissue penetration. Superficial infections can be relatively common in healthy 
individuals, and tend to occur in the oral and vulvovaginal cavities or urinary tract. It is 
estimated that approximately 75% of females will suffer from at least one case of 
vulvovaginal candidiasis (thrush) during their lifetime (Sobel, 2007) and 5-7% of infants 
under the age of one may contract oral candidiasis (North American Centre for Control and 
Disease prevention, CDC). Such infections are typically benign, and readily treated with 
antifungals.  
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However, in the immunocompromised, infections can rapidly progress to disseminated 
candidaemia as C. albicans migrates to internal organs of the body.  Dissemination to internal 
organs may occur via two major routes; transport through the bloodstream (systemic 
infection) or via direct penetration of epithelia in the gut (invasive infection). Disseminated 
candidaemia infections are remarkable for the diversity of organs colonised by the fungus- 
commonly including the kidneys, liver, lungs, eyes, cardiovascular system and central 
nervous system (CNS) (Jarvis, 1995). Disseminated infections have high associated mortality 
rates in immunocompromised individuals; estimated to be between 45-75% (Gudlaugsson et 
al., 2003; Pfaller and Diekema, 2007). In comparison, average mortality rates attributed to 
hematogenously disseminated Staphylococcus aureus infections are estimated to lie between 
10-40% (van Hal et al., 2012). An estimated ~400,000 deaths are caused by C. albicans 
annually (Pfaller and Diekema, 2007). 
Concerns regarding the high mortality rates associated with invasive candidaemia are 
compounded by the prevalence of this organism in hospital settings. C. albicans is the fourth 
leading cause of nosocomial infections (after Staphylococci and Enterococci species), 
accounting for ~8-10% of nosocomial bloodstream-infections (BSIs) in the US (Pfaller et al., 
1998; Wisplinghoff et al., 2004).  It has been demonstrated that the most common health-care 
associated risks for systemic candidiasis are long-term intensive care unit (ICU) stays (Pfaller 
and Diekema, 2007), or use of intravenous or indwelling catheters and haemodialysis 
(Blumberg et al., 2001). This can be attributed in part to the ability of the fungus to form 
persistent biofilms on medical implants (Dominic, 2007) permitting delivery to the 
bloodstream. Combined with the steady increase in resistance observed in Candida species to 
conventional azole and echinocandin antifungals (Nett et al., 2010; Walker et al., 2010), ICUs 
are arguably heading towards a perfect storm. Between the years 2003-2009, US Medicare 
expenditure on antifungals rose from an estimated $93.87 million to $143.76 million (Centers 
for Medicare and Medicaid, CMS.gov), and there is a critical need for development of novel 
antifungals to supplant broad spectrum azoles in treatment of C. albicans infection. 
1.1.3 The significance of fungal infections in plants; B. graminis as a case 
study 
Whilst C. albicans and other fungal pathogens are increasingly recognised as important 
sources of emerging infectious diseases (EIDs) in humans, the impact of fungal plant 
pathogens is well established. Fungi are the leading source of infection in plants, causing 
diseases manifest as smuts, rusts, ergots or mildews. Fungal pathogens affect approximately 
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25% of crops worldwide each year, resulting in annual losses of 1 billion metric tonnes of 
food products (Aulakh, 2013).  
Analogously to human fungal pathogens, plant pathogens may be classified according to the 
nature of their association with the host and feeding strategy as primary, opportunistic or 
additionally biotrophic (Prell and Day, 2001). As in humans, opportunistic fungi can live 
harmoniously with a plant and typically take advantage of stressed or senescent hosts to cause 
disease, gaining entry via damaged tissues. Opportunistic and primary plant fungal pathogens 
tend to be saprophytic (feeding on dead host material) or necrotrophic (killing their hosts for 
nutrition) (Prell and Day, 2001). Conversely, biotrophic pathogens feed off metabolites from 
their living host, and for obligate biotrophs such as B. graminis, growth of the fungus can 
only be sustained on the plant host (Prell and Day, 2001). Biotrophic pathogens thus exhibit 
an exceptionally high degree of evolutionary specialisation in host specificity. 
B. graminis is an obligate biotrophic pathogen of the powdery mildew family (Erysiphales, 
Ascomycota) (Braun, 1987). It infects angiosperm grasses such as wheat and barley, two of 
the most agriculturally important crops worldwide (FaoStat, 2013). The species B. graminis 
comprises eight “formae speciales” that are specific for a single host genus or a narrow range 
of related grasses (Troch et al., 2014). B. graminis f.sp. hordei exclusively infects barley (H. 
vulgare). Barley is the fourth largest grain crop worldwide (FaoStat, 2013), and is widely 
cultivated in the Northern hemisphere, predominantly for biofuels, animal feed and brewing. 
Yield reductions in barley following B. graminis infection are significant in these regions; 
annual crop losses in the range of 10-60% have been reported in European regions (Tratwal, 
2014). 
B. graminis infections are characterised by a powdery white residue formed from collections 
of conidia (asexual spores) on the plant surface, from which the name ‘powdery mildew’ is 
derived (Jarvis et al, 2002). The fungus infects the barley ears, stem and leaf, but is 
predominantly visible on the leaf. Epidemics of Blumeria tend to occur in spring, where 
periods of alternating dry and wet weather with some wind are optimal for germination 
conditions and dispersal of spores (Parry, 1990; Spencer, 1978). However, infections can also 
occur in autumn. 
Typical crop protection strategies such as crop rotation are largely ineffective against B. 
graminis, due to the rapidity and efficiency of the spread of fungal spores (Sanchez-Martin et 
al., 2011). Epidemics are currently controlled via careful disposal of infected material, and 
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application of fungicides to aerial organs or seeds. However, resistant strains of B. graminis 
to widely used azoles such as triadimenol are emerging (Reis et al., 2013). Whilst crossing 
and breeding of resistant plant cultivars is also used (Rubiales et al., 2001), only the mlo 
resistance gene (effective at the pre-invasive stage) has proved durable in preventing B. 
graminis infection (Hovmoller et al., 2000; Jorgensen, 1992), and pathogens rapidly evolve to 
overcome host resistance. A recent study also documented possible host-expansion in the 
fungus, and adaption to the triticale plant (Walker et al., 2011). There is thus a pressing need 
for an improved understanding of infection and development of antifungals.  
1.1.4 Pathogenesis in C. albicans and B. graminis 
The pathogenesis of fungal disease can be characterised via several main stages, irrespective 
of the host organism (Figure 1.2). Fungal adhesion and colonisation of the host are 
prerequisites for infection. Following adhesion, the fungus invades the host tissues, often 
causing mechanical damage to host cells via hyphal growth, or chemical damage associated 
with secretion of hydrolytic enzymes. Once infection has been established, the fungus may 
spread to other tissues, facilitated via evasion of the host’s immune system and acquisition of 
host nutrients. Various morphological changes in the pathogen often underlie the different 
stages of infection. 
C. albicans colonises human epithelia via a combination of non-specific hydrophobic cell 
surface interactions mediated by glycans in the fungal cell wall, and specific protein-protein 
interactions mediated by cell surface adhesins such as Hwp1 (Staab et al., 1999), Eap1 (Li 
and Palecek, 2003) and the Als family. Capacity for adhesion is critical to C. albicans, and 
appears to correlate directly with virulence (Hoyer, 2001). Morphological switching of the 
fungus from the yeast form to a pseudohyphal form is associated with more tenacious 
adhesion, as expression of various adhesins (including Als3) is upregulated in hyphae (Hoyer 
et al., 2008, Argimon, 2007) .   
The yeast- hyphal transition in C. albicans is also critical for cellular invasion via both active 
penetration, and induced endocytosis (Zhu and Filler, 2010). Active penetration results from 
hyphal growth, as the associated turgor pressure causes hyphae to penetrate the epithelium. 
This process is facilitated by secretion of hydrolytic enzymes such as SAPs (secreted aspartyl 
proteases) that degrade host cell material (Zakikhany et al., 2007). In contrast, induced 
endocytosis is a passive invasion mechanism mediated by the host. Hyphal invasins such as 
Als3 and Ssa1 interact with host mucosal receptors such as E and N-cadherins, EGF and 
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HER2, inducing clathrin-dependent pseudopod formation around the hyphal cells and uptake 
(Phan et al., 2007a, Zhu, 2012)  Active penetration appears to constitute the primary invasion 
mechanism in gastrointestinal Candida infections (Wachtler et al., 2009, Wachtler, 2012) 
whilst endocytic uptake is important in the early stages of C. albicans infection.  
 
 
 
 
 
 
 
Figure 1.2: The C. albicans pathogenesis cycle. Pathogenesis may be characterised by adhesion to epithelia, 
invasion (via active or passive mechanisms), and then damage and subsequent dissemination to other organs in 
the body. EM micrographs were taken from Naglik et al, 2011(Naglik et al., 2011). 
Active penetration contributes directly to cellular damage, and endocytosis of C. albicans can 
also induce cellular necrosis and apoptosis, leading to further tissue damage (Villar and Zhao, 
2010). Damage to capillaries and blood vessels also allows C. albicans entry into the 
bloodstream, and the fungus is hematogenously disseminated to other organs in the body to 
re-initiate colonisation. 
Biofilm formation is also a critical virulence factor in C. albicans infection (Figure 1.3). 
Biofilm development involves the initial adhesion of a basal layer of yeast cells to a substrate, 
followed by induction of hyphal development, and deposition of extracellular filamentous 
proteins (Ramage et al., 2005). C. albicans biofilms form on epithelia and abiotic substrates 
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and are thus highly problematic in a clinical context. Biofilms form a protective environment 
for microbial communities, and C. albicans cells within biofilms are highly refractory to 
antifungals (one study reported a 30-2000-fold increase in fluconazole resistance for cells in a 
biofilm relative to free cells) (Seneviratne et al., 2008). This can be linked to the 
transcriptional upregulation of efflux pumps in biofilms, and it is possible that extracellular 
filamentous proteins impede drug diffusion (Douglas, 2003; Ramage et al., 2012). As one of 
the leading sources of fungal biofilm formation on medical implants and prostheses, C. 
albicans biofilms facilitate transfer of the fungus into the bloodstream following 
catheterization (Douglas, 2003). Indeed, use of intravenous catheters is one of the chief risk 
factors in disseminated candidiasis. Finally, the presence of additional microbial species 
within mixed C. albicans biofilms further potentiates the risk for infection; S. aureus, 
Pseudomonas aeruginosa and Porphyromonas gingivales have been identified in mixed oral 
biofilms (Sziegoleit et al., 1999, Jenkinson, 1990). 
  
 
 
 
 
 
 
Figure 1.3: Depiction of C. albicans biofilm maturation. SEM (scanning electron micrograph) images are 
taken from Ramage et al, 2009. 
 
Blumeria infection is governed by a highly controlled asexual lifecycle that is characteristic 
of many obligate biotroph phytopathogens (Figure 1.4). Fungal asexual spores (conidia) are 
deposited on host stems or leaves, and then germinate to produce primary and secondary 
germ tubes. The latter differentiates into a specialised “appressorium” adhesion structure 
(Wright et al., 2000, Both et al., 2005). The appressorium is firmly attached to the hydrophobic 
leaf surface via extracellular adhesion molecules; long chain aldehydes and lipids derived 
from breakdown of the host waxy cuticle appear to be important for adhesion and 
appressorium formation (Feng et al., 2009, Tsuba et al., 2002). Analogously to C. albicans, 
hyphal switching is critical for the next stage of the infection cycle; host invasion. 
Early (0-11hr)                 Intermediate (12-30hr)            Maturation (31-72hr)   
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Figure 1.4: The B. graminis pathogenesis cycle. Infection is characterised by adhesion of the conidium to the 
leaf surface, active penetration following development of a specialised appressorium and hyphal peg (8-15hpi), 
and infection spread to neighbouring cells via hyphal development. Dpi and hpi stands for days and hours post 
inoculation respectively. Figure adapted from Both et al (Both et al., 2005), and electron micrographs and plant 
leaf images reproduced with permission from Prof. Pietro Spanu. 
 
Approximately 8-15 hours post infection, a hyphal peg develops from the appressorium. This 
penetrates the cuticle and host cell wall via a combination of turgor pressure and secretion of 
hydrolytic enzymes, later differentiating to form infection hyphae in the plant apoplasm. 
Upon contact with a plant cell, a specialised “haustorium” structure develops from the hyphae 
and generates additional haustorial feeding structures that invade the host cell. The structure 
remains surrounded by a host- derived extrahaustorial membrane and interfacial matrix 
(Huckelhoven and Panstruga, 2011), although this membrane differs markedly in terms of 
protein constituents from the host plasma membrane (Roberts et al., 1993). In obligate 
biotrophs, haustoria form a key interface with the host; allowing for uptake of host-nutrients 
that can be translocated to hyphae on the plant surface. Electron microscopy analysis of the 
ultrastructure of haustoria reveals a high density of vesicles in the extrahaustorial space and 
cytoplasm, as the fungus hijacks host vesicular trafficking (Giraldo and Valent, 2013). 
However, haustoria also have a critical function in delivery of soluble secreted effectors to 
the plant cell; an arsenal of proteins that manipulate host metabolism and immunity to the 
benefit of the fungus. 
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The proteins discussed in this thesis act at different stages of the fungal infection cycles, but 
are both critical to infection in the host. The Als adhesins from C. albicans, discussed in 
Section Two of this introduction, act in the initial stages of infection, mediating adhesion to 
and colonisation of the human host. BEC1054 from B. graminis, discussed in Section Three 
of this introduction, acts post host colonisation and development of the haustoria; 
manipulating the plant’s immunity to sustain biotrophic infection.  
1.2 The Als adhesins from C. albicans 
1.2.1 The Als adhesin family: adhesive virulence factors from C. albicans 
Amongst a range of C. albicans surface proteins demonstrated to mediate adherence to the 
human host are the Als (agglutinin-like sequence) family of adhesins; named for their 
sequence homology to the alpha-agglutinin mating factor protein in S. cerevisiae (Sag-1). The 
Als adhesins have multifaceted roles in C. albicans adhesion, mediating binding to a broad 
range of host cells and peptide substrates, in addition to playing a role in biofilm formation.  
The Als family of adhesins comprises 8 members, Als1-7 and Als9 (Als8 was later found to 
localise to the same gene locus as Als3) (Gaur and Klotz, 1997; Hoyer et al., 2001; Hoyer et 
al., 2008; Hoyer and Hecht, 2000; Hoyer et al., 1998; Hoyer et al., 1995; Jones et al., 2004; 
Zhao et al., 2004). Sequence variability in the two alleles encoding Als9 has also lead to 
characterisation of two different Als9 protein variants (Als9-1 and Als9-2) (Zhao et al., 
2003).  
Transcriptional upregulation of ALS gene expression in C. albicans isolated from murine 
infection models and clinical samples indicate that these proteins are critical virulence 
factors, but may have varying roles in infection. Specifically, increased levels of ALS1, 2, 3 
and 9 transcripts have been identified in vaginal, oral and invasive C. albicans disease 
isolates from clinical specimens and disease models (Cheng et al., 2005; Green et al., 2006; 
Green et al., 2005; Mochon et al., 2010). ALS5 and ALS4 expression is upregulated in oral 
candidiasis alone (Green et al., 2005). Elevated levels of ALS2 and 5 transcripts have been 
identified following infection of hepatic human cell lines (Sandovsky-Losica et al., 2006), 
and their expression is also upregulated in murine models for liver invasion (Wilson et al., 
2009). Expression of ALS6 and 7, the two most genetically divergent members of the ALS 
gene family (section1.2.5) does not appear to be associated with infection (Cheng et al., 
2005).  
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The importance of the Als proteins in infection can be correlated with their adhesive 
functionalities. Deletion of ALS genes 1, 3, 9 and 5 from C. albicans resulted in impaired 
adherence of the fungus to vascular endothelial monolayers, correlating with reduced 
endocytosis and cell damage (Gaur and Klotz, 1997; Zhao et al., 2004; Zhao et al., 2005). 
Adherence was restored following complementation of the ALS gene. Reductions in adhesion 
were most pronounced for ALS3 null cells (Zhao et al., 2005) and in a separate study, 
targeting of Als3 with polyclonal antibodies lead to a severe reduction in C. albicans 
adherence to epithelial and endothelial cell lines (Beucher et al., 2009; Brena et al., 2007; 
Coleman et al., 2009; Laforce-Nesbitt et al., 2008). Indeed, many studies have indicated that 
Als3 has the greatest contribution to infection virulence of the Als family, possibly 
correlating with the more adhesive phenotype of this protein (Hoyer et al., 1998). In murine 
candidiasis models, infection with ALS3 null mutants resulted in a reduction in mortality rate 
(Tsai et al., 2011), whilst in a separate study, infection of mice with Candida glabrata 
(lacking in Als homologues) transformed with Als3 lead to trafficking of the fungus to the 
brain and kidneys (Fu et al., 2013).  
Als3 also exhibits other functions that have not been demonstrated in other members of the 
Als family. Als3 has been implicated in scavenging of host ferritin and iron acquisition 
(Almeida et al., 2008); a metal critical to C. albicans metabolism (Almeida et al., 2008) 
(Almeida et al., 2009). Additionally, Als3 induces host cell internalisation of C. albicans via 
endocytosis to a greater extent than other members of the Als family, prompting discussion of 
Als3’s role as an invasin (Phan et al., 2005; Phan et al., 2007b; Sheppard et al., 2004). Latex 
beads coated with Als3 were endocytosed by endothelial and epithelial cells via a clathrin 
dependent pathway; followed via immunofluorescence labelling and live cell imaging (Phan 
et al., 2013; Phan et al., 2005; Phan et al., 2007b). In a separate study, ablation of Als3 in C. 
albicans resulted in a 65% reduction of internalisation rates by human epithelium relative to 
wild type cells (Wachtler et al., 2012). The authors proposed that residual uptake observed 
could be due to other Als proteins exhibiting invasin activity.  
However, the importance of Als3 in infection has been contested in recent years. Studies with 
C. albicans in two separate models of murine candidiasis argued that virulence for ALS3 null 
mutants was comparable to that of wild type cells (Cleary et al., 2011; Fu et al., 2013). The 
degree of functional degeneracy between different members of the Als family is currently 
poorly understood, and it is possible that C. albicans is able to compensate for loss of one 
adhesin via transcriptional upregulation of another. 
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Transcriptional upregulation of all of the Als genes has also been observed in C. albicans 
models of biofilm formation (Zhao et al., 2006), illustrating the roles of Als in adhering to 
fungal cells in addition to those of the host. The roles of the Als in biofilm formation will be 
discussed in section 1.2.4; also an important virulence attribute of C. albicans.  
1.2.2 Substrate specificities in the Als adhesins 
Adhesive functionality of different Als family members has primarily been characterised via 
gene knockouts in C. albicans, or expression of the proteins in heterologous systems such as 
S. cerevisiae, conferring adhesive phenotypes on a non-adhesive, non-invasive yeast. These 
assays have demonstrated that the Als adhesins have the capacity to adhere to an 
exceptionally broad range of substrates, including different human cell lines, plastics, and 
peptides. Crucially, broad binding specificity of the Als proteins correlates with the broad 
tissue tropism characteristic of C. albicans (Gaur and Klotz, 1997) and appears to be critical 
to pathogenesis.  
Human cell types that are bound by the Als include HBEC (human buccal epithelial cells), 
HUVEC (human umbilical vein epithelial cells), and RHE (reconstituted human endothelial 
cells). Adhesion to these cells is thought to be mediated by interactions with a wide range of 
extracellular proteins, such as N and E-cadherin (Als1 and 3), (Donohue et al., 2011; Phan et 
al., 2007a), the HER2 receptor (Als3) (Zhu et al., 2012), in addition to extracellular matrix 
proteins such as laminin, fibronectin, collagen, entactin, vitronectin and tenascin (Gaur and 
Klotz, 1997; Gaur, 2004; Chaffin, 2008; Williams, 2003; Shepherd et al., 2004). 
However, despite the broad binding specificity of the Als proteins, some differences are 
apparent within the family. Whilst deletion of ALS alleles resulted in reduced adherence to 
vascular endothelial monolayers for both Als1 and 3, adhesion to HBEC was reduced for 
Als3 alone (Phan et al., 2007a; Zhao et al., 2004). Analogously, Als2 and 4 have been 
implicated in binding to vascular endothelium and RHE but not HBEC (Zhao et al., 2005). 
Als9-2 and not Als9-1 has been shown to bind to HUVEC and HBEC (Zhao et al., 2007), 
whilst Als5 has been implicated in adhesion to HBEC (Gaur and Klotz, 1997). Intriguingly, 
following deletion of Als5, 6 and 7, increases in C. albicans adhesive capacity have been 
observed (Murciano et al., 2012; Zhao et al., 2004).  
To probe Als binding specificities at the protein substrate level, several studies have 
measured adherence of C. albicans and S. cerevisiae ALS transformants to PEG beads or 
ELISA (enzyme-linked immunosorbent assay) plates functionalised with proteins (Klotz et 
30 
 
al., 2004; Sheppard et al., 2004). S. cerevisiae transformants expressing Als1, 3 and 5 were 
able to bind to all protein substrates tested (gelatin, laminin, fibronectin), whilst Als6 bound 
to gelatin alone and Als9 bound minimally to laminin. Als7 did not bind to any of the 
sequences tested (Sheppard et al., 2004). Similarly, analysis of S. cerevisiae transformants 
adherence to a library of randomly generated heptapeptide sequences indicated that Als3 and 
5 bound to a wider range of sequences than Als1 (Klotz et al., 2007; Klotz et al., 2004). 
Following sequencing of 16 of the peptides bound by Als1 and 5 (selected at random); the 
authors proposed the requirement for a tripeptide motif (τφ+) for Als peptide recognition. The 
proposed motif contained an amino acid with high turn propensity (A, D, G, P, N, S) 
followed by a bulky hydrophobic or aromatic (F, Y, W, L, M, I, V), followed by a residue 
with a positively charged side chain (R or K).  
However, several caveats must be considered when analysing Als substrate binding 
specificities in a cellular context. Expression of Als proteins in S. cerevisiae does not control 
for differences in codon usage between these fungal species, potentially leading to protein 
misfolding, whilst overexpression of proteins can often disrupt the integrity of the fungal cell 
wall. Both of these factors can feasibly contribute to non-specific adherence. Equally in C. 
albicans models, it must be demonstrated that adhesive differences resulting from ablation of 
different ALS genes do not simply reflect differences in basal expression levels of the Als. 
For example, gene knock-out studies consistently suggest that Als3 contributes more to 
adhesion than other family members, but expression of this protein is usually high relative to 
other Als. This is particularly true in hyphae, which tend to adhere more strongly to host cells 
than the yeast form of C. albicans (Almeida et al., 2008). Nonetheless, the study performed 
by (Sheppard et al., 2004) effectively controlled for differences in Als expression levels, 
suggesting that differences in substrate specificities observed for Als1, 3 and 5 are genuine. 
1.2.3 Characteristics of the Als substrate adhesion mechanism 
It has been demonstrated that Als peptide interactions are highly resistant to shear forces, 
detergents, additives and sugars, and stable over a broad pH range (4-8) (Klotz et al., 2007). 
However, exposure to chaotropic agents such as formamide (at concentrations exceeding 
50%) and 6M urea disrupted binding, suggesting that hydrogen bonding is critical to the 
adhesion mechanism. Binding to polyalanine peptides and enhanced binding to substrates 
following denaturation (BSA, fibronectin and laminin) indicated that hydrogen bonds were 
primarily formed to the peptide backbone (Gaur, 2004). However, enhanced adherence of S. 
cerevisiae transformants to polyserine peptides (10mers) relative to polyalanine suggested 
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that hydrogen bonding to side chains also contributes to the stability of interaction (Gaur et 
al., 2002). The authors termed the adhesion mechanism SRS- stable, reversible and specific 
adherence. 
For Als5 expressing S. cerevisiae, flocculation of the yeast cells was also observed in a time-
dependent manner following initial adhesion of cells to PEG beads (Gaur, 2004; Gaur and 
Klotz, 1997). This could relate to the ability of Als proteins to mediate biofilm formation 
(section 1.2.4). 
1.2.4 The role of the Als adhesins in biofilm and amyloid formation 
Transcriptional upregulation of ALS adhesin genes in C. albicans biofilms relative to 
planktonic cells has been detected by (Q)RT-PCR and Northern blotting, for biofilms formed 
on both RHE and abiotic surfaces (Chandra et al., 2001; Green et al., 2004). Later studies 
explicitly identified transcripts as ALS1 (Green et al., 2004; O'Connor et al., 2005) or ALS3 
(Garcia-Sanchez et al., 2004; Nailis et al., 2009).  
ALS3 and ALS1 null C. albicans mutants exhibit deficiencies in biofilm formation (Nobile et 
al., 2008; Zhao et al., 2006), including abnormal cell morphologies and sparse deposition. 
However, only deletion of both ALS1 and 3 genes completely abolished C. albicans biofilm 
formation in an in vivo catheter model, indicative of some functional redundancy between the 
proteins (Nobile et al., 2008). Indeed, overexpression of ALS5, 6, 7 and 9 in defective ALS1 
and 3 null strains rescued biofilm formation in vitro and in vivo to varying extents, suggesting 
that despite differing ligand binding specificities, biofilm formation may be a function 
common to many Als proteins.  
Biofilm formation has been linked to the amyloid forming propensities demonstrated for 
several of the Als adhesins. Purified Als5 can aggregate to form fibrils in vitro at 
concentrations exceeding 0.5mgml-1, where fibrils enhance Congo Red (CR) fluorescence (a 
property typical to amyloid) (Otoo et al., 2008). Overexpression of ALS5 in S. cerevisiae lead 
to autoagreggation upon binding to PEG beads derivatised with fibronectin, and a 
concomitant increase in birefringence and ANS (8-anilino-1-napthalene-sulfonic acid)-
induced fluorescence; characteristics of amyloid (Rauceo et al., 2004). The latter properties 
were also observed in S. cerevisiae cells expressing Als1 (Ramsook et al., 2010).  Prior 
incubation of cells with reagents that bind amyloid such as ANS or CR prevented cell surface 
birefringence and cell-cell aggregation. AFM and fluorescence microscopy experiments 
performed with Als5 expressing S. cerevisiae and C. albicans suggested that amyloid forms 
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in response to force and propagates over the cell surface, forming regions enriched in Als or 
“nanoadhesomes” 50-100nm in area (Figure 1.5) (Alsteens et al., 2010). The authors 
proposed that the formation of such nanoadhesome domains results from a conformational 
change in the Als proteins towards a state that is more adhesion competent (for both host and 
Candida cells).  
 
 
 
 
Figure 1.5: Clustering of surface expressed Als5 and formation of “nanoadhesomes” in S. cerevisiae.  (A) 
An S. cerevisiae cell, where boxed regions correspond to areas probed by an AFM tip functionalised with an 
anti-Als5 antibody.  (B) Following ligand binding of the antibody, Als5 molecules (originally distributed across 
the cell surface) appeared to form clusters. Colours correspond to the density of Als5 (red highest-blue lowest). 
Image taken from Alsteens et al, 2010. 
1.2.5: The generic domain structure of the Als proteins 
The Als proteins share a generic domain architecture outlined in Figure 1.6. The N-terminal 
domain comprises a 17 residue secretory signal peptide sequence that is cleaved upon export 
of the protein, followed by a ~300 residue region composed of two tandem immunoglobulin 
domains (Hoyer et al., 2001; Salgado et al., 2011). The central portion of the Als protein is 
composed of a “T rich” domain of ~107 residues (enriched in threonines and highly 
conserved between different members of the Als family), followed by a variable number of 
36 residue tandem repeats. The C-terminal domain (CTD) is attached to β-1,6- glucans in the 
fungal cell wall via a modified glycosyl phosphatidyl-inositol (GPI) anchor (Loza et al., 
2004; Rauceo et al., 2006).  
The CTD and tandem repeat regions of the Als proteins are rich in N- glycosylation, as 
demonstrated by EndoH treatment of Als proteins, and O- glycosylation, evident from 
analysis of Als proteins produced by C. albicans strains defective in O-glycosylation 
(Kapteyn et al., 2000). Conversely, no glycosylation has been observed in the T domains, 
despite enrichment in threonine residues (Rauceo et al., 2006). Extensive glycosylation in C-
terminal regions of the protein is predicted to favour an extended conformation of the Als, 
allowing for correct presentation of the distal NT (Kapteyn et al., 2000). C. albicans 
A                                         B 
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containing a single Als3 allele with 12 tandem repeats were substantially more adhesive than 
cells encoding Als3 with only 9 tandem repeats (Oh et al., 2005). 
 
Figure 1.6: Schematic illustrating domain organisation in mature Als cell-wall proteins. N-terminal Ig-like 
domains (N1 and N2) are followed by a threonine-rich (“T”) region, tandem-repeat region, and CTD (C-
terminal domain). The CTD is linked to a GPI anchor (ω denotes the GPI addition site), which is cleaved in the 
fungal cell membrane and thus linked to β-1,6-glucan in the fungal cell wall. Afr (red) refers to an amyloid 
forming region. 
Adhesive functionality of the Als proteins has been localised to the NTs; both for C. albicans 
amyloid formation and binding to host cells. S.cerevisiae transformed with Als1 NT deletion 
constructs (∆29-285 and ∆218-285) show reduced adherence to epithelium relative to cells 
transformed with full length Als1 (Loza et al., 2004). Additionally, chimeric Als5 and 6 
proteins retain binding specificities of the parent NT in domain swap experiments (Sheppard 
et al., 2004). Sequence identities in the NTs of the Als range from 42.4% to 84.3%; where 
Als1 and 3 exhibit the highest sequence identity (84.3%) and Als4 and Als7 sequences are 
most divergent (42.4 % identity). The Als NTs form three clusters according to their 
sequence similarity (Figure 1.7); Als1, 3 and 5 forming group one, Als 2, 4, 6 and 9 forming 
a separate group, whilst Als7 exhibits only around 40% identity with any other family 
members. Intriguingly, sequence segregation in the Als family correlates with differences in 
substrate binding specificities observed by Sheppard et al (section 1.2.2); where proteins were 
grouped as “Als5 like” (Als1, 3 and 5) or “Als2-like” (Als 2, 4 and 9) based on similarities in 
substrates bound (Sheppard et al., 2004). This further reinforces the importance of the Als NT 
in adhesion. 
Analogously, capacity for amyloid formation correlates with a sequence IVIVATT (residues 
313 to 317) at the edge of the NT domain that is relatively conserved within the Als family, 
termed the amyloid forming region or afr (Garcia et al., 2011; Otoo et al., 2008). Peptides of 
this sequence formed a gel-like substance following in vitro stirring, formed fibres as 
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following peptide recognition, with constituent bulky residues (Y21, V19 and P29 in Als9) 
excluding the peptide from N1. C-terminal strand βG2’ associates with domain N1 (Figure 
1.8). Approximately six residues of the peptide are accommodated within the cavity. 
 
Figure 1.8: Crystal structure of the γ-fibrinogen peptide bound form of NT-Als9 and detail of the peptide 
binding cavity (pbc), solved at 1.46Å resolution. The pbc primarily localises to domain N2, coloured grey. 
The pbc is defined by secondary structural elements βA2 and βG2b (orange), the A1B1 loop (cyan) from 
domain N1 (blue) and K59 (red) from strand C1*. Residues that form contacts to the peptide (directly or via the 
cavity water network) are shown in a space-fill representation and labelled. Figure created in Pymol using PDB 
coordinates 2Y7L. 
The Als peptide interaction is predominantly mediated by hydrogen bonding between the 
peptide backbone and side chains, and Als residues from the βA2 and βG2b strands, A1B1 
loop and F2 strand. Many of these hydrogen bonds are mediated by intermediary water 
molecules, accommodated by the breadth of the cavity. Of note, the fibrinogen peptide 
carboxyl terminus is coordinated by the positive charge of Als K59 Nε3 projecting into the 
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cavity, an unprecedented feature of the interaction. This residue is universally conserved in 
the Als family, and believed to be central to peptide recognition. 
Notably, the Als9 fibrinogen complex crystal structure provides a structural basis for the 
broad binding specificity of Als so critical to C. albicans infection (Salgado et al., 2011). 
Through recognition of universal features of (protein primary structure), namely the peptide 
backbone and C-terminus, the Als proteins are able to recognise a diverse range of substrates. 
Additionally, rearrangements in the cavity water network could feasibly accommodate a 
range of different side chain sequences. 
The broad binding specificity of the Als adhesins was further highlighted by a crystal 
structure of Als9 obtained in the apo form; where C-terminal β-G2b strands from symmetry-
related Als molecules in the crystal extend into the pbc of neighbouring Als molecules 
(Figure 1.9). This causes the Als molecules to tesselate in the crystal, termed “self-
complementation”.  
Figure 1.9: Crystal 
structure of the apo form 
of NT-Als9 and symmetry 
related molecules to 
illustrate binding of free 
C-termini. (A) The C-
terminal βG2’ strand 
(yellow) coordinates K59 
(red) from a neighbouring 
molecule (Salgado et al., 
2011). (B) The interaction 
causes proteins to tessellate 
in the crystal (illustrated via 
a surface representation and 
schematic). 
1.2.7. Crystal structures from other Als proteins- sNT constructs 
NOEs observed between Als C-terminal residues and those in the pbc during calculation of 
the Als1 NMR structure (Salgado et al., 2011) suggested that self-complementation was not 
merely a crystallisation artefact, and could also occur in solution. Furthermore, the T2 
relaxation times observed for residues at the Als1 C-terminus were substantially lower than 
A                                                                      B 
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values typically observed for protein termini; which usually tumble rapidly and 
independently of the protein core due to inherent flexibility. This could further correlate with 
the presence of the C-terminus within the cavity, reducing mobility. In addition, several NT-
Als constructs appeared to be highly aggregative; most significantly Als3 (Dr. Jing Lin, PhD 
thesis). It must be noted that C-terminal complementation is a non-physiological association 
mechanism, and merely an artefact of expressing the isolated Als-NTs.  
To circumvent hypothesised C-terminal aggregation mechanisms, Dr. Lin designed a 
monomeric N-terminal Als3 construct (“short” NT-Als3 or sNT-Als3) lacking the βG2’ 
strand that facilitated crystallisation of Als3 (Figure 1.10). The crystal structure of sNT-Als3 
was solved in both an apo and heptathreonine peptide bound form at 1.75Å and 1.4Å 
resolution respectively (PDB codes 4LE8 and 4LEB). This strategy was also later applied to 
crystallisation of Als1, and a high resolution structure of sNT-Als1 in complex with 
heptathreonine (2.4Å) was solved during my PhD by a fellow PhD student in this laboratory, 
Dr. Lisa Hale.   
Figure 1.10:  Crystal structures 
of NT-Als9 (A) and sNT-Als3  in 
the apo form (B). The sNT-Als3 
construct is truncated at residue 
R302 (corresponding to K302 in 
Als9) at the edge of the βG2b 
strand (orange). sNT-Als3 thus 
lacks the βG2’ strand and afr 
region (labelled in Als9).  
 
Comparison of the sNT-
Als3, sNT-Als1 and Als9 peptide complex structures reveals that they overlay with very low 
RMSD, and that the hydrogen bonding network to the peptide backbone is highly conserved 
(Figure 1.11). Side chains T294, R296, S170 and V172 from the βG2 and βA2 strands 
(completely conserved between Als1 and Als3) form hydrogen bonds to the peptide backbone 
in an antiparallel arrangement. In Als9, bonds are contributed by T294, T296 and S170 and 
I172 from identical positions in the βG2b and βA2 strands. In all structures, the hydrogen 
bond register to the peptide is established by the salt bridge formed between K59 Nε3 of the 
C1* strand and the peptide C-terminus. Additional bonds are formed to the peptide side 
R302 
K302 
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38 
 
??????? ????? ????????? ??? ???? ??? ???????? ???? ??????? ???? ??? ??? ????? ??? ??????? ???? ???
???????????????????????? ??????????????????????????????????
?
?
?
?
?
?
?
?
?
?
?
?
?????????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????????
????????????? ????????????????????????????????????? ???????????? ??????? ?????????????????? ??? ???????????????????
??????????????????????????????????????????????????????
A)? 
 
 
 
 
 
 
 
 
 
 
 
 
B) 
39 
 
Significantly, many of these residues differ in sequence between Als family members, an 
observation that will be discussed further in Chapter 5. 
1.2.8 Remaining questions in the field 
The crystal structures of Als9 and 3 provided a basis for the broad peptide binding specificity 
characteristic of the Als proteins, but raised additional questions regarding the mechanism of 
host-cell adhesion. Prevailing models in the literature implicated the Als afr directly in 
adhesion to host cells (Chan and Lipke, 2014; Garcia et al., 2011), or suggested that afr-
mediated amyloid formation induces structural transitions in the Als to promote binding of 
host ligands (Alsteens et al., 2012). Vice versa, it has been proposed that forces induced upon 
C. albicans binding to the host cell may reveal the afr region, thus “activating” Als 
autoaggregation mechanisms. However, in the light of the Als9 and sNTAls3 crystal 
structures, it is perhaps more likely that Als mechanisms of host cell binding are distinct from 
autoaggregation, and that these properties are mediated by separate regions of the NT. 
Furthermore, although the hydrogen bonding network to the peptides in the Als1, 3 and 9 
crystal structures are relatively conserved, many of the residues within the pbc that form 
bonds to the peptide side chains differ between the proteins; specifically residues located in 
the A1B1 loop and βA2 strands. These pbc differences may form the basis for differences in 
substrate binding preferences that have been observed in the literature (see Section 1.2.2). 
1.2.9 Aims for this PhD: Als project 
1) To further investigate the peptide binding mechanism, and assess the relative 
contributions of the Als afr and pbc to Als adhesion. This involved design of 
mutations in the pbc and afr, and characterisation of the solution aggregation 
properties of the proteins. The peptide binding properties of these mutants were also 
assessed in vitro, and in vivo by collaborators.  
2) To analyse specificity differences between two clinically relevant Als family 
members, Als1 and 3. This involved design of constructs to circumvent Als 
autoagreggation and self-complementation mechanisms, and trialling different 
binding techniques to find one optimal for KD determination in these proteins. 
Following this, peptide binding was compared in Als1 and 3 via biophysical 
techniques and crystallography.  
These aims are addressed in Chapters 3, 4 and 5 of this thesis. 
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1.3 BEC1054 from B. graminis 
1.3.1 Effectors from biotrophic pathogens in targeting host immunity; 
“secretory warfare” 
Following invasion of a plant host, to establish and sustain infection many fungal plant 
pathogens deliver an arsenal of small, soluble effector proteins to the plant cell in an 
analogous fashion to bacterial pathogens (Kamoun, 2007). For obligate biotrophs such as B. 
graminis, the roles of effectors are two-fold; suppression of host immunity and re-
orchestration of the host’s metabolism to re-route essential metabolites to the fungal cell. Co-
evolution of fungal pathogens and their plant hosts has led to an effective infection “arms 
race”; where the plant host evolves cognate resistance (R) proteins to suppress effector 
function, and effectors must evolve to avoid detection by R proteins (Flor, 1971). Indeed, 
early fungal effectors were identified via their association with R proteins (Skamnioti and 
Ridout, 2005), and the roles of fungal effectors in infection are poorly understood. To date, 
only the roles of a relatively small subset of effectors from other biotrophic fungal pathogens 
have been elucidated, in part due to the difficulties in genetic manipulation of biotrophs 
(summarised in Figure 1.12). Effector function from obligate biotrophs has been investigated 
in planta using host-induced gene silencing (HIGS) (section 1.3.3), fluorescence labelling of 
effectors and localisation with fluorescence microscopy (Doehlemann et al., 2009) (Giraldo 
and Valent, 1013), or BiFC (bimolecular fluorescence complementation) assays (Lee and 
Gelvin, 2014). 
Effector function is intricately linked to the feeding-lifestyle of fungal plant pathogens (Lo 
Presti et al., 2015), and the discussion here will thus be limited to effectors from other 
biotrophic fungi (rather than necrotrophs or opportunists, Section 1.1.3).  
 
Effectors identified from all fungal pathogens may be broadly classified as apoplastic or 
cytosolic in terms of their mechanism of action. With the exception of plant cell wall 
degrading proteins required for host penetration, apoplastic effectors (acting within the 
apoplast and possibly the interfacial extrahaustorial space in B. graminis) generally have a 
role in inhibition of the plant’s basal and first line defences. PTI (or PAMP triggered 
immunity) is a central component of first line-defence; apoplastic host enzymes degrade 
invading microbial structures, and the fragments released are recognised by membrane bound 
PRR (pattern recognition receptors) analogous to TLRs in other metazoans (Lemaitre et al., 
1996). PTI signalling cascades typically lead to extensive transcriptional reprogramming in 
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the host, and rapid accumulation of antimicrobial compounds (non-proteinaceous molecules, 
enzymes that degrade pathogen structures, reactive oxygen species) (Nishimura and Dangl, 
2010). Clearly, this must be avoided for successful host colonisation. Pathogenic inhibition of 
PTI is typically two-pronged; targeting both host enzymes and PRR receptors. This is well 
illustrated in Cladosporium fulvum, a fungal pathogen of tomatoes, where effector protein 
Avr4 binds to chitin in the fungal cell wall to protect against degradation by host chitinases 
(de Jonge et al., 2010) and effector protein Ecp6 sequesters the oligosaccharides released to 
prevent their recognition by PRRs (de Jonge et al., 2010, 2013). Other examples of enzymatic 
inhibitors include Avr2 from C. fulvum and Pit-2 from U. maydis; inhibitors of apoplastic 
cysteine proteases (Rooney et al., 2005; Shabab et al., 2008). Secreted effector Pep-1 from U. 
maydis inhibits the apoplastic ROS producing enzyme Pox-12, thus directly suppressing PTI 
(Hemetsberger et al., 2012).  
 
The functions of cytosolic effectors are likely to be more diverse; targeting host metabolism 
in addition to subverting host ETI (effector triggered immunity). ETI occurs following 
intracellular recognition of pathogenic effectors, and involves production of cognate R 
proteins and transcriptional reprogramming of the host cell via production of phytohormones; 
salicylic acid being one of the best characterised in defence signalling (Glazebrook, 2005; 
Kumar et al., 2004). The U. maydis effector chorismate mutase Cmu1 is delivered into the 
plant cell to reduce chorismate levels; a precursor to the synthesis of salicylic acid in plastids 
(Djamei et al., 2011). Secretion of Cmu1 could be crucial in disrupting salicylic acid 
signalling pathways, which typically culminate in cell death (Glazebrook, 2005) (Kumar et 
al., 2004). Suppression of host cell death is likely to be a common theme amongst biotrophic 
effectors; Avr Piz-t from M. oryzae suppresses BAX-induced cell death when expressed in 
tobacco (Li et al., 2009).  
 
Cytosolic effectors from fungal pathogens are generally less well characterised than those in 
the apoplasm, and it is likely that many more diverse functions will be discovered. Effectors 
derived from bacterial plant pathogens also have identified roles in inhibiting MAPK 
cascades, inhibition of intracellular enzymes, hijacking of host vesicular trafficking, and 
reprogramming of transcription (Feng et al., 2009).  
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Figure 1.12: Overview of mechanisms of action of effectors from other biotrophic plant pathogens. Host 
plant defence mechanisms associated with PTI (PAMP triggered immunity) or ETI (effector triggered 
immunity) are summarised in blue, whilst some examples of effectors from other biotrophic fungi that have 
been identified in subversion of these mechanisms are depicted in red. 
1.3.2 Identification of novel effector proteins from the B. graminis genome: 
a highly divergent class of proteins 
The recent sequencing of several important fungal plant pathogen genomes has allowed for 
identification of effector proteins bioinformatically, thus opening up the field of fungal 
effectoromics (the study of effector function) (Dean et al., 2005; Galagan et al., 2003; Spanu 
et al., 2010). 
Sequencing of the B. graminis genome identified a collection of candidate secreted effector 
proteins, or CSEPs; proteins containing a signal peptide but lacking any transmembrane 
domain or homologues outside of Blumeria (as determined by BLAST) (Spanu et al., 2010). 
491 CSEPs have been identified to date, and RT-PCR analysis of CSEP transcripts revealed 
that ~81% of these proteins are expressed in haustoria rather than epiphytic structures 
(Pedersen et al., 2012). The number of CSEP effector genes (corresponding to ~7% of the 
genome) significantly exceeds the number of curated functional genes within the genome, 
reflecting the biotrophic lifestyle of this fungus and the importance of these proteins in 
pathogenesis (Spanu et al., 2010).  
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407 of the predicted 491 identified B. graminis CSEP genes were classified into 72 families 
according to Markov sequence clustering (MCL) (Pedersen et al., 2012). Around 50% of the 
families comprise 2-10 CSEP members, but seven families are composed of over 11 
members. CSEP sequences are highly divergent, and phylogenetic relationships between 
families are relatively poorly resolved. Whilst CSEP genes are spread throughout the 
genome, in 82% of cases members from the same gene family are clustered together 
positionally, and are flanked by regions of highly repetitive DNA or retrotransposons 
(Pedersen et al., 2012). It thus appears likely that CSEP families propagated through the 
genome via transposition, whilst gene duplication events within families and subsequent 
diversification further increased the CSEP repertoire (Spanu et al., 2010). 
Compartmentalisation of the genome in this manner allows for rapid evolution of effectors in 
the context of a slower evolving proteome and relatively slow fungal reproductive cycle. This 
is reinforced by the fact that the effectoromes of related powdery mildews Erisyphe pisi and 
Golovinomyces orontii  are highly divergent in the context of an otherwise well conserved 
genome (Max Planck Institute).  
1.3.3 Many B. graminis CSEPs exhibit RNAse folds 
The CSEPs were further classified according to predicted fold type. IntFold and InterProScan 
analysis of the B. graminis CSEPs revealed that 72 proteins distributed across 15 families 
were predicted to have an RNAse T1 or U2 type fold, despite a low degree of sequence 
similarity with the T1 RNAse family (typically ~20%) (Pedersen et al., 2012). The majority 
of RNAse type CSEPs cluster to families 2 (containing 27) and family 3 (containing 11), 
whilst the remainder are distributed across other families. The predicted size of these proteins 
varies from ~10kDa to ~20kDa. RNAse type folds are thus considerably overrepresented 
amongst CSEPs; only 4 additional non-CSEP proteins with a predicted RNAse type fold (all 
RNAses) were identified from the remainder of the B. graminis genome (Spanu et al., 2010). 
However, in all CSEPs predicted to have an RNAse type fold, the catalytic residues requisite 
for RNA hydrolysis are absent, suggesting that CSEPs may have derived from a common 
RNAse ancestor and diverged evolutionarily via gene duplication events and diversifying 
selection (Pedersen et al., 2012). 
Aside from RNAse type folds, hydrolase folds were also prevalent amongst CSEPs (many 
effectors identified from other fungal plant pathogens are metalloproteases), and nine had 
predicted coil coil domains. Again, these folds were dispersed throughout the CSEP families.  
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Sequence analysis of CSEP proteins demonstrated that the majority were enriched in amino 
acids C, F, H, I, N, S, and Y and residues typically found in loops, whilst several other amino 
acids were underrepresented (A, D, E, G, and K). Cysteines are almost universally conserved 
in families (present in even numbers) and are generally predicted to form disulphides; a 
feature common to other known fungal effectors (Stergiopoulos and de Wit, 2009). Prolines 
and glycine residues are also quite highly conserved. 63% of all CSEPs also contain a 
conserved ψxC motif at the protein N-terminus where ψ denotes an aromatic residue (YxC in 
47% of cases, 49% FxC, and 4%WxC) that is predicted to have a role in protein transport or 
host vesicular trafficking. A short sequence motif previously identified in the majority of 
oomycete effectors is predicted to have a similar function (RxLR-DEER) (Dou et al., 2008).  
 
1.3.4 Functional analysis of CSEPs identified BEC1054 as a critical effector 
Whilst bacterial plant pathogens such as P. syringae deliver around 30 soluble effectors to the 
host plant cell, the number of predicted effectors identified from fungal plant pathogen 
genomes such as B. graminis is vast. This suggests that effectors may target diverse pathways 
in the host, and equally that some functional redundancy may exist between proteins.  
Of the CSEPs identified from the B. graminis genome, 43 were also identified from a 
separate proteomic analysis of haustoria, and have been termed Blumeria effector candidates, 
or BECs (Bindschedler et al., 2011). To investigate BEC function, 50 were selected for 
analysis via host-induced genome silencing (HIGS) (Pliego et al., 2013). HIGs allows for 
genetic manipulation of obligate biotrophs, where the fungus’ dependence on the host for 
growth prevents simple genetic modification (Nowara et al., 2010; Nunes and Dean, 2012). 
Briefly, cDNAs encoding the BEC gene of interest were introduced into H. vulgare 
epidermal cells via particle bombardment, and expressed as siRNAs. Subsequent inoculation 
of the plants with B. graminis induced RNAi of the effector gene, thought to occur via 
transfer of siRNAs from the host to the pathogen. HIGS of 8 of the 50 tested BECs 
(BEC1005, BEC1054, BEC1011, BEC1038, BEC1016, BEC1019, BEC1040 and BEC1018) 
significantly reduced the haustorial index (HI) in host cells; defined as the frequency of full 
haustorial development relative to that obtained with empty controls. 
 
The most significant reduction in HI (between 40-60%) upon silencing was observed for 
BEC1011 and BEC1054 (Pliego et al., 2013). Exhibiting 75% sequence identity, both 
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BEC1054 and BEC1011 are members of CSEP family 21 (containing 5 members in total), 
and are predicted to have an RNAse type fold (Pedersen et al., 2012). 
RT-QPCR analysis of BEC1011 and BEC1054 transcripts in infected plants revealed that 
both were preferentially expressed in haustoria, with transcript levels increasing gradually 
during the early stages of infection and reaching a maximum (~60 fold relative to the zero 
time point) at 24h post inoculation (hpi) (Pliego et al., 2013). In the B. graminis infection 
cycle, this follows host penetration and precedes formation of the first mature haustoria, 
indicating that these BECs may have roles in the initial stages of infection establishment. 
Complementation of the BEC1054 cDNA silencing construct via co-bombardment of the 
plant host with a corresponding “wobble” cDNA construct did not significantly affect 
haustorial formation, confirming that gene silencing of BEC1054 had reduced HI and that 
BEC1054 is a bona fide effector in planta (Pliego et al., 2013). The protein has also been 
identified in H. vulgare leaf extracts by Western blotting following infection with B. graminis 
(Dr. Giulia Bonciani, Spanu lab). 
1.3.5 Functional analysis of BEC1054 to date 
BEC 1054 was selected for further functional analysis and localisation studies by members of 
the Spanu lab. Expression of BEC1054 as a GFP fusion in an Arabidopsis thaliana plant 
reveals that BEC1054 is distributed throughout the cytosol and nucleus of epidermal leaf 
cells as punctate dots (Helen Pennnington, Spanu lab, unpublished data).  
Experiments performed with a transgenic wheat line encoding a copy of BEC1054 have 
reinforced the importance of this effector in infection establishment, revealing a possible role 
for BEC1054 in suppression of host immunity. Transgenic plants infected with Blumeria f.sp. 
tritici were much better able to support infection than wild type plants; exhibiting increased 
HI and proliferation of the fungus on the plant (Spanu lab, unpublished data). Additionally, 
wild type host cells typically senesce as part of a hypersensitive response mounted against a 
pathogen (Bushnell, 1967), leading to breakdown of chlorophyll and eventual cell death to 
prevent infection spread. Conversely, infected transgenic BEC1054 lines exhibited a “green 
island effect” where chlorophyll is retained in infected host cells against a background of 
cellular senescence (Figure 1.13) (Spanu lab, unpublished data).  
A similar infection phenotype was also observed following expression of BEC1054 in 
Nicotiana benthamiana and infection with an unrelated oomycete, Peronospora (Spanu lab, 
unpublished data). These results strongly suggest a role for BEC1054 in suppression of a core 
pathway in the host hypersensitive response that is not restricted to the H. vulgare species. 
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Figure 1.13: Infection of wild type wheat plants and a transgenic BEC1054 line with B. graminis f.sp. 
tritici. reveals a potential role for BEC1054 in suppression of the host hypersensitive response. (A) Excised 
leaves from wild type wheat plants inoculated with B. graminis exhibit a loss of chrolophyll pigment, 
characteristic of cellular senescence. Senescence prevents sustained growth of the fungus; an obligate biotroph. 
(B) In leaves from a transgenic line containing two allelic copies of the BEC1054 gene (+/+ BEC1054) cellular 
senescence is reduced following challenge with B. graminis, resulting in a “green island” phenotype and 
increased proliferation of the fungus. This result was not observed in plants azygous for BEC1054 (-/-
BEC1054);the progeny of transgenic  lines where the transgene has been lost through segregation. 
 
To probe potential protein interactors of BEC1054, pull down assays were performed with 
recombinant his-tagged BEC1054 and plant cell lysate extracted from H. vulgare according 
to the method of Bindschedler et al. (Bindschedler et al., 2009, 2011). Following elution and 
proteolysis of putative interactors, peptides were sequenced via liquid chromatography 
tandem mass spectrometry and used as query sequences in BLAST database searches (Dr. 
Gheorghe and Helen Pennington, Spanu lab, unpublished data). A significant enrichment in 
ribosomal associated sequences was observed relative to controls, including proteins that 
localise to the 30S and 50S subunits and elongation factors (Helen Pennington, unpublished 
data). Many elongation factor sequences identified (eEF1a, eEF1g) form part of the eEF1 
complex; a eukaryotic transcription complex that delivers all aminoacyl-tRNAs (aside from 
initiator tRNAs) to the ribosomal acceptor (A) site in translational elongation (Mateyak and 
Kinzy, 2010). 
1.3.6 A hypothesised role for BEC1054 in a novel infection inhibition 
pathway 
An effective first line defence against pathogenic obligate biotrophs is initiation of a 
hypersensitive response; characterised by rapid cell death in infected regions of the plant. 
This restricts infection, but also deprives the pathogen of food sources critical to its survival. 
A 
 
 
B 
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In plants, ribosomal inactivation is a characteristic symptom of hypersensitive responses. 
Salicylic acid (SA) or jasmonic acid (JA) phytohormones are secreted in response to 
pathogens, leading to transcriptional induction of ribosome inactivating proteins (RIPs) 
(Lodge et al., 1993; Moons et al., 1997). RIPs are N-glycosidases that target the SRL (sarcin 
ricin loop), a region of the 28S RNA that is highly conserved throughout the kingdom of life, 
deadenylating conserved base A4324 (rat 28S numbering) (Endo, 1987). Deadenylation of 
A4324 renders the SRL susceptible to subsequent nucleolytic cleavage, leading to ribosomal 
dissociation and inactivation of protein synthesis (Endo, 1987). The endogenous role of the 
SRL is debated; it has been proposed to facilitate GTP hydrolysis in elongation factors eEF1 
or eEF2 positioned in the ribosomal A site during the elongation stages of translation 
(Clementi et al., 2010), or to anchor eEF2 to the ribosome (Shi, 2012). Cleavage of the SRL 
by host RIPs ultimately leads to senescence or apoptosis of the plant cell, and it has been 
proposed that RIPs function as part of a “suicide mechanism”, thus preventing infection 
spread (Ready et al, 1986).  
Pull-down assays have suggested that BEC1054 may interact with ribosomes, possibly 
localising to a region close to the ribosomal A site. Coupled with evidence for an 
immunosuppressive role for BEC1054 from HIGs analysis and infection studies in transgenic 
plants, the Spanu lab have proposed a hypothesis for BEC1054 as an inhibitor of the RIPs 
induced as part of the host hypersensitive response in infection. Specifically, it is proposed 
that BEC1054 associates with the SRL in the 28S RNA of the plant ribosome, thus 
competitively inhibiting RIP-mediated cleavage to promote host viability and sustain 
infection (Figure 1.14). To date, no pathogenic inhibitors of plant RIPs have been identified. 
 
Figure 1.14: Hypothesised RIP inhibitory 
function for B. graminis effector protein 
BEC1054. The Spanu lab have hypothesised that 
BEC1054 inhibits RIP mediated modification of 
the ribosomal SRL, leading to inhibition of 
downstream stages indicated in grey. MeJA 
denotes methyl jasmonate, a signalling molecule 
formed from jasmonic acid that has been 
demonstrated to induce expression of host RIPs 
during the hypersensitive response. 
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1.3.7 Aims for this PhD: BEC1054 project 
Structural analysis of proteins can often provide critical insights into their biological function. 
Whilst BEC1054 is predicted to adopt an RNAse type fold, it is uncertain whether this is 
merely a scaffold, or whether the protein has the ability to recognise nucleic acid (such as the 
SRL). The aims of this PhD were thus: 
1) To solve the structure of BEC1054 
2) To characterise BEC1054 by NMR and assign the backbone of the protein for 
future binding assays 
3) To perform biophysical assays testing the hypothesised function of the protein 
These aims are addressed in Chapters 6 and 7 of this thesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
49 
 
Chapter Two: Materials and Methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50 
 
???????????????????????????????????????????????
?????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
??????????? ??????????? ?????????????????? ????????????????????????????? ??????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
?????? ???? ??????? ??? ?????????? ???????? ???? ?????? ??? ???????????? ??????????? ???????????
????????? ????????? ?????? ??? ??????? ??????????????????? ??? ?? ??????? ???????? ??????? ????????
?????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????
?
??????? ????? ?????????? ??? ???? ????? ???? ??????????? ????
???????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????
??????? ???????? ???????????????????????????? ???? ???????
??? ???? ???? ???????? ?????????? ?????? ??????????? ?????
??????????? ??? ?? ????? ???? ????? ????????? ?????????? ????? ??
??????? ????????? ??? ?? ???????????? ???????? ????? ?????????
?????????? ??????????????????????? ??????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????
?
TAG             sNT-Als 
315 
TAG              NT-Als 
TAG              NT-Als                  CBD 
1 
 
 
1 
 
 
315 
299 (also 302, 300)
 
 
 
 
1 
 
 
 
TAG              - l 299 
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All constructs were either expressed as N-terminally hexahis-tagged thioredoxin fusions from 
pET32a-Xa/LIC based vectors (Novagen), or with an N-terminal his-tag from a pRSETa 
based vector (Invitrogen) modified to contain a thrombin cleavage site in place of the 
enterokinase site. These vectors are outlined schematically in figure 2.1.  
Construct Vector 
Method of 
generation 
Primers 
Prim
er 
Tm/o
C 
NT-Als31-
315 
pET32a-
Xa 
Provided Not applicable.  
NT-Als3pbc 
( K59M, 
A116V, 
Y298F) 
pET32a-
Xa 
Quikchange® 
f-GAATATGCCGTGTGTGTTCATGTTCACTACTTCTCAAACCTCTG 
r-CAGAGGTTTGAGAAGTAGTGAACATGAACACACACGGCATATTC 
f-GTACTGTCACCTTACCACTTGTTTTCAATGTAGGCGGAAC 
r-GTTCCGCCTACATTGAAAACAAGTGGTAAGGTGACAGTAC 
f-
CCTTTCACATTAAGATGGACTGGATTTAGAAATAGCGATGCTGATC 
r- 
GATCCAGCATCGCTATTTCTAAATCCAGTCCATCTTAATGTGAAAGG 
 
 
68 
68 
66 
66 
 
68 
 
68 
 
 
NT-Als3gk 
(S170Y) 
pET32a-
Xa 
Quikchange® 
f-ACTTAACTGATTATAGAGTTCATCC 
r- GGATGAACTCTATAATCAGTTAAGT 
 
51 
51 
NT-Als3afr 
(I311S, 
I313S) 
pET32a-
Xa 
Quikchange® 
f-TGGATCTAACGGTTCTGTCTCTGTTGCTTAAGGGTC 
r- GACCCTTAAGCAACAGAGACAGAACCGTTAGATCCA 
 
66 
66 
 
NT-
Als3pbcafr 
pET32a-
Xa 
Quikchange® Primers above  
sNT-Als31-
302 
pET32a-
Xa 
pET32a-
TEV 
Provided Not applicable.  
sNT-Als31-
300 
pRSETa-
thr 
Restriction 
cloning 
f-CCGTGGATCCAAGACTATCACTGGTGTTTTCAACAG 
r-ATCAAGCTTCTATCCAGTCCATCTTAATGTGAAAG 
 
65 
64 
 
sNT-Als31-
300gk 
(S170Y) 
pRSETa-
thr 
Restriction 
cloning 
f- CCGTGGATCCAAGACTATCACTGGTGTTTTCAACAG 
r- ATCAAGCTTCTATCCAGTCCATCTTAATGTGAAAG 
65 
63 
sNT-Als11-
302 
pRSETa-
thr 
Restriction 
cloning 
f- GGATCCAAGACAATCACTGGTGTTTTTGATAG 
r- AAGCTTATTCTTGTATCCAGTCCATCTTAAAG 
 
60 
60 
sNT-Als11-
300 
pRSETa-
thr 
Quikchange® 
f-CTTTAAGATGGACTGGATAGTAGAATAGTGATGC 
r-GCATCACTATTCTACTATCCAGTCCATCTTAAAG 
 
61 
61 
sNT-Als11-
299 
pRSETa-
thr 
Quikchange® 
f-CTATTCTTGTATCCCTACCATCTTAAAGTGAAAGG 
r- CCTTTCACTTTAAGATGGTAGGGATACAAGAATAG 
 
61 
61 
NT-
Als1afrS-S 
(I105C, 
V314C, afr 
mutations) 
pRSETa-
thr 
Q5 
f-GCTTTGAAGTCATCCTGTAAGGCATTTG 
r-GTCGTTCACAGTACATGTTAATGTAGAAA (I105C) 
 
f-GGTTCTGTCTCTTGTGCTTGACTCACC 
r- GTTAGATCCGGCATCACTATTCTTGTATC (V314C+ afr) 
59 
56 
 
 
60 
58 
 
NT-
Als1CBDafr 
pRSETa-
thr 
Q5 
And overlap 
f-GATCTAACGGTTCAGTCTCAGTTGCTAGC 
r-CGGCATCACTATTCTTGTATCCAAGTCCA (afr) 
f-TTATTAGGATCCAAGACCATCACTGGTGTTTTCAACAGT 
62 
61 
 
64 
52 
 
pET32a-
TEV 
extension 
PCR 
r-AATATTAAGCTTTTCATTGCAACTGCCACAAGGC 
f-CCTTTCACATTAAGGATGGACTGGATATAGGAATAGCGATGC 
r-CTATTCCTATATATCCAGTCCATCTTAATGTGAAGGTG (CBD) 
64 
67 
62 
 
NT-
Als1CBDafr 
No NTtag 
pRSETa Q5 f-AAGACAATCACTGGTGTTTTTG r-CATATGTATATCTCCTTCTTAAAG 
50 
52 
NT-
Als1CBD 
A22N 
pRSETa-
thr 
Q5 f-TGCTAACTATAACTTCAAAGGGCCAGG r-GCGTTCGACCAAGTTCAAAGGGCCAGG 
59 
63 
NT-
Als1CBD 
F23Y 
pRSETa-
thr 
Q5 f-TAATTATGCTTACAAAGGGCCA r-GCAGCGTTGGACCAAGTTAATG 
51 
55 
NT-
Als1CBD 
Y28T 
pRSETa-
thr 
Q5 f-AGGGCCAGGAACCCCCAACTTGGAATG r-TTGAAAGCATAATTAGCAGCATTGGACCCA 
62 
62 
NT-
Als1CBD 
Y168T 
pRSETa-
thr 
Q5 -TGGGTATCTTACAGCTTCCAGAGTTATGCCAAC r-GTTTGAAAAGTCTACCGTTGACCCAAG 
63 
57 
Table 2.1: Als1 and 3 constructs used in this study. Forwards and reverse primers for PCR-based 
amplification are listed with their corresponding Tms.  
The following clones of Als1 and 3 from Table 2.1 were provided by predecessors in the 
Cota lab at the outset of the study: 
NT-Als3 pET32a-Xa 
sNT-Als31-302 pET32a-TEV 
NT-Als1 pRSETa 
All other constructs listed were generated from these clones as outlined in later Sections. 
2.1.2 Mutation and truncation of Als1 and 3 NT constructs 
Site-directed mutagenesis was used to introduce mutations in the peptide binding cavity (pbc) 
and amyloid forming regions (afr) of NT-Als1 and 3, in addition to producing sNT truncated 
constructs through introduction of a premature stop codon in the DNA sequence. 
Mutagenesis was performed via polymerase chain reaction (PCR), using Quikchange II 
(Agilent) or Q5 (New England Biolabs) kits. Forward and reverse primers (listed in Table 
2.1) containing the mutation of interest were used to amplify the template plasmid under 
conditions outlined in Table 2.2. Primers were custom synthesised by Invitrogen. 
Following digestion of the Dam-methylated parental DNA with DpnI according to the 
manufacturer’s instructions, a NEB5α E.coli strain was transformed with the reaction mixture 
as outlined in Section 2.1.6.  
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Reaction component 
Final Concentration Thermocycler: 25-
30x  
5 X Q5 PCR buffer 
1 x  Denaturation 
(95oC)- 10s 
10mM dNTP mix 2mM Annealing (Primer 
Tm-5oC)- 30s 5’ Sense primer (20pM) 20μM 
3’ Anti-sense primer (20pM) 20μM Extension (72oC)- 
30s per kB  Template plasmid DNA  (12-25ng) 12-25 ng 
Q5 DNA polymerase (1U/ µl) 
0.5U Extension (72oC)- 10 
min 
Table 2.2: Standard conditions for a PCR reaction. Reactions were typically performed in 50μl volumes. 
Where an annealing temperature 5oC below the lowest primer Tm did not yield any reaction product, an 
annealing temperature 10oC below the Tm was used. DMSO was also used at a final concentration of 2% to 
improve the yield in selected reactions. 
2.1.3 Restriction based cloning of NT-Als3 pRSETa constructs 
The following Als3 constructs were cloned into pRSETa from existing pET32a vectors using 
restriction enzyme based methods; sNT-Als31-300/pRSETa-thr, sNT-Als31-300(S170Y) 
/pRSETa-thr, and NT-Als1CBD/pRSETa-thr. 
All inserts for cloning were amplified from the template using the standard PCR protocol and 
primers designed to introduce 5’ restriction recognition sites, listed in Table 2.1.  
NT-Als1CBD fusion inserts were generated via overlap extension PCR according to the 
method of Higuchi et al (Higuchi et al, 1998). Als1 and CBD sequences amplified from 
separate plasmids were designed to have around 30 base pairs of sequence complementarity 
with an annealing temperature of 60oC. These templates were allowed to prime and extend 
for 10 cycles of PCR with an annealing temperature of 55oC, before adding in the forwards 
and reverse primers highlighted in Table 2.1 and performing routine PCR. 
Following PCR, reaction products were resolved on 1% agarose gels, and inserts 
corresponding to the correct length excised and purified using a Stratagene gel extraction kit 
according to the manufacturer’s instructions.  
The purified inserts and empty pRSETa vectors were digested separately with BamHI-HF 
and HindIII-HF restriction enzymes (NEB). 1μg of vector or insert was digested in a 50μl 
reaction volume according to the manufacturer’s instructions, and purified as outlined.  
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For ligation, inserts and vectors were typically combined on a 3:1 molar ratio to yield 100ng 
of total DNA in a 20μl reaction, and incubated for 1 hour at 22oC with T4 ligase (NEB) 
according to the conditions outlined in Table 2.6.   
DH5α E. coli strains were transformed with 1μl of the cloning mixture according to Section 
2.1.6. 
Reaction component Amount for T4 ligation 
Reaction 
Insert DNA (ng) 50-100 
Vector DNA (ng) 50-100 
10x reaction buffer (μl) 2 
enzyme (U) 1  
PCR grade H2O Up to 20μl 
Table 2.3 T4 ligation reaction conditions 
2.1.4 BEC1054 constructs 
The following BEC1054 constructs were generated for this study (listed in Table 2.4):  
Construct Vector Method of 
generation 
Primers Primer 
Tms/ 
oC 
BEC10541-
97strepII∆ 
pET53 Provided Not applicable  
BEC10541-
97 
pNIC/LIC 
NTH, trx 
LIC 
cloning 
f-
TACTTCCAATCCATGGCAGCTTACTGGGACTGTGACGGTACTG 
r-
TATCCACCTTTACTGTCAGCCCTCAACAAATGTACACTTATTGC 
 
70 
 
67 
Table 2.4: BEC1054 constructs. LIC sequences and restriction enzyme recognition sites are indicated in bold.  
The full-length BEC 1054 protein sequence excluding the signal peptide (residues 1-22, 
corresponding to 1 to 97 of the mature fungal protein), was provided in a pET53 plasmid 
(Novagen) lacking the strep tag by the Spanu lab, Imperial College (Dr. Dana Gheorghe). 
The BEC1054 LIC constructs were generated in a PNIC plasmid (Oxford SGC) as outlined in 
Section 2.1.5.   
2.1.5 Ligation idependent cloning (LIC) of BEC1054 and putative protein interactors 
A BEC1054 insert for cloning was generated via PCR from the BEC1054strepII∆ vector 
using primers in Table 2.4. Primers have 5’ sequence complementarity to LIC sites in a 
pNIC-LIC plasmid system (Oxford SGC), with the reverse complement of a stop codon 
included after the LIC site of the reverse primer. Following linearization of pNIC plasmids 
with BsaI-HF restriction enzyme (NEB) and gel extraction as outlined, 20pmol of inserts and 
plasmid were treated separately with 1 unit of T4 polymerase in the presence of 2.5mM CTP 
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or GTP (final concentration) respectively to produce recessed cohesive ends. Reactions also 
contained 1mM DTT, 2μg of BSA (bovine serum albumin) and 1x T4 reaction buffer. 50-
100ng of T4-treated insert was thus combined with 50-100ng of T4-treated vector (typically 
at a 3:1 calculated molar ratio) in a 20μl reaction volume (made up with PCR grade H2O). 
Following incubation at room temperature for 10 minutes, the NEB-α E.coli strain was 
transformed with 2μl of the ligation mixture (Section 2.1.6). 
2.1.6 Transformation of E. coli strains and sequencing of clones 
A 20μl suspension of the requisite E. coli strain (Table 2.5) was incubated on ice with 1-2μl 
of plasmid (100ng/μl) for 30 minutes, and heat shocked by heating to 42oC for 45 seconds 
before returning to ice to induce uptake of the DNA. Cells were thus incubated with 150μl of 
SOC medium for one hour at 37oC with shaking prior to plating on LB agar containing the 
antibiotics necessary for selective growth (outlined in Figure 2.1). Plates were incubated at 
37oC overnight. 
For sequencing of clones, 5ml of LB containing the necessary antibiotic was inoculated with 
an individual colony and grown at 37oC for 16 hours. Plasmid DNA was extracted using a 
Qiagen QIAprep® miniprep kit according to the manufacturer’s instructions. All plasmids 
were sequenced via primer extension using T7 forward and reverse primers (Source 
Bioscience sequencing) to verify for the presence of an insert or mutations. 
E.coli strain Genotype Purpose 
NEB- α (K12) fhuA2 Δ(argF-lacZ)U169 phoA glnV44 ϕ80 Δ(lac)M15 
gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
Cloning 
BL21 (DE3) fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS  
λDE3= λ sBamHIo ∆EcoRI-B int::(lacI::PlacUV5::T7 gene1) 
i21 ∆nin5 
Cytoplasmic 
protein 
expression 
SHuffleT7 
Express (DE3) 
fhuA2 lacZ::T7 gene1 [lon] ompT ahpC gal λatt::pNEB3-r1-
cDsbC (SpecR, lacIq) ΔtrxB sulA11 R(mcr-73::miniTn10--
TetS)2 [dcm] R(zgb-210::Tn10 --TetS) endA1 Δgor ∆(mcrC-
mrr)114::IS10 
 
 
Cytoplasmic 
expression of 
proteins 
containing 
disulphides 
Table 2.5: E. coli cloning and expression strains used in this study. 
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2.2 Protein expression and purification 
2.2.1 Expression of unlabelled Als and BEC proteins  
All Als protein constructs and the BEC1054 thioredoxin fusion (BEC1054-trx-pNICLIC) were 
expressed in a SHuffle T7 Express E. coli strain (NEB) to facilitate cytoplasmic disulphide 
bond formation. (SHuffle cells are BL21 derivatives containing mutations in cytoplasmic 
thioredoxin (trxB) and glutathione reductases genes to render the cytoplasm non-reducing. In 
addition this strain contains a chromosomal copy of disulphide bond isomerase DsbC lacking 
the signal sequence to facilitate cytoplasmic disulphide formation.) The BEC1054 
pET53a_strepIIΔ construct was expressed in an E. coli BL21 strain (NEB).  
Strains were transformed with vectors as outlined in Section 2.1.6. Transformants were used 
to inoculate 10ml starter cultures of LB broth supplemented with the necessary antibiotic, and 
grown at 37oC overnight. Starter cultures were used to inoculate 1l of LB, and incubated at 
37oC with shaking until reaching an OD600 of 0.8 for SHuffle and 0.6 for BL21 strains. 
0.5mM IPTG (Melford) was subsequently added to induce protein expression, carried out 
overnight at 18.0oC. 
2.2.2 Expression of isotopically labelled NT-Als and BEC1054 for NMR 
Transformants were used to inoculate 5ml of LB starter culture, incubated at 37oC for 7 
hours. 0.5ml of this culture was thus used to inoculate 50ml of M9 minimal medium 
containing 15NH4Cl as a nitrogen source (0.7g/l, Sigma-Aldrich or Cortecnec) for single 
labelled proteins, with 13C glucose replacing 12C glucose (Sigma-Aldrich or Cortecnec) as a 
carbon source for double-labelled samples. Cultures were grown at 37oC overnight, and used 
to inoculate 1l of the same medium to achieve a starting OD600 of ~0.2 for large scale 
expression. Expression of labelled proteins was thus carried out using a protocol identical to 
that for unlabelled proteins.  
2.2.3 Expression of selenocysteine labelled BEC1054 for crystallography 
Large scale BEC1054 M9 based minimal media cultures (containing unlabelled NH4Cl) were 
prepared as outlined in Section 2.2.2, and grown until reaching an OD600 of 0.8  Prior to 
induction, 1.6 g of serine, 1 g of leucine, 0.4 g of alanine, glutamate, glutamine, arginine and 
glycine, 0.25 g of aspartate, 0.1 g of lysine, threonine, phenylalanine, asparagine, histidine, 
proline, tyrosine, methionine and tryptophan, 50 mg of isoleucine and valine and 0.1 g of Se-
cysteine were added to each litre of culture. Cultures were incubated at 37oC for 15 minutes 
before addition of IPTG and expression at 18oC as outlined for native proteins. 
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2.2.4 Optimised purification of NT-Alshis6 and NT-Alstrx fusion constructs 
All stages of the purification were carried out at 4oC unless stated otherwise. Cells were 
harvested by centrifugation at 3750xg, and each pellet obtained from 1l of culture 
resuspended in 20ml of lysis buffer (50mM sodium phosphate, 400mM NaCl, pH8.0) 
containing 5μM protease inhibitors leupeptin, aproteinin and pepstatin (SigmaAldrich). 
Bacteria were lysed using a cell disruptor (Constant Systems) at 25 kpsi, and lysates 
incubated on ice for 15minutes with DNAseI (Sigma) at 10μgml-1. Following clarification by 
centrifugation at 27,000xg for 45 minutes, supernatants were applied to Ni-NTA agarose 
resin (Qiagen, 0.5ml per litre of culture) pre-equilibrated with lysis buffer. Supernatants were 
incubated in batch with the resin on a roller for 1 hour. The resin was collected and applied to 
a column, which was washed with 400ml of lysis buffer containing 10mM imidazole to 
remove non-specifically bound proteins. His-tagged Als proteins and Als-thioredoxin fusions 
were eluted in 5 column volumes of lysis buffer containing 300mM imidazole, pH8.0.  
The eluates of Als proteins expressed as thioredoxin fusions were dialysed overnight into 
factor Xa cleavage buffer (50mM Tris, 100mM NaCl, pH 8.0) for trx-fXa-Als constructs, or 
TEV cleavage buffer (50mM Tris, 150mM NaCl, 0.5mM EDTA, pH 8.0) for trx-TEV-Als 
constructs. To cleave the Thioredoxin tag, Factor Xa (Novagen) was added at a concentration 
of 1U per 30μg of Als protein, whist TEV was added at a ratio of 1μg to 25μg of Als. The 
amount of Als protein present was estimated according to a Bradford assay (Section 2.2.6), 
and percentage purity of the sample estimated using an SDS-PAGE gel. Cleavage reactions 
were performed at room temperature on a roller for 16 hours. Cleaved samples were applied 
to a Ni-NTA column and eluted in 15ml of 50mM Tris, 300mM NaCl, pH8.0 whilst the 
histidine-thioredoxin tag was retained by the resin. 
All cleaved NT-Als proteins and his-tagged NT-Als proteins expressed from pRSETa vectors 
were subjected to size exclusion chromatography. Samples were filtered and concentrated to 
2ml using centrifugal concentrators with a 10kDa MW cut off (Sartorius). Samples were 
applied to a HiLoad Superdex 75 16/60 column (GE Healthcare) pre-equilibrated with gel-
filtration buffer (50mM sodium phosphate, 150mM NaCl, pH 6.0), and eluted at a flow rate 
of 1mlmin-1 using an ӒKTA FPLC machine (GE Healthcare). SDS-PAGE was used to assess 
the purity and Als protein content of fractions. 
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2.2.5 Purification of his-tagged sNT-Als constructs using a urea gradient 
Cell harvesting, lysis and lysate clarification were performed as outlined in Section 2.2.4. 
However, post centrifugation, lysates were loaded onto a 5ml HisTrap FF column (GE 
Healthcare) using an ӒKTA FPLC machine (GE Healthcare). The column was washed with 
lysis buffer containing 10mM imidazole until flow through UV absorption stabilised, and 
then with a 0-4M urea gradient over a volume of 20ml to remove anything bound non-
specifically within the peptide binding cavity. sNT-Als3 was eluted with 300mM imidazole, 
dialysed into gel-filtration buffer overnight to remove urea and imidazole, and gel-filtration 
was performed as outlined. 
2.2.6 Purification of natively expressed BEC1054-thioredoxin constructs 
Cells were harvested by centrifugation at 3000xg, and cell pellets resuspended in 50mM Tris, 
300mM NaCl, pH8.0 containing protease inhibitors as outlined in Section 2.2.4 (20ml lysis 
buffer per pellet from 1l of culture). Cell lysis, DNAseI incubation and centrifugal removal of 
cell debris was performed as described in Section 2.2.4 Following incubation of Ni-NTA 
resin (Qiagen) with supernatants in batch, resin was washed with 15 column volumes of lysis 
buffer containing 10mM imidazole, and protein eluted in 10ml of lysis buffer containing 
300mM imidazole. Eluates were dialysed into TEV cleavage buffer overnight, and TEV 
cleavage performed with 1μg of TEV to 50μg of BEC-trx fusion as outlined in 2.2.4. 
Following filtration of the digested sample and application to a Ni-NTA column pre-
equilibrated with lysis buffer, the cleaved BEC protein was collected from the flow through 
and concentrated to 2ml for gel-filtration using centrifugal concentrators (Sartorius) with a 
5kDa MW cut off. Gel filtration was performed as outlined in 2.2.4 but using 20mM Tris, 
150mM NaCl, pH 7.0 as a buffer. 
2.2.7 Purification and refolding of BEC1054 NTH  
BL21(DE3) pellets harvested by centrifugation were resuspended in 30ml (per pellet from 1l 
of culture) of 20mM Tris buffer pH 7.9, 300mM NaCl, 0.1% Tween-20 supplemented with a 
Complete® protease cocktail inhibitor Tablet (Roche). Cells were lysed by sonication 
(Sonoplus, Bandelin) for 5 minutes at 40% amplitude. Following incubation with DNAseI on 
ice (10mgml-1, Sigma Aldrich), lysates were centrifuged at 16,000g for 30 minutes. 
Supernatants were discarded, and the pellets were resuspended in lysis buffer containing 
8.0M urea with stirring at room temperature overnight.  
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Denatured samples were refolded by progressive dialysis into Tris buffer (pH 8.0) containing 
decreasing concentrations of urea (6M, 4M, 2M, 1M, 0.5M, 0.25M, 0M) for 12 hours at each 
concentration. At concentrations below 4M, dialysis was performed at 4oC.  
Following refolding, samples were filtered and applied to a 5ml HisTrap FF column (GE 
Healthcare) pre-equilibrated with lysis buffer at a flow rate of 1mlmin-1 using an ӒKTA 
FPLC machine (GE Healthcare). The column was washed with lysis buffer containing 20mM 
imidazole until UV baselines stabilised, and the BEC1054 was subsequently eluted using an 
imidazole gradient (0-600mM imidazole over a 15ml volume). Fractions that contained the 
BEC1054 protein as assessed by SDS-PAGE were pooled and concentrated for gel filtration. 
Gel filtration was performed as outlined for BEC-trx in Section 2.2.5. 
2.2.7 Estimation of protein concentrations 
Protein concentrations for enzymatic digests during the purification process were estimated 
using a Bradford assay. Briefly, 100μl of sample was added to 1ml of Bradford Coomassie 
reagent (Bio-Rad), and incubated at room temperature for 5 minutes. Absorption at 595nm 
was subsequently measured relative to a blank sample containing 100μl of buffer. Protein 
concentration was estimated from a standard curve prepared using different concentrations of 
bovine serum albumin (BSA, Bio-Rad), according to the manufacturer’s instructions. 
Concentrations of purified protein samples for biophysical assays were calculated using the 
Beer-Lambert law from A280 values obtained spectrophotometrically with a NanoDrop1000 
device (NanoDrop). Protein absorption coefficients at this wavelength were calculated using 
the online prediction tool “Protparam” (http://www.scripps.edu/~cdputnam/protcalc.html) 
according to the method of Gill and von Hippel (Gill and Vonhippel, 1989). 
2.3 Crystallography 
2.3.1 Als and BEC1054 Crystallisation  
Purified sNT-Als3 and sNT-Als1 proteins were dialysed into 10mM sodium phosphate, 
150mM NaCl, pH 6.0, concentrated to 10mgml-1 and incubated with peptides at a 10-25x 
molar ratio for co-crystallisation. Crystal screens were set up using a Mosquito robot (TTP 
LabTech), where complexes were combined with mother liquor on a 1:1 ratio in sitting drops 
with a total volume of 100-200nl. Screens were designed around crystallisation conditions 
previously identified for sNTAls1 and sNTAls3 peptide complexes (Dr. Hale and Dr. Lin). 
To improve sNT-Als3 peptide crystal quality, samples were buffer exchanged into 100% 
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2H2O as described previously (Dr. Lin, PhD thesis) yielding a final concentration of 50% 
2H2O in the crystallisation drop. 
Purified BEC1054 was dialysed into crystallisation buffer (10mM Tris, 150mM NaCl, pH 
7.0) and concentrated to 10mgml-1 for broad screen crystallisation trials (Hampton Research). 
Sitting drops containing a 1:1 ratio of protein and mother liquor in a total volume of 200nl 
were set up to encourage crystallisation via vapour diffusion in 96 well MRC plates 
(Molecular Dimensions). 
Conditions yielding crystals were optimised in manual screens in 96 well MRC plates. 
Additive screens (Hampton Research) were also used in an attempt to improve crystals 
obtained for refolded BEC1054; combined with protein and mother liquor in 100nl drops on a 
0.1:1:1 ratio additive: protein: mother liquor.  
2.3.2 Diffraction data collection and processing 
Crystals harvested for data collection were transferred to mother liquor containing 30% 
glycerol, and flash frozen in liquid nitrogen. Native data was collected at 100K using I04 and 
I04-1 Beamlines (DIAMOND, Oxford), typically with 0.1o oscillations and 200o rotation of 
the crystal. Data collection parameters including detector type, beam transmission and 
wavelength are provided in Tables in the main text.  
For halide- single wavelength anomalous diffraction (SAD) phasing (Dauter et al., 1999), 
BEC1054 crystals were soaked in mother liquor containing sodium iodide at a final 
concentration of 0.25M-1M, for a period of 10s to 1 minute prior to flash freezing. Data was 
collected using the I04 beamline (DIAMOND, Oxford), at a wavelength of 0.95Å (the 
bromide K-edge as determined by a fluorescence scan).  
Initial data processing, scaling and structure factor calculation were performed using XDS 
(Kabsch, 2010), SCALA (Evans, 2006) and TRUNCATE (French and Wilson, 1978) 
respectively, from within the XIA2 program (Winter, 2010).  
2.3.3 Phasing with Molecular Replacement and Single Wavelength Anomalous 
Dispersion (SAD) 
BEC1054 datasets from iodide soaked crystals were phased via SAD using programs from 
within the autoSHARP pipeline (Global Phasing Ltd.). The iodide ion substructure was 
solved using SHELXC/D (Sheldrick, 2008) and positions refined iteratively along with 
61 
 
calculated phases and map coefficients until convergence. Solvent-flipping and density 
modification procedures were performed using SOLOMON (Abrahams and Leslie, 1996) 
Phasing of sNT-Als3 peptide complexes was performed via molecular replacement in Phaser 
MR (McCoy et al., 2007), using apo sNT-Als3 (PDB code 4LE8.0) and apo sNT-Als1 
(unpublished) as search models.  Molecular replacement of BEC1054 native datasets was 
performed using the refined PDB model from SAD phased dataset as a search model.   
2.3.4 Model building, refinement and validation 
Iterative cycles of model building and refinement were performed with Coot (Emsley et al., 
2010), and Refmac5 (Murshudov et al., 1997) respectively. Refinement was performed until 
convergenece of Rwork values, with 5% of the reflections excluded for cross-validation. PDB-
REDO (Joosten et al., 2014) was used to perform a Hamilton R- ratio test to determine 
whether sufficient data were present for anisotropic B factor refinement. Model validation 
was performed using tools in Procheck (Laskowski et al., 1993b), SfCheck (Vagin et al, 
1999) and Molprobity (Chen et al., 2010). 
2.4 NMR experiments 
2.4.1 NMR Spectrometer and protein sample preparation details 
All NMR experiments were recorded using Bruker 600MHz AvanceIII and Bruker 800MHz 
AvanceII spectrometers equipped with TCI cryoprobes (Cross Faculty Centre for NMR, 
Imperial College London). Typical buffers and protein concentrations used for NMR 
experiments with Als and BEC1054 protein samples are outlined in Table 2.6. 10% 2H2O v/v 
was added to each sample to provide a deuterium lock signal for experiments. Sample tubes 
used included standard 5mm tubes (Norrell), 5mm microscale tubes (Shigemi) and 2mm 
tubes (Sigma) for 500μl, 300μl and 190μl sample volumes respectively. Data were processed 
using NMR-Pipe (Delaglio et al., 1995), and analysed in CCPN analysis (Vranken et al., 
2005) or using an in-house version of NMRView (One Moon Scientific) (Marchant et al., 
2008).  
2.4.2 1D proton NMR 
1D 1H NMR experiments were recorded using a Hahn-Echo pulse sequence (Hahn, 1950), 
with Shaka excitation sculpting (Shaka and Hwang, 1995) for water suppression. Spectra 
were acquired with 128 scans. 
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2.4.3 2D 1H15N NMR experiments 
2D 1H15N NMR experiments were recorded using an HSQC pulse sequence (Kay et al., 1992, 
1994) at 600MHz for BEC1054 protein samples, or with a TROSY-HSQC pulse sequence 
(Pervushin et al., 1997) at 800MHz for Als protein samples. 
For protein-observed ligand binding experiments, chemical shift perturbations (CSPs) in 
HSQC or TROSY-HSQC spectra were monitored following titration of the protein with a 
ligand. Sample pH was checked to ensure that this remained stable during the experiment. 
Where estimates of dissociation constants for interactions were available from other 
techniques, Equation 2.7 in Appendix 1 was used to calculate the number of molar 
equivalents of ligand required to reach maximal saturation and obtain at least 8.0 data points 
in the titration series. 
2.4.4 BEC1054 backbone assignment 
The chemical shifts of the Cα, Cβ, HN, and CO atoms of the 13C1H15N labelled BEC1054 
protein were obtained from HNCACB/CBCA(CO)NH and HNCO/HN(CA) CO experiments 
using standard methods. Sample conditions and experimental parameters used for recording 
the spectra are outlined in Table 2.6. 
2.4.5 Relaxation experiments 
BEC1054 T2 relaxation times were estimated from CPMG-HSQC experiments (Carr and 
Purcell, 1954), recorded according to conditions outlined in Table 2.6. T2 values were 
calculated in CCPN Analysis, and compared for BEC1054 alone and BEC1054 in the 
presence of wheat polysomes. 
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Experiment Sample Buffer Temperature 
(K) 
Number of points 
in F1, F2 (F3) 
Spectral 
width in 
F1, F2 (F3) 
(Hz) 
Spectrometer 
frequency (MHz) 
Other-  
1H15N TROSY 
(structural characterisation and 
heptathreonine titrations) 
Als1CBD 
sNTAls1 
sNTAls3 
(15N labelled) 
50mM sodium 
phosphate, 
150mM NaCl, pH 
6.0 
308 256 
2048 
6793 
1946 
800  
1H15N TROSY 
 
NT-Als3 and NT-Als3 
mutants 
(15N labelled) 
50mM Tris-HCl, 
150mM NaCl, pH 
8.0 
308 1024 
1024 
5000 
2666 
800  
1H15N HSQC* 
 
BEC1054 
(15N labelled) 
50mM Tris-HCl, 
150mM NaCl, pH 
7.4 
308 513 
513 
3750 
2067 
600  
HNCACB BEC1054 
(15N13C labelled) 
 
50mM Tris-HCl, 
150mM NaCl, pH 
7.4 
308 386, 256, 256 2945, 
1946, 1057 
600 
 
 
CBCA(CO)NH 386, 256, 256 2945, 
1946, 1057 
 
HNCO 386, 256, 256 1470, 
1946, 1057 
 
HN(CA)CO 386, 256, 256 1470, 
1946, 1057 
 
1H15N HSQC 
(ribosome binding titration) 
BEC1054 
(15N labelled) 
40mM Tris-HCl, 
200mM KCl, 
30mM MgCl2, 
5mM EGTA, pH 
8.0 
298 513 
513 
3750 
2067 
600  
1H15N HSQC 
(with CPMG pulse sequence for 
measuring T2) 
BEC1054 
(15N labelled) 
40mM Tris-HCl, 
200mM KCl, 
30mM MgCl2, 
5mM EGTA, pH 
8.0 
298 513 
513 
4808 
2067 
600 CPMG delay 
times: 
0ms, 20ms, 
30ms, 40ms, 
65ms, 100ms 
*During initial NMR-based structural characterisation of BEC1054, several buffers were trialled across a pH range, in addition to a range of temperatures at both 600 and 
800MHz. Optimal conditions identified are shown here.           Table 2.6: NMR experimental parameters and sample conditions.
64 
 
 
 
2.5 Biophysical techniques 
2.5.1 Differential Scanning Fluorimetry (DSF) 
Protein thermal stability assays were performed using DSF. 2μM Als samples (50mM sodium 
phosphate, 150mM NaCl, pH 8.0) were combined with Sypro Orange (Sigma) at a 500 fold 
dilution in 20μl volumes in a 96 well real-time PCR plate (Eppendorf). Dye fluorescence was 
monitored over a temperature range of 20-95oC with a Mastercycler ep realplex real-time 
PCR instrument (Eppendorf). Melting curves were analysed in a customised Excel 
Spreadsheet (Microsoft Excel) for extraction of Tms.  
For ligand binding assays, peptide was added to the wells at a final concentration of 2mM, 
and melting curves were compared to that of the apo protein. All readings were performed in 
triplicate. 
2.5.2 Size-exclusion chromatography with multi-angle laser scattering (SEC-MALS) 
Solution-based molecular mass analyses of NT-Als constructs were performed via SEC-
MALS. 50μl samples were injected onto an S75 10/300 analytical column (GE Healthcare) 
(pre-equilibrated in 50mM sodium phosphate buffer, 150mM NaCl, pH 6.0) at protein 
concentrations ranging from 1mM to 10μM. Separations were performed at a flow rate of 
0.5mlmin-1 using a 1260 Infinity HPLC system with UV detector (Agilent Technologies). 
On-line light scattering and refractive index measurements were recorded using miniDAWN 
Heleos (Wyatt Technologies) and Optilab T-rex (Wyatt) detectors respectively, using a laser 
emitting at 690nm. UV measurements were recorded at 280 and 320nm. Molecular masses 
were calculated from refractive index and light scattering measurements using ASTRA 
software (Wyatt Technologies).  
2.5.3 Isothermal titration calorimetry (ITC) 
ITC experiments were performed using a VP-ITC calorimeter (Microcal) at 300K. 
Polythreonine peptide was titrated in 10μl volumes into cells containing 100μM Als protein 
until binding reached apparent saturation. Experiments were performed in 50mM sodium 
phosphate, 150mM NaCl, pH 6.0; freeze-dried peptides were dissolved in protein dialysis 
buffer to avoid buffer mismatch. Blank experiments where peptide was titrated into buffer 
solution were subtracted from the data. Data were analysed using MicroCal Origin software. 
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2.5.4 Microscale Thermophoresis (MST) 
For Als peptide titrations, peptides conjugated to an N-terminal carboxyfluorescein label 
were obtained from collaborators (Dr. Soo-Mei Chee, Tate lab Imperial College). 50nM 
peptides were titrated with Als proteins in a 1:1 dilution series from a protein starting 
concentration 20x the estimated interaction KD. Assays were performed in MST optimised 
buffer (20mM Tris pH 7.4, 150mM NaCl, 10mM MgCl2, 0.05% Tween).  
BEC protein was labelled using the Monolith NT.115 protein labelling kit (NanoTemper 
technologies, Germany) using red fluorescent dye NT-647 NHS (amine-reactive) according 
to the manufacturer’s instructions.  Excess labelling reagent was removed using a PD-10 
column (GE Healthcare). 100nM BEC protein was titrated against polysomes in a 1:1 dilution 
series from a starting concentration of 15mgml-1, or with nucleic acids at a starting 
concentration of 2-10mM. Additionally, unlabelled BEC protein was titrated with a DNA 
oligonucleotide conjugated to Cy®-5 at the 5’ end of the molecule (Integrated DNA 
Technologies). Nucleic acid binding assays were performed in MST optimised buffer.  
Assays were performed using a Monolith NT.115 MST machine (Nanotemper Technologies), 
in standard or hydrophilic capillaries. LED power was maintained at 20% to yield 200-1000 
fluorescence counts and minimise fluorescence bleaching, and laser power varied between 
20-50%. Where possible, binding assays were performed in triplicate at minimum. Curve 
fitting was performed using the NTAnalysis software (Nanotemper Technologies) in the 
Thermophoresis + T-Jump mode, and KD values calculated using non-linear regression.  
2.6 Ribosome techniques 
2.6.1 Polysome extractions 
Polysomes were extracted from 50g of four day old barley germlings (Levington F2+S) of 
the Hordeum vulgare Golden promise variety, according to a protocol adapted from Hari et 
al., 1980. Seedlings were homogenised in 200 mM Tris-HCI (pH 9.0) containing 35 mM 
MgCl2, 400 mM KCl, 200 mM sucrose, 25mM EGTA, 10mM β-mercaptoehtanol and 0.5% 
NP-40 (6ml per gram of seedlings). Lysates were filtered through Miracloth (CalBiochem) 
prior to centrifugation at 27,000xg (4oC) to remove cell debris. All subsequent stages were 
performed at 4oC. Clarified supernatants were layered onto a sucrose cushion (40mM Tris-
HCl pH 9.0, 200mM KCl, 1.75M sucrose, 30mM MgCl2, 5mM EGTA, ~8.0ml of lysate per 
2ml cushion) and subjected to ultracentrifugation using an SW-41Ti rotor (Beckmann 
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Coulter) at 28.0krpm (~13,400xg) for 2 hours. Following draining of the solutions, pellets 
were gently resuspended and ‘washed’ in ribosome storage buffer (40mM Tris-HCl, 200mM 
KCl, 30mM MgCl2, 5mM EGTA) via centrifugation at 27,000xg. Ribosome aliquots were 
flash frozen and stored at -80oC.  
2.6.2 BEC1054 polysome pull-downs 
Polysomes were incubated with recombinant BEC1054 at an estimated 10 molar excess at 
4oC for 1 hour, and then subjected to centrifugation through a sucrose cushion as outlined in 
Section 2.7.1. Samples from sucrose centrifugation were resolved on a 12% acrylamide gel 
via electrophoresis, and transferred to a nitrocellulose membrane through semi-dry blotting 
(30V for 1 hour, according to the manufacturer’s instructions). Following blotting, the 
membrane was blocked using a 5% milk solution in TBST-T (50mM Tris, 100mM NaCl, 
0.05% Tween, pH 7.4) for 1 hour at room temperature. Membranes were thus washed with 
TBST-T 4 times for 15 minutes prior to overnight incubation with a primary anti-BEC1054 
rabbit polyclonal antibody (produced by CovaLabs UK) in TBST containing 2% milk. 
Following an additional 4 x 15 minute washes of the membrane, an anti-rabbit secondary 
antibody conjugated to horse-radish peroxidase was applied to the membrane for 1 hour in 
TBST. Final washing of the membrane preceded incubation with chromogenic substrate 
(ThermoFisher Scientific, category number 34840), and development for 10 minutes 
according to the manufacturer’s instructions. Chemi-luminescence of blots was observed 
using a LAS3000 luminescent analyser (Fujifilm). 
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Chapter Three: Dissecting adhesion and 
aggregation mechanisms in NT-Als1 and NT-
Als3 
 
Chapter summary 
Previous crystal structures of sNT-Als3 and NT-Als9 (Salgado et al, 2011) revealed a role for 
the peptide binding cavity (pbc) of the Als proteins in recognition of peptide ligands. 
Additionally, the involvement of the Als N-termini in C. albicans cellular aggregation has 
been documented (Otoo et al, 2008, Alsteens et al., 2011). However, it was unclear whether 
these binding mechanisms were linked, and whether pbc binding was the primary mechanism 
of host-cell recognition in C. albicans infection.  
To test these hypotheses, mutants were designed in the pbc and proposed amyloid forming 
region (afr) of NT-Als3; the Als family member demonstrated to contribute most 
significantly to host adhesion and virulence. NMR experiments used to assess the aggregative 
properties of these mutants suggested that the pbc and afr have separate roles in adhesion. 
Mutation of the pbc alone abolished Als peptide binding in vitro, whilst afr mutants remained 
competent for ligand recognition; supporting the distinct functionalities of these regions. 
These mutations were incorporated into full length Als3 expressed at the surface of C. 
albicans in an Als deletion mutant by collaborators (Oh and Hoyer, University of Illinois at 
Urbana- Champaign). Crucially, for C. albicans expressing Als3-pbc mutants, binding to 
freshly collected or cultured human cells was comparable to that of ALS3Δ/ ALS3Δ cells. 
Conversely, mutation of the afr did not impair host cell adhesion, but reduced the aggregative 
phenotype of C. albicans. Together, in vitro and in vivo results have confirmed that the pbc is 
critical to host binding, whilst the afr may have a role in Als-mediated autoaggregation of C. 
albicans. 
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3.1 Background  
Whilst the adhesive functionality of Als proteins has been localised to their NTDs, molecular 
mechanisms underlying adhesion were a subject of debate in the literature at the outset of this 
thesis. The crystal structures of NT-Als9 (Salgado et al., 2011) and sNT-Als3 in complex 
with peptides demonstrated a clear role for the pbc of the Als in ligand binding. However, it 
was debated whether this mechanism was also the primary means of binding to host cells. 
Specifically, early models have proposed that the afr identified in the Als NT (Otoo et al., 
2008) has a role in ligand binding; directly (Frank et al., 2010), or through inducing 
conformational changes in the Als to a more adhesive state (Chan and Lipke, 2014). This 
raised several important questions: are pbc and afr adhesion mechanisms distinct? Are 
external stimuli/mechanical shear forces required for exposure of cryptic afr domains for 
amyloid formation? And importantly, does the afr have a role in ligand binding?  
We sought to address these questions through mutagenesis of the pbc and afr regions, and 
characterisation of protein binding and aggregation properties in vitro and at the C. albicans 
cell surface. For in vitro assays, the properties of these mutants will be compared with NT-
Als3 and truncated sNT-Als3; constructs that had been previously characterised by Dr. Lin 
(Cota lab). 
3.2 Production of Als3 constructs 
All NT-Als3 constructs described in this chapter were expressed from a pET32a vector with a 
thioredoxin tag in NEB SHuffle® T7 Express E.coli to permit disulphide formation within 
the bacterial cytoplasm. Proteins were purified according to a protocol established in the Cota 
lab (Dr. Robert Yan and Dr. Jing Lin, outlined in chapter 2.2.4). Briefly, following nickel 
affinity purification, the thioredoxin tag was cleaved from the Als with factor Xa protease, 
and removed using a second nickel column prior to size exclusion chromatography of the 
sample. Yields were typically low due to inefficient cleavage of factor Xa; 6 mg of NT-Als3 
were obtained per litre of LB, and 3 mg per litre of M9 minimal media. However, yields and 
purity of samples were deemed sufficient for performing NMR experiments (Figure 3.1). 
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 Figure 3.1 Example SDS-PAGE gel of the different stages in purification of an NT-Als3 construct from a 
pET32a vector. The fusion protein, corresponding to a molecular weight of 49kDa (34+15) is highlighted 
(black arrow), in addition to NT-Als3 (red arrow), corresponding to a molecular weight of 34kDa following 
cleavage and removal of the Thioredoxin tag via factor Xa digestion. 
3.3 Dissecting functions of the pbc and afr through mutagenesis 
As it has been hypothesised that both the pbc and afr of Als contribute to adhesion, non-
functional mutants were generated in each of these regions to assess their separate 
contributions to adhesion. 
Two separate mutants were designed to ablate pbc activity; NT-Als3pbc, containing three 
mutations at the core of the pbc, and NT-Als3gk (gatekeeper), containing a single mutation 
closer to the entrance of the cavity (Figure 3.2).  
NT-Als3pbc was designed with the aim of disrupting the salt-bridge formed between free 
peptide C-termini and K59; a residue that is universally conserved in the Als family. 
Preliminary studies in Als9 (Master’s thesis) had demonstrated that mutation of this residue 
alone induced significant destabilisation or unfolding of the protein, despite selection of 
methionine as a structural analogue. Yields for K59M mutants were poor, and resultant 1D 
spectra indicated that samples may have been unfolded (Salgado et al, 2011). However, 
protein stability could be rescued through introduction of two neighbouring complementary 
hydrophobic mutations; T116 to valine and Y297 to phenylalanine on neighbouring beta 
strands E1 and G2b, possibly through creating a stabilising hydrophobic patch at the N1 N2 
domain interface. Due to the high sequence identity between the N-termini of Als9 and Als3 
1    2    3   4    5    6    7    8   9  10   M 
212 
158 
97.2 
66.4 
42.7 
34.6 
27 
20 
14.3 
6 
1. Cells post- induction 
2. Cells post-induction 
3. Cell lysate (40ml) 
4. Supernatant post- centrifugation 
(40ml) 
5. Ni-NTA flow through (40ml) 
6. Ni-NTA wash (40ml, 10mM imid.) 
7. Ni-NTA eluate (5ml, 300mM imid.) 
8. Post fXa digest (5ml) 
9. Ni-NTA flow through (S75 load) 
10. Ni-NTA eluate 
M NEB Broad range marker  
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(68%), analogous mutations were generated in NT-Als3 (K59M, A116V, Y298F) to generate 
NT-Als3pbc at the start of this project. Residues A116 and Y298 form direct contacts to 
polyT in the wild type sNTAls3 crystal complex. 
 
Figure 3.2 Mutations designed in the pbc of NT-Als3. (A) The crystal structure of NT-Als3pbc (PDB 
coordinates 4LEE), with mutated residues Y298F, A116V and K59M labelled. (B) The wild-type apo sNTAls3 
structure (PDB coordinates 4LEY). Both crystal structures were solved by Dr.Lin. (C) A model for the NT-
Als3gk mutant (containing an S170Y mutation), generated from the wild type structure using Coot and pymol. 
For each mutant, details of the the pbc are also shown as sticks (above) or as a surface (below), demonstrating 
that the S170Y mutation occludes the cavity, whilst the Y298F, A116V and K59M mutations  form a 
hydrophobic bulk at the base of the cavity. βA2 and βG2b and βG2’ strands are orange, whilst domain N1 is 
yellow and the A1B1 loop is cyan. 
The NT-Als3gk mutant targeted S170, a residue in the βA2 strand that defines the entrance of 
the pbc and forms direct contacts with the peptide backbone in the sNT-Als3 polyT complex 
crystal structure. Whilst the Als3-pbc mutations form a hydrophobic patch at the base of the 
cavity to prevent peptide binding via C-terminal coordination of K59, proximity of S170 to 
the mouth of the cavity suggested that mutation to a bulkier aromatic sidechain could 
sterically exclude peptide entry, thus serving as a form of “gatekeeper” mutation. 
A                                                                                                                C 
B 
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Figure 3.3: Mutation of two residues in the afr region of NT-Als3 is predicted to reduce propensity for 
amyloid formation. (A) Propensity for amyloidogenesis in NT-Als3, as predicted by TANGO (Escamilla et al, 
2004). (B) The program was used to guide design of the NT-Als3afr mutant, where amyloidogenic potential of 
the afr (boxed and shown in detail in C) is predicted to be ablated following mutation of I311 and I313 to 
serines. Other regions in the Als sequence predicted to have high amyloid forming propensity are located within 
the Als fold and are not exposed. (D) Detail of the afr from the NT-Als9 structure.  
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A V325N mutation in peptide sequences derived from the C-terminal strand of Als5 (Otoo et 
al., 2008) had previously been demonstrated to abolish amyloid formation, in addition to 
reducing “nanoadhesomes” formation at the cell surface in response to shear forces (Alsteens 
et al., 2010; Garcia et al., 2011). Analogously, structurally conserved isoleucine to serine 
mutations (I311S and I313S) were designed in the afr of NT-Als3 to abolish afr function 
(Figure 3.3). Mutant design was guided by TANGO (Fernandez-Escamilla et al., 2004), a 
software that predicts propensity for amyloid formation on a sequence basis. The program 
predicted that the mutation should reduce the propensity score for amyloid formation from 
~90 to 0 (sequences with values exceeding 20% are predicted to form amyloid if exposed).  
3.4 The pbc and afr have distinct roles in binding 
Previously, it had been demonstrated that truncation of the βG2’ strand in Als3 substantially 
improved the aggregation properties of this protein (Dr. Lin, Cota lab), hypothesised to be 
due to removal of the afr, and reduced C-terminal complementation.  
Mutation of the pbc (via the gatekeeper or hydrophobic mutation) or the afr also appeared to 
substantially improve the solution properties of NT-Als3 (Figure 3.4). The SEC (size 
exclusion chromatography) elution profile for NT-Als3 is broad, suggesting that the peak 
corresponds to a range of species with differing molecular weights, whilst peak elution at a 
volume close to the column’s void is indicative of sample aggregation. Conversely, peaks 
corresponding to NT-Als3pbc and NT-Als3afr mutants are narrower and elute at volumes 
closer to that predicted for a protein of 32kDa (a column calibration curve is included in 
Appendix 1); indicative of increased sample homogeneity, and reduced aggregation.   
However, only the combined NT-Als3pbcafr mutant and sNT-Als3 elute as single, 
monodisperse peaks at ~64ml; a volume corresponding to the predicted Mw for an Als3 
monomer (32 or 34kDa for sNT and NT proteins, Appendix 1). This suggests that both 
amyloid forming and self-complementation mechanisms contribute substantially to solution 
aggregation, and that in NT-Als3, these mechanisms are additive.  
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 Figure 3.4: Overlay of size exclusion chromatography profiles for NT-Als3 (red), sNT-Als3 (light blue), 
NT-Als3pbc (purple), NT-Als3gk (green), NT-Als3afr (yellow) and NT-Als3pbcafr (navy). Pbc and afr 
mutants are significantly less aggregative than the wild type NT-Als3 protein; evident from narrower peaks and 
later elution volumes. However, only sNT-Als3 and NT-Als3pbcafr elute at a volume of ~64ml, corresponding 
to a monodisperse Als3 monomer. All samples were expressed from a pET32a vector, and purified from 3l of 
M9 minimal media. The additional peak in the NT-Als3pbcafr profile corresponds to a cleaved Thioredoxin tag, 
which was removed via Ni-NTA chromatography post cleavage in other Als samples. 
Furthermore, 1D and 2D NMR spectra of the NT-Als3pbc and NT-Als3gk mutants are 
substantially improved relative to NT-Als3 (Figure 3.5). Linewidths in the NT-Als3 1D are 
relatively broad for a protein of ~34kDa; peak broadening resulting from rapid T2 relaxation 
as sample aggregates tumble with a higher apparent molecular weight. Conversely, 
linewidths for the Als3-pbc mutants are significantly sharper; indicative of faster tumbling in 
solution and slower relaxation.  
The resulting improvement in resolution in the mutant 1Ds allows for identification of 
additional spectral features relative to wild type NT-Als3; sharper signals at ~10ppm 
corresponding to tryptophan indole protons, and peaks at ~0.5ppm corresponding to “ring-
current” shifted methyl protons. Shielded by delocalised electrons in the planes of adjacent 
aromatics, these signals are typically indicative of the presence of a defined hydrophobic core 
in the protein. The magnitude of linewidths (in Hz) is more comparable to the short 
constructs (Figure 3.5). Comparison of an isolated peak in Als3NT-gk and Als3NT-pbc 
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spectra reveals that linewidths are marginally narrower for the pbc mutant, a factor that may 
be related to residual afr association. In an NT-Als3pbc crystal structure (solved by Dr. Lin), 
the βG2’ strand forms interactions with the NT-Als3 surface, mimicking the peptide bound 
conformation and possibly restricting afr mediated association. Conversely, in the NT-Als3gk 
mutant, it is hypothesised that this strand may be flexible and available for interactions. 
Analogously, mutation of the afr region alone (NT-Als3afr) appeared to reduce the 
aggregation properties of NT-Als3; peak dispersion improved in the 1D spectrum. However, 
linewidth narrowing is not equal to that for pbc mutants (figure 3.5)- suggesting that 
autoaggregation of NT-Als constructs via binding of free C-termini and afr interactions are 
not equal, and perhaps surprisingly, that the self-complementation mechanism contributes 
more significantly to aggregation. 
 
Figure 3.5: 1D 1H NMR spectra showing detail of ring current shifted methyl region for NT-Als3 (red), 
sNT-Als3 (light blue), NT-Als3pbc (purple), NT-Als3gk (green), NT-Als3afr (yellow) and NT-Als3pbcafr 
(navy). Linewidths for a selected methyl peak (marked with an asterisk) are indicated. Mutants are less 
aggregative, but linewidths are most improved for sNT and NT-pbcafr constructs. Spectra recorded at 308K in 
50mM sodium phosphate, 150mM NaCl, pH 6.0 at 800MHz. Linewidths are estimated at half the maximal 
height of the peak as indicated, although this peak could not be resolved in the NT-Als3 spectrum. 
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The improved relaxation properties of NT-Als3 mutants relative to NT-Als3 are particularly 
pronounced through comparison of TROSY spectra (Figure 3.6). For NTAls3, overall peak 
dispersion is poor, and the spectrum is severely lacking in peaks for a protein of 34kDa; 
likely due to rapid relaxation. In addition, a high concentration of peaks in the centre of the 
proton frequency (7.5-8.3ppm) suggests that many peaks present in the spectrum actually 
correspond to amides located in unstructured elements (such as loop regions) rather than the 
main fold of the protein. 
In contrast, peaks in the 2D spectrum of sNTAls3 and the pbc mutants are very well resolved 
for a protein of this molecular weight, with good dispersion in both nitrogen and proton and 
frequencies (in the range of 6-10ppm, typical for amides in secondary structural elements). 
However, the NT-Als3pbc TROSY HSQC retains signs of self-association. Whilst the sNT 
Als3 spectrum contains a total of 280 peaks, a feasible number for a protein of 299 amino 
acid residues containing 12 prolines, the NT-Als3 pbc mutant only contains ~260 when 
picked at the same contour level, despite the presence of the additional βG2’ strand. For an 
equal number of scans, signal is also lower (a factor that could be attributed to the protein 
tumbling as a higher molecular weight species and faster relaxation), and peak intensities in 
the spectrum are more variable than in the sNT construct. Many resonances corresponding to 
side chain asparagine and glutamine residues are absent in both spectra. This can be 
attributed to increased rates of base-catalysed amide-solvent proton exchange at pH 8 that 
exceed sampling on the NMR timescale- a factor that could also account for a loss of some 
backbone amide peaks. It is only when both afr and pbc mutations were combined (NT-
Als3pbcafr), that the sNTAls3 2D spectrum can effectively be “reconstructed” (Figures 3.6 
and 3.7); here the protein contains peaks in excess of the sNT construct.   
It should be reinforced that the C-terminal aggregation mechanism is merely an artefact of 
expressing isolated NT domains, and is thus non-physiological. Nonetheless, a crucial 
conclusion can be drawn from SEC and NMR results; in solution, NT-Als proteins have two 
distinct and unequal potential binding/adhesion mechanisms. 
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Figure 3.6: TROSY-HSQC spectra of NT-Als mutants. Spectra were recorded at 308K, in 50mM Tris, 150mM NaCl, pH 8.0 on an 800MHz Bruker spectrometer 
equipped with a TCI cryoprobe. 
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 Figure 3.10: Fluorescence labelling of Als3 demonstrates no difference in expression levels or protein 
localisation for wild type and Als3 mutants. Single alleles encoding the Als proteins were integrated into an 
ALS3∆/ALS3∆ C. albicans null mutant under control of the native Als3 promoter, and the germ tubes labelled 
with a fluorescent anti-Als3 monoclonal antibody. 
Single alleles encoding the mutant Als3 constructs were integrated into the ALS3 gene locus 
in C. albicans ∆ALS3/∆ALS3 null strain (1843) to create strains 3465 (Als3-pbc), 3466 (Als3-
gk), 3467 (Als3-afr), and 3468 (Als3-pbcafr). An identical cloning cassette was used for 
reintegration of a single wild type ALS3 allele to create (positive) control strain 3464 
(Als3wt). Immunolabelling of the cells with an NT-Als3 specific monoclonal antibody 
confirmed that surface distribution and abundance of the mutant proteins was comparable to 
that of the wild type control (Figure 3.10).  
Adhesion of C. albicans mutant strains to cultured monolayers of human umbilical vein 
endothelial cells and FaDu cells in addition to freshly collected buccal epithelial cells (BECs) 
was thus assayed quantitatively using microscopy (as described in Zhao et al., 2004 and Oh et 
al, 2005) (Figure 3.11). Crucially, in all assays, adhesion levels of Als3-pbc mutant strain 
3465 were statistically indistinguishable from those of the ALS3Δ/ALS3Δ strain 1843, 
demonstrating that the pbc is a prerequisite for binding of host cell surface proteins in 
addition to peptide ligands. Adhesion of the Als3-pbcafr mutant was also statistically 
indistinguishable from the null control, confirming in vitro observations from NMR that the 
afr cannot rescue adhesive capacity in the absence of a functional pbc.  
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 Figure 3.11: Differences in adhesion levels of C. albicans cells expressing Als3 mutant proteins to  human 
epithelial monolayers (A and B) and buccal epithelial cells (C). Strains 3465, 3466 and 3468 expressing the 
pbc mutant, gk mutant and pbcafr mutations respectively showed significantly reduced levels of adhesion to 
cells relative to the wild type strain, and were statistically indistinguishable from an ALS3 null mutant (strain 
1843).   
Of note, expression of C-terminal anchored Als3 at the C. albicans cell surface also permitted 
characterisation of the Als3-afr mutant’s adhesive capacity in the presence of a functional 
pbc; hampered in in vitro solution based assays due to C-terminal complementation and the 
aggregative nature of the NT-Als3afr construct.  
In monolayer assays, Als3-afr strain 3467 exhibited increased adhesion relative to the control 
strain (3464), suggesting that mutation of the afr enhances the accessibility of the Als3 pbc to 
host cell ligands. Conversely, adhesion to BEC cells in culture was reduced relative to the 
control strain, suggesting that the afr may act synergistically with the pbc to promote binding. 
However, these differences can be attributed to differences in wild type C. albicans (strain 
3464) aggregative phenotypes. In monolayer assays, wild type C. albicans cells tended to 
adhere in isolation to the host cell surface, whereas in BEC adhesion assays cells tended to 
form adherent clumps. This brings a greater number of germ tubes into contact with the 
human cells to increase the potential for “adherence”; in this case a measure of C. albicans 
aggregation plus specific recognition of host ligands. Following mutation of the afr the 
clumping of C. albicans germ tubes was reduced (7.7 ± 0.7 cells per aggregate for wild type 
A                                                                      B                 
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strain 3464 relative to 5.2 ± 7.7 for the afr mutant, p< 0.05), leading to a lower number of 
overall adherent cells counted in the assay. 
3.7 Concluding remarks; a hypothesised bipartite Als binding mode at the 
C. albicans cell surface 
The data presented here are the first in the Als literature to explicitly focus on the role of the 
peptide binding cavity, and to attempt to delineate different contributions to Als adhesion 
(aggregative vs. adhesive). 
Even following publication of the NT-Als9 co-crystal structure, as late as 2014 Lipke et al. 
have argued that Als interactions with peptide substrates is mediated by the afr and related to 
amyloid formation. Models have proposed that the afr can adhere directly to the host (Rauceo 
et al, 2006, Frank et al, 2008), or that the afr enhances ligand binding by inducing a transition 
to an adhesion competent state via amyloid formation.  
However, in vitro NMR and ITC experiments performed with pbc and afr mutants 
demonstrate that the pbc is critical for binding and cannot be rescued by a functional afr; 
confirming that the role of the afr is more aggregative than adhesive as proposed in other 
models (Frank et al., 2010, Rauceo et al., 2004, Lipke et al, 2014). We demonstrate that 
ligand binding by the pbc is passive, and does not require force-induced activation of the afr 
by shear forces or laminar flow as proposed by Alsteens et al, 2010. Crucially, mutation of a 
few select residues in the C. albicans pbc reduced adhesion to levels indistinguishable from 
an als3 null mutant, confirming that pbc mediated recognition is the sole means of binding to 
the host. This rules out other host adhesion mechanisms that have been proposed; including 
adhesion via the afr (Rauceo et al., 2004) Lipke et al, 2007) a surface complementation 
binding mode (Phan et al., 2007b), and recognition of host proteins via hypervariable loop 
regions (Sheppard et al., 2004). These  results also correlate with observations made by 
Garcia et al. 2011, that S. cerevisiae overexpressing Als5 containing a V326N mutation were 
still competent for binding to magnetic beads coated with heat denatured BSA, despite a less 
aggregative phenotype.  
Our NMR data further demonstrated that the pbc and afr have distinct roles. Many authors 
have suggested that ligand binding and amyloid formation are synergistic; where ligand 
binding induces a conformational change in Als to a more aggregative form, or vice versa 
(Rauceo et al., 2004) Lipke et al, 2011).However, in the peptide bound form of NT-Als9 
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(Salgado et al., 2011), the βG2’ strand containing the afr forms multiple interactions with the 
NT-Als N1 domain surface, restricting access to the afr for amyloid formation. This 
conformation of the βG2’ is also observed in the NT-Als3pbc mutant crystal structure (solved 
by Dr. Lin at the outset of this PhD), which appears to mimic the bound state of Als. This has 
lead us to propose a model for binding at the Als surface that modifies current models in 
literature (Figure 3.12). This model suggests that pbc and afr functions are mutually 
exclusive; ligand-free Als molecules at the cell surface may be competent for host ligand 
binding or C. albicans aggregation. Upon ligand binding, the afr is no longer available to 
induce C. albicans aggregation. As described, C. albicans strain 3464 shows that pbc-
mediated ligand binding by Als3 is unaffected by potential afr induced clustering of Als 
proteins. 
 
 
 
 
 
Figure 3.12: A hypothesised bipartite binding model for Als at the C. albicans cell surface. The afr (red) 
forms interactions with residues in the N1 domain (black). 
Importantly, this model does not exclude avidity effects, where a high concentration of Als 
molecules at the cell surface reduces ligand interaction koff rates to dramatically increase the 
macroscopic KD. However, it is unlikely that avidity is increased via afr-mediated recruitment 
of other Als at the cell surface, as proposed by other models (Alsteens et al., 2010, Lipke, 
2014).  
It would be interesting to evaluate the proposed model and roles of the pbc in the context of 
other phenotypes, such as biofilm formation or invasion. Furthermore, if the roles of the pbc 
and afr really are mutually exclusive, this could have important implication for design of 
biofilm inhibitors, where inhibitors targeting the pbc could inhibit amyloid formation. 
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Chapter Four: Construct design for binding 
assays provides new insights into the Als peptide 
binding mechanism 
 
 
Chapter summary 
For in depth characterisation of Als interactions, quantitative measures of interaction 
affinities are a prerequisite. However, previous attempts to determine dissociation constants 
(KDs) with full length NT-Als proteins were hampered by the aggregative nature of the 
constructs.  
Informed by insights into Als self-association mechanisms provided by NT-Als3 mutants 
described in Chapter 3, a series of constructs were designed in NT-Als1 and NT-Als3 with 
the aim of circumventing self-complementation and afr mediated aggregation. Constructs 
were based on removal of the C-terminal G2’ strand, or modification of the C-terminus to 
prevent binding in the pbc.  
For the first time, KD measurements were obtained for NT-Als proteins in solution with a 
model peptide substrate. Truncations tested in sNT constructs revealed differences in binding 
preferences within the Als pbcs, and tighter binding observed in constructs comprising the C-
terminal βG2’ strand suggest that interactions formed with the N1 domain in binding 
contribute substantially to the interaction. Impaired binding in a mutant where the βG2’ was 
stapled to the N1 domain via a disulphide suggests that this may occur via a “dock, lock and 
latch” mechanism as proposed for homologous SdrG adhesins from Staphylococcus 
epidermidis. Constructs were finally optimised via removal of their N-terminal his tags 
following discovery of an unprecedented interaction mode by a fellow post-doc (Dr. Perez 
Dorado) who observed self-complementation of Als molecules via binding of their N-termini 
in the pbc in crystals of apo-sNTAls1. Removal of the NT his tag further increased the 
affinity for heptathreonine, possibly by removing residual self-association. 
The constructs designed for KD measurements outlined in this chapter will be crucial for 
analysis of Als binding affinities; allowing for inhibitor development, and characterisation of 
binding specificity differences within the Als family. 
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4.1 Background 
To further understand the binding of NT-Als proteins to peptides previously demonstrated by 
crystallography and NMR (Salgado et al, 2011), quantitative measures of interaction 
affinities were necessary. In biology, affinities are typically quantified via dissociation 
constants (or a KD); defined as the ligand concentration at which the concentrations of bound 
and unbound protein are equal. However, previous attempts to derive dissociation constants 
(KDs) for NT-Als peptide interactions in solution based assays had been hampered by the 
aggregative nature of the proteins.  
Binding of heptathreonine to 15N NT-Als1 had been demonstrated by NMR, where HSQC 
chemical shift perturbations (CSPs) were observed for pbc residues upon titration with the 
ligand (Salgado et al, 2011). However, complex behaviour of the CSPs resulting from C-
terminal complementation of NT-Als1 prevented estimation of a KD (Robert Yan, thesis). 
Residues involved in the interaction exhibited CSPs in the slow exchange regime on the 
NMR timescale (Figure 4.1); where two separate resonances corresponding to free and bound 
states can be observed (with peak volumes proportional to their populations). Assuming a 
simple two state binding mechanism and diffusion controlled kon, this would place the KD for 
heptathreonine in the low/sub µM range (see Appendix 2: a note on KD determination).  
 
Figure 4.1: Ligand binding exchange regimes on the NMR timescale. νA and νB correspond to resonances 
for the free and ligand-bound states of the protein respectively. The difference between the koff  rate for an 
interaction and δν (νA-νB) determines whether peak shifts are in fast, slow or intermediate exchange. Slow 
exchange results in a disappearance of a peak corresponding to the unbound form and appearance of another 
peak at the resonance frequency of the bound form, whilst fast exchange results in a shift in a single peak’s 
position (representing an average of free and bound populations) until the bound resonance frequency is reached 
upon saturation. Chemical shift differences between free and bound states typically lie within the range of 100-
300Hz for 15N and proton nuclei, thus for fast exchange, koff >3000Hz (s
-1) and assuming a diffusion controlled 
kon, interactions with a KD > ~3μM tend to be fast exchange. 
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However, over 35 molar equivalents of peptide were required to reach saturation, implying a 
much weaker affinity (μM-mM range). It was unclear whether slow exchange was due to 
tight binding, or weak binding and a low kon rate reflecting the need for displacement of Als 
C-termini from the pbc for peptide binding.  Analogously, initial ITC experiments performed 
with NT-Als9 and the fibrinogen peptide were unsuccessful, likely owing to self-association 
of the protein. 
In order to extract meaningful KDs for peptide binding, it was clear that Als self-association 
mechanisms had to be circumvented. Several constructs were thus developed in NT-Als1 and 
Als3, with the aim of eliminating afr function and C-terminal complementation based on 
insights provided by NT-Als3 mutants described in Chapter 3. In accordance with previous 
studies, (Klotz et al., 2004, Salgado et al., 2011, Lin, 2014) heptathreonine (henceforth 
referred to as polyT) was selected as a model ligand for binding assays.  
Previous SPR assays performed between laminin or fibronectin and the N-terminal and T 
domains of Als1 (Donahue et al., 2011) had suggested that binding affinities may lie in the 
low micromolar range, whilst no prior estimates had been obtained for Als3 interactions. In 
the light of this, various assays adapted for KD determination in the micromolar range were 
trialled (see Appendix 2- a note on binding assays for KD determination). For direct binding 
assays, NMR is best suited for calculation of KDs in the mid micromolar-millimolar range, 
where koff rates are significantly above ∆υ, CSPs are in fast exchange and a KD is readily 
fitted from the change in peak resonance as a function of ligand concentration (Fielding, 
2007). Conversely, isothermal titration calorimetry (ITC), is more accurate for higher affinity 
interactions (nanomolar-low micromolar range), due to the requirement for sufficient 
curvature in isotherms from integration of peaks. Microscale thermophoresis (MST), a 
technique that measures differences in thermophoretic movement of molecules along a 
temperature gradient as a function of ligand binding, has been used to accurately calculate KD 
values over a wider range (nanomolar-millimolar) assuming that near saturation of the protein 
is reached in a titration. Whilst SPR may have been the first choice method, allowing for 
accurate KD determination in the nanomolar-millimolar range, and conjugation of the Als 
proteins to a chip via their C-termini to mimic their presentation on a C. albicans cell in vivo, 
the absence of an SPR machine of sufficient sensitivity to detect signals from binding of 
small peptides at Imperial College meant that other techniques were performed in preference. 
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4.2 Production of sNT-Als constructs for binding studies 
Lacking the afr or a flexible C-terminal βG2’ strand for inter-molecular pbc binding, the 
sNT-Als3302 construct was a promising candidate for binding studies, appearing monomeric 
by SEC-MALS and NMR (Chapter 3). A series of sNT mutants truncated at different points 
in the βG2’ strand were thus designed in Als1 and 3 to find an optimal construct for binding 
assays (Figure 4.2a).  
 
 
 
 
 
 
 
 
 
 
 
 
However, yields of sNT constructs from pET32a vectors (Chapter 3) were very low owing to 
inefficient enzymatic cleavage of the thioredoxin tag (Section 3.2). This was problematic for 
solution based binding assays requiring large amounts of protein (NMR titrations, ITC 
experiments with a VP-ITC calorimeter). Thus, sNT-Als constructs were cloned into a 
Figure 4.2: Production of sNT constructs (sNT-Als1 shown) from a pRSETa vector. (A)  Schematic of 
Als N-terminally his tagged constructs. Truncations for different sNT constructs are highlighted with black 
arrows, numbered according to the NT-Als family sequence alignment from Salgado et al., (Appendix 3). (B) 
Constructs were purified by Ni-NTA chromatography and then subjected to size exclusion (C). The his tag 
thrombin sequence (indicated in bold in (A)) was not cleaved. Despite extensive attempts to optimise the 
purity of samples, NT-Als co-elute with several low molecular weight contaminants (marked with an asterisk) 
of ~27kDa, ~20kDa and ~15kDa.  
A      
 
 
 
B                                                                                   C                                                                                                   
298 299 302     315 
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pRSETa vector, previously shown to yield high amounts of NT-Als1 as a hexahistagged 
fusion when expressed in an E. coli Shuffle T7 Express ® strain (NEB) (Vincent Chu, Cota 
lab).  Whilst thrombin-mediated cleavage of the histag was also highly inefficient, due to the 
small size of the tag (HHHHHHGLVPRG) cleavage was typically bypassed for binding 
experiments. Yields of sNT-Als proteins significantly increased (~15mg/l for sNT-Als1 
constructs). Although the change in expression system greatly facilitated solution based 
binding assays, retention of the his-tag would have important consequences outlined later in 
this chapter. All constructs outlined in Chapter 4 were generated in this vector, and purified 
via Ni-NTA affinity chromatography and size exclusion chromatography (SEC) (Figure 4.2). 
4.3 sNT constructs yield the first KD estimates but suggest peptide ligands 
need to compete with E. coli contaminants  
SEC of the sNT-Als proteins produced relatively broad elution profiles, reflecting co-elution 
of multiple lower molecular weight (MW) species (Figure 4.2 c). This could introduce errors 
in KD estimates; highly dependent on accurate knowledge of protein concentration. Despite 
extensive attempts to optimise purification of sNTAls3 and sNTAls1, including anion 
exchange, application of detergents and imidazole gradients, low MW contaminants could 
not be removed. It was hypothesised that E. coli proteins could be co-purifying with the Als 
via association with the pbc, a consequence of the broad binding specificity of the adhesins. 
In support of this, preliminary ITC experiments with sNT-Als3299 and polyT exhibited very 
low heats of injection and insufficient curvature in isotherms for estimation of a KD, 
suggesting that bound contaminants could be impeding peptide binding (Figure 4.4). To test 
this hypothesis, samples were washed extensively with a urea gradient (0-4M over ~500ml 
per ml of resin) during Ni-NTA affinity chromatography, in an attempt to disrupt interactions 
with the cavity and remove contaminants from the pbc. Stable to pH, high salt and 
temperature, authors had previously demonstrated that Als-peptide interactions (largely 
mediated by hydrogen bonds) could be disrupted effectively using chaotropic agents (Gaur et 
al., 1999).  
Post washing with urea, symmetry of gel filtration profiles and sample purity improved 
markedly (as assessed by SDS-PAGE), although a few lower weight contaminants were 
retained (Figure 4.3a). However, final pooled samples were determined to be over 90% pure, 
and thus suitable for binding assays (Figure 4.3b). Following elution of the Als, any urea was 
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removed via dialysis and gel filtration. Resultant 2D NMR spectra confirmed that the Als 
fold had not been perturbed.  
 
 
 
 
 
 
 
Figure 4.3: Urea washing during Ni-NTA affinity purification may improve sNT-Als purity via removing 
contaminants that associate with the pbc. (A) Use of a 0-4M urea gradient in Ni-NTA purification 
(chromatogram inset) results in a narrower SEC profile and reduction in contaminant levels as assessed by SDS-
PAGE. Final samples from pooled fractions (bracketed) were estimated to be >90% pure (shown in B). The 
sNT-Als protein is marked with an arrow, and lower molecular weight contaminants indicated with an asterisk. 
Post urea-washing, Als3 samples exhibited a substantial increase in injection heats in ITC 
experiments with polyT (Figure 4.4a), allowing for fitting of KDs in the range of ~130μM. 
This represents the first quantitative measurement of an Als3-peptide interaction in the 
literature to date. KD estimates for the sNT-Als1 heptathreonine interaction were also halved 
for urea-washed samples, as measured by ITC experiments (Figure 4.4b). All KD estimates 
from ITC were subsequently confirmed by MST (Figures 4.5 and 4.6). 
Whilst samples purified in the presence of urea retain some lower MW impurities (Figure 
4.3), it is possible that urea washing also removed peptide contaminants that were too small 
to be resolved on a 12% SDS-PAGE gel from the pbc, or proteins below the detection level 
of Coomassie blue. The more marked improvement in KD values observed for Als3 may 
reflect the ability of this protein to bind a broader range of sequences relative to Als1, 
reinforced by the fact that sNT-Als3 samples are often not as pure as Als1 samples (Figure 
4.3b). This may be due to underlying differences in the pbc, and will be discussed in more 
depth in Chapter 5. 
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Figure 4.4: Purification with a urea gradient substantially improves the affinity of sNT-Als constructs for 
polyT, as measured by ITC. (A) For sNTAls3299, injection heats for ITC experiments increased substantially 
for urea-washed samples, and a KD could not be estimated for samples purified in the absence of urea. (B) The 
sNTAls1299 KD was halved. Tabulated values are the average of three experiments, performed at 308K in 50mM 
sNT-Als1299 KD (μM) ΔH (kJmol-1) ΔS (JK-1mol-1) n 
No urea wash, room temp 36.3 ± 4.4 13.4  ± 4.3 -8.5 ± 0.1 0.71 ± 0.008 
4M urea wash, 4oC 21.2 ± 6.3 34.4  ± 4.3 9.5 ± 3.4 1.45 ± 0.15 
sNT-Als3299     
No urea wash, room temp No estimate No estimate No estimate No estimate 
4M urea wash, 4oC 133.5 ± 23.5 22.2 ± 3.7  2.5 ± 0.5 
A 
 
 
 
 
 
 
 
B 
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sodium phosphate, 150mM NaCl, pH 6.0 with a VP-ITC Calorimeter (Microcal). KD estimates were 
subsequently corroborated by MST measurements (Figure 4.5 and Figure 4.6). 
ITC data obtained for both sNTAls299 constructs demonstrated that binding to polyT is 
enthalpically driven (Table 4.3), correlating with the large number of H bonds formed 
between the peptide backbone and binding cavity in Als-peptide crystal structures. However, 
it is perhaps surprising that the entropic penalty for peptide binding is so small, due to the 
number of water molecules secluded within the cavities of the Als co-crystal structures.  
It must be noted that the low c value of the data (<1) limits the accuracy of enthalpy and 
entropy estimates for sNTAls3. Defining the level of curvature in an ITC isotherm, the c 
value is proportional to both the KD and concentration of macromolecule within the cell (see 
Appendix2), and a value within the range of 10 or 20-100 is recommended for accurate 
estimation of experimental parameters (Tellinghuisen and Chodera, 2011; Wiseman et al., 
1989). Here, this could not be obtained; requiring mM concentrations of Als protein within 
the cell. Additionally, stoichiometry values differ significantly from 1; a factor that will be 
discussed in Section 4.6. 
4.4 Optimisation of sNT constructs reveal differences in the pbcs of Als1 
and 3  
To identify a construct optimal for binding assays, truncations at residue 302, 299 and 298 in 
the βG2’ strand were generated in sNTAls1 and sNTAls3 constructs. (Sequences are 
numbered according to the NT-Als family alignment from Salgado et al, see Appendix 3).  
Although the original sNTAls3302 construct had appeared monomeric in solution and was a 
promising candidate for binding assays (Chapter 3), in the apo-crystal structure of sNT-Als3 
the side chain of K59 forms a salt bridge with the C-terminal carboxylate of R302 from the 
same molecule (Figure 4.5). It was hypothesised that this may also occur in solution, 
generating competition for the pbc. 
MST experiments confirmed that sNTAls3-302 bound to polyT with an affinity in the mM 
range; a value significantly lower than that predicted for an Als-peptide interaction (Klotz 
and Gaur, 1999, 2004, Donahue et al., 2011). However, this value improved ~10 fold 
following further truncation by two residues to G299 (108.8μM ± 10.1μM in an identical 
MST assay, and ~130μM by ITC). As suggested by the crystal structure, in successfully 
abolishing intermolecular C-terminal complementation in the Als3-302 construct, intra-
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molecular complementation had been introduced. Truncation to residue 299 appeared to 
alleviate both of these complementation mechanisms, reducing competition for the pbc 
(Figure 4.5). 
 
 
 
 
Figure 4.5: Intra-molecular self-complementation observed in sNT-Als3302 constructs is alleviated 
following truncation to residue 299. (A) A crystal structure of sNT-Als3302 in the apo form reveals that R302 
is bound in a pocket in the pbc, leading to a low affinity for polyT (see table). (B) Despite fitting of a mM KD, 
saturation could not be reached due to the low interaction affintiy. Truncation by 2 residues to G299 lowers the 
peptide binding KD by roughly an order of magnitude. Experiments performed in triplicate in 50mM sodium 
phosphate, 150mM NaCl, pH 6.0 with 0.05% Tween-20. 
A KD could not be estimated from NMR titrations as CSP shifts did not exceed a linewidth in 
magnitude (Figure 4.6). However, CSPs were in fast exchange, in agreement with a KD in the 
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Figure 4.7: Comparison of polyT binding affinities in sNT-Als1 constructs. (A) Truncations generated in the 
βG2b strand are labelled red in the sNT-Als1 crystal structure. (B) MST data demonstrating that affinity is 
highest for proteins truncated at residue 302, suggesting that intra-molecular self-complementation does not 
occur in sNT-Als1, and that the βG2b-βG2’ linker may have a role in stabilising peptide interactions. (C) 
Although residue G299 does not form any contacts to polyT in the crystal structure of the complex, further 
truncation toT298 is sufficient to abolish binding (D). MST and ITC Experiments performed in 50mM sodium 
phosphate , pH 7.0, 150mM NaCl.  
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binding through hydrophobic interactions with other regions of the Als pbc and reducing the 
koff. Intriguingly, although G299 also does not form contacts to polyT (directly or indirectly 
via the coordinating water network), further truncation of sNT-Als1 or sNT-Als3 to residue 
T298 appeared to be sufficient to abolish peptide binding, as demonstrated by ITC (Figure 
4.7).  
Analysis of the sNT constructs thus defined residue 299 as the limit for defining the pbc, 
whilst improvements in affinities observed for sNTAls1302 relative to sNTAls1299 suggested 
that the C-terminal βG2b-βG2’ linker could have an important role in the peptide binding 
mechanism. This is reinforced by differences in the position of the βG2’ strand in crystal 
structures of sNT-Als9 in the “apo” and peptide bound forms (Salgado et al., 2011), and by 
CSPs observed for residues in the N1 domain of NT-Als1 upon titration with polyT in NMR 
experiments; suggesting that the βG2’ strand may form interactions with N1 residues upon 
ligand binding (Dr. Yan, PhD thesis).   
4.5 The C-terminal βG2’ strand has an important role in peptide 
interactions 
To test the importance of conformational changes in the βG2’ strand in the binding 
mechanism and as an alternative to truncation, two new NT-Als1 constructs were designed 
(Figures 4.8 and 4.9). In both constructs the βG2’ strand was retained, but C-terminally 
modified to “block” any interaction with the pbc and prevent self-association  These 
constructs were initially made in Als1, due to easier sample workability relative to Als3.  
In a construct where the βG2’ strand retained conformational flexibility, NT-Als1 was C-
terminally extended with a 5 kDa chitin binding domain (CBD) via a short linker (SGLT). 
CBD was chosen as an inert domain, where the C-terminus forms an integral part of the 
fold’s β-sheet and would thus be unavailable for interaction with the Als pbc (Figure 4.8a). 
Mutations in the afr analogous to those outlined for NT-Als3 in chapter 3 (I311S, I313S) 
were introduced into NT-Als1CBD to ablate amyloid formation and autoaggregation. The 
NT-Als1CBD construct was cloned by a student in the Cota lab, Vincent Chu.  
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Figure 4.8 NMR based characterisation of the NT-Als1 CBD construct. (A) Schematic showing design of 
the Als1-CBD construct, with the structure of the CBD domain (PDB code 1ED7). (B) SDS-PAGE shows that 
the construct co-purifies with the same impurities as the sNT constructs. (C) TROSY HSQC spectra of NT-
Als1CBD, (D) sNTAls1302, and (E) NT-Als1CBD (cyan) overlaid with peaks corresponding to the CBD (black). 
The latter are visualised at a lower contour level, due to rapid tumbling of the CBD. Comparison of the NT-
Als1CBD and sNTAls1spectra (C+D) shows that the majority of Als1 peaks are present, whilst CBD peaks 
correlate well with peak positions observed for an isolated CBD domain (F) reproduced from (Ikegami et al., 
2000). 
                                                                                                                                           
                                                                      
A                                                                                     B 
C                                                                      D 
E                                                                        F 
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The NT-Als1CBDafr construct was confirmed to be folded by NMR, exhibiting surprisingly 
well resolved peaks and narrow linewidths in 1D 1H and 2D TROSY spectra for a non-
deuterated protein of 42kDa. The majority of sNT-Als1 peaks are also observed in the NT-
Als1CBD spectrum (compare Figure 4.8c and d) and peaks corresponding to the CBD can 
also be identified based on comparison with HSQCs reported in a paper describing the 
solution structure of this domain (Ikegami et al., 2000) (Figure 4.8f). Favourable relaxation 
properties could be explained by independent tumbling of the NT-Als1 and CBD domains. 
Peaks corresponding to the CBD are more intense and can be visualised at lower contour 
levels (Figure 4.8e), whilst many peaks corresponding to NT-Als1 are of comparable 
linewidths to the sNT construct. Critically, this made the construct a suitable candidate for 
future NMR- based ligand binding studies. 
In an alternative construct, a disulphide bridge was engineered between adjacent beta strands 
βE1 and C-terminal βG2’, thereby preventing conformational rearrangement of strand βG2’ 
(NT-Als1SS) (Figure 4.8). Disulphide locked mutants were designed using the “Disulphide by 
design” software, a program that scores potential disulphide pairs in cysteine mutants based 
on inter-residue distance and predicted energies (Craig and Dombkowski, 2013)  
http://cptweb.cpt.wayne.edu/DbD2/index.php). On the basis of the output, three disulphide 
locked mutants were designed; S104C-V314C, I105C-V314C, and K106C-I313C (Figure 
4.9). S104 lies in an accessible loop adjacent to the βG2’ strand, with the Cγ positioned ~6Å 
from the Cγ of V314, a distance slightly suboptimal for disulphide bridge formation. Whilst 
the sidechain Cγ of V314 is 6.5Å from I105, rotation of V314 in the protein’s flexible C-
terminus about χ1 could feasibly place a cysteine side chain within 4.3Å of the I105 Cγ 
without disrupting hydrogen bonding interactions in the β-sheet. Correlating with these 
predictions, an I105C-V314C mutant yielded folded protein, demonstrated by good peak 
resolution for ring-current shifted methyls and amides in 1D 1H NMR spectra (Figure 4.9) 
and a single species from the pooled gel filtration peak as confirmed by SDS-PAGE. The 
formation of the disulphide was subsequently confirmed by mass spectrometry, where the 
MW of an oxidised sample was increased by 2Da relative to a reduced sample (corresponding 
to two protons).  
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Figure 4.9: Characterisation of C-terminally disulphide locked NT-constructs. (A) Schematic and PDB 
model of the disulphide locked mutant, created in pymol using the sNTAls1 and NT-Als9 PDB coordinates. (B) 
Disulphide mutants designed using “Disulphide by Design” software (Craig and Dombkowski, 2013), where 
partners from the βE1 and βG2’ strand are coloured blue, and inter-Cγ sidechain atom distances are indicated. 
Whilst the sidechain Cγ of V314 is 6.5Å from I105, rotation of χ1 could place the cysteine side chain within 
4.3Å of I105. (C) Soluble, folded protein was produced for a I105C-V311C mutant, whilst the S104C-V311C 
appeared to be unfolded. 
The affinity of the NTAls1-CBDafr construct for polyT was comparable to that for 
sNTAls1299; yielding a KD estimate of 0.9μM from MST that correlated well with 
independent fluorescence polarisation (FP) measurements (Dr. Chee, Tate lab, Imperial 
College London). Analogously NMR demonstrated that binding to the peptide was in slow 
exchange with CSPs; appearing to saturate at around 1-1.5 molar equivalents (in the region 
predicted for a KD of this magnitude (Figure 4.10)). (As ligand binding is in the slow 
exchange regime on the NMR timescale, a KD for polyT binding could not be derived from 
NMR.) Crucially, no CSPs were registered for peaks corresponding to the CBD domain 
(Figure 4.10c), suggesting that enhanced affinity for the peptide relative to the sNTAls1-299 
construct was solely due to the presence of the βG2’ strand. 
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Conversely, the KD for polyT binding to the disulphide locked mutant was over two orders of 
magnitude weaker relative to Als1CBD or sNTAls1299, suggesting that flexibility of this 
strand may be important for binding (Figure 4.11). It is possible that the strand participates in 
a “dock, latch and lock” mechanism reminiscent of that proposed for a homologous 
MSCRAMM adhesin from Staphylococcus epidermis SdrG (Ponnuraj et al., 2003).  
Figure 4.11: Affinity comparisons for the NT-Als1 constructs. Inclusion of the βG2’ strand in the NT-
Als1CBD construct (yellow) increases affinity relative to sNT constructs (dark and light blue). Locking of the 
strand via a disulphide (NT-Als1S-S, green) in a proposed “closed” conformation significantly impairs binding to 
polyT, suggesting that strand flexibility is important to the binding mechanism. MST experiments performed in 
triplicate in 50mM Na phosphate, 150mM NaCl, pH 7.0, with 0.05% Tween-20. 
4.6 N-terminal self-association via the pbc reveals a novel interaction mode 
for the Als proteins 
Despite truncation or “blocking” of the Als C-terminus to circumvent C-terminal 
complementation, several factors were indicative of residual self-association in sNT and NT-
Als1CBD constructs. Gel filtration profiles for these proteins were relatively broad, whilst 
deviation of stoichiometry (n) estimates from 1 in ITC experiments performed with sNT-Als1 
and 3 constructs (Table 4.4) could result from self-association. (It must be noted that 
discrepancies in n values could also arise from residual occupancy of the pbc by 
contaminants, or poor definition of the curve’s inflection point due to the low c value of the 
data (7 for Als1 and <1 for Als3). It has been argued that within this range of c values, 
stoichiometries cannot be accurately estimated from the curve inflection point, and should be 
fixed (Tellinghuisen and Chodera, 2011; Turnbull and Daranas, 2003).) 
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Furthermore, various factors suggested that residual self-association may be occurring via the 
pbc. Truncation of sNT-Als1 to residue 298 (thus rendering the pbc inactive) not only 
abolished binding to polyT in ITC and MST assays (Section 4.4), but also appeared to yield 
completely monomeric constructs. sNTAls1298 exhibited improved peak resolution in 2D 
TROSY spectra relative to sNTAls1299 and narrower gel filtration profiles, correlating with a 
SEC-MALS molecular weight estimate equal to that predicted for a monomer (Figure 4.12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12: Self-association of sNTAls1 constructs occurs via the pbc. (A) Pymol diagrams illustrating 
sNTAls1 truncations at residues 299 and T298. (B) In addition to preventing peptide binding, truncation to 
residue 298 and also rendered constructs monomeric, evident from narrower gel filtration profiles and SEC 
MALS MW estimates obtained for a 100μM sample (the predicted MW of sNT-Als1 is ~32.4kDa). (c) Peak 
resolution also improved in 2D NMR TROSY spectra. 
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Conversely, for constructs possessing a functional/intact pbc (sNT-Als1299 and NT-
Als1CBD), molecular weight estimates from SEC-MALS exhibited shifts of up to 15% as a 
function of protein concentration (over a trialled range of 5-115μM). Self-association 
appeared to be most severe in the sNTAls1299 construct, where additional elution peaks at a 
molecular weight corresponding to higher order oligomers were also observed (Figure 4.13). 
However, for both sNTAls1299 and NT-Als1 CBD, samples only appeared completely 
monomeric at final concentrations below 5μM; below that required for most binding assays. 
 
 
 
Figure 4.13: SEC-MALS data reveals that sNTAls1299 self-associates as sample concentration is increased. 
Shifts in chromatogram elution volumes and MW estimates for the sample are apparent with increasing protein 
concentration. At concentrations of sNTAls1 exceeding 80μM a second peak with an estimated MW of ~70kDa 
(corresponding to a possible dimer is observed) (arrow). It must be noted that even at a concentration of 5μM, 
fluctuations in MW values obtained from dRI data (inset) indicate that samples are not completely 
monodisperse, possibly due to the presence of oligomers. 
Finally, titration of the NT-Als1CBD construct with saturating amounts of polyT 
substantially increased the number of peaks observed at a given contour level, indicative of 
improved relaxation and minimised self-association following displacement of something 
from the pbc (Figure 4.14). 
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C-termini, as the N-terminus could be effectively displaced from the pbc in ITC and NMR 
experiments to measure KD values (Sections 4.4 and 4.5). 
 
4.15: N-terminal self-complementation via the pbc presents a mechanism for in solution self-aggregation. 
Crystals structures of sNT-Als1 obtained in the apo form (Dr. Perez Dorado) reveals that Als1 can bind the N-
terminal thrombin tag sequence from other Als molecules in a linear (A) or loop conformation (B). Although 
K59 is bypassed, hydrogen bond register with the G2b strand is entirely conserved (panels inset). 
4.7 Removal of the NT-histag in Als1 yields an optimised construct for 
binding assays 
To remove the effects of self-association via the N-terminal thrombin sequence, NT-
Als1CBD was produced from a pRSETa vector without an N-terminal tag, according to a 
protocol designed by Dr. Perez Dorado. Briefly, following affinity chromatography of the 
protein with chitin resin (samples were washed extensively with urea to remove contaminants 
from the pbc), proteins were eluted from the resin with 6M urea, and progressively refolded 
via dialysis prior to SEC.  
Removal of the N-terminal tag substantially improved the purity and homogeneity of 
samples, as affirmed by SDS-PAGE and SEC. Additionally, the KD for polyT binding 
measured by MST was reduced by a third relative to that obtained for NT-Als1CBD 
containing an N-terminal histag thrombin sequence (Figure 4.16). ITC experiments will be 
A 
B 
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performed with this sample to corroborate this KD value, and determine whether 
stoichiometry estimates closer to 1 can be obtained. 
 
Figure 4.16: Production of NT-Als1CBD without an N-terminal his-tag thrombin sequence (red) 
substantially improves affinity for polyT, suggesting that self-association has been abolished. KD values 
were obtained via MST; the average of 3 measurements performed in buffer conditions indicated previously. 
4.8 Conclusions and Perspectives 
At the outset of this thesis, quantitative measures of peptide binding affinities could not be 
obtained for the Als proteins in our lab.  
Factors such as N-terminal and C-terminal self-association mechanisms and binding of 
endogenous E. coli contaminants within the pbc impeded binding assays; consequences of the 
broad binding specificities of the Als proteins and the need to express them as isolated NTDs. 
However, via careful construct development and optimisation of purification protocols, an 
optimised NT-Als1 construct has successfully been produced for KD measurements; a 
template that can ideally be extended to other members of the Als family. 
A KD of ~250nM for NT-Als1CBDnotag binding to polyT is roughly six-fold below the 
estimate obtained by Donahue et al. (2011) via SPR for Als1 binding to fibronectin (1.6± 
0.6μM). Whilst these KD values are within the same range, it is possible that Donahue’s 
samples suffered from Als aggregation or contamination of the pbc, and that the KD for 
fibronectin (an endogenous ligand for the Als) is actually much lower. Indeed, Als1 samples 
for SPR (expressed in S. cerevisiae and purified from culture supernatants), contained the T 
domain and functional afr in addition to the intact NT (Donahue et al., 2011). This could 
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account for the presence of aggregates observed by the authors in tapping-mode AFM, 
although solution samples were predominantly determined to be monomeric. 
The reduction in KD values from a μM to nM range following construct development (Figure 
4.17) will significantly facilitate KD measurements across a wider affinity range, additionally 
minimising sample requirements and extending the number of ligand-binding techniques that 
can be used (see Appendix2). KD measurements will permit comparison of different binding 
specificities within the Als family, whilst collaborators are currently using the NT-Als1CBD 
construct to develop antimicrobial peptides and screen for novel small molecule inhibitors of 
Als.  
 
 
 
 
 
Figure 4.17: Improvements in polyT affinity with Als1 constructs. Schematics represent (from left) NT-Als1 
with an intact afr , NT-Als1S-S, sNTAls1299, NT-Als1CBD, and NT-Als1CBDnotag. NT-Als1 associates via the 
afr and pbc, preventing KD estimation. Association is predicted to be minimised via disulphide locking of the C-
terminal strand and mutation of the afr, but increases the interaction KD relative to the sNT construct, 
presumably due to the need for flexibility in the βG2’ strand. NT-Als1CBD yields the lowest KD estimate, 
improved further by removal of the tag to circumvent Als self-association via N-termini. 
Additionally, construct development has provided new insights into the Als peptide binding 
mechanism. Truncated sNT mutants and a disulphide locked mutant suggested that 
conformational rearrangements in the βG2b-βG2’ linker and G2’ strand may have an 
important role in peptide binding, suggesting this may occur via a “dock, lock and latch” 
mechanism as observed for bacterial MSCRAMM adhesins such as SdrG(Ponnuraj et al., 
2003). According to this mechanism; in a  flexible “open” conformation the Als pbc is 
accessible to peptide binding, and following “docking” of the peptide within the pbc the βG2’ 
strand folds over the peptide to “lock” it in place. The βG2’ strand thus hydrogen bonds to 
strand βE1 to complement the N1 domain’s beta-sheet (“latching”) thereby reducing the 
interaction koff.  
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In SdrG, truncation of the C-terminal strand at residue 580 (corresponding to 298 in sNT-
Als1) also abolished binding. Truncation to residue 589 (the tip of the C-terminal strand) 
significantly reduced affinity for the peptide relative to the wild type protein.  Due to the 
deeper cavity and binding of fibrinogen within the SdrG structure, this construct can be 
considered analogous to truncation at residue 299 in sNT-Als1; observed to reduce affinity 
~10 fold relative to an Als with an intact C-terminal strand. However, whilst locking of the 
βG2’ strand also reduced affinity for heptathreonine in NT-Als1, peptide binding was 
completely abolished in SdrG (Bowden et al., 2008). This suggests that there may be some 
subtle differences between the Als and MSCRAMM binding mechanisms. 
NT-Als association via N-terminal and loop binding modes also raises exciting new questions 
regarding Als-protein interactions. Previously, the presumed requirement for a free 
carboxylate for Als mediated recognition of host proteins led to hypotheses that concomitant 
expression of C. albicans proteases (such as secreted aspartate proteases or SAPs) resulted in 
cell damage and exposure of free C-termini (Salgado et al., 2011), including those that are 
located intracellularly (type I membrane proteins). However, the possibility that Als can 
recognise loops in protein structures or N-termini could expand the possible pool of Als 
interaction partners at the cell surface, without invoking SAP activity.  
Finally, an analogous bacterial MSCRAMM is known to bind specifically to a human 
thrombin cleavage sequence in a fibrinogen peptide, thus inhibiting clotting in the host 
inflammatory response to promote infection (Davis et al, 2001). Whilst the thrombin site 
engineered into the pRSETa N-terminal tag differs at several points in the sequence, it is 
possible that this represents a biologically relevant interaction for the Als protein in C. 
albicans infection. The capability of Als proteins to bind loops in proteins will be tested in 
this laboratory via pull down assays and KD measurements, using the NT-Als1CBD construct 
designed. 
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Chapter Five: Preliminary analysis of specificity 
differences between NT-Als1 and NT-Als3 
 
Chapter summary 
The pbc of the Als proteins is crucial for ligand recognition and cellular adhesion. Of note, 
for all Als family members, much of the sequence variability in the NTD localises to the pbc, 
suggesting that pbc sequence variation could underlie differences in adhesion to host tissues 
and biological functions in the family. 
Due to the broad binding specificities of the Als proteins, differences in binding preferences 
for host or peptide ligands within the family is currently poorly understood. This chapter 
outlines preliminary characterisation of binding specificity preferences between two Als 
family members demonstrated to be critical infection virulence factors; Als1 and Als3. Als1 
and Als3 exhibit 84% sequence identity in their NTDs; the highest between any Als family 
members. Following analysis of cavity differences, mutations designed to promote binding to 
either protein were introduced into a model polyT peptide, and binding differences between 
NT-Als1 and 3 analysed via DSF, MST and X-ray crystallography (using constructs 
developed in previous chapters). Results demonstrate a clear preference for accommodation 
of aromatics or basic residues in the 1st, 2nd and 4th amino acid positions from the peptide’s C-
terminus for Als3, whilst these residues are less tolerated in Als1. Structural analysis suggests 
that these two residues are mainly responsible for the observed changes in binding 
specificities; the side chains of Y28 and Y168 constrict the cavity in Als1, whereas residues 
T28 and T168 define a wider cavity in Als3. Furthermore, this binding trend can be reversed 
through mutating these positions in Als1 to the analogous residues in Als3, suggesting that in 
future experiments, binding specificities of the Als adhesins may be “swapped” with a 
minimal number of pbc substitutions. 
Although further analysis of binding preferences will require a higher throughput assay, this 
is an important step towards characterising specificity differences in the Als family, perhaps 
leading to an improved understanding of their endogenous ligands and roles in infection. 
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5.1 Background  
The C. albicans genome encodes eight members of the Als family of adhesins, with sequence 
identities for the protein NTDs ranging from 83.4% (NT-Als1 and NT-Als3) to just 42.6% 
(NT-Als7 and NT-Als4 or 6). The presence of multiple Als proteins suggests that family 
members may have distinct roles in infection, possibly resulting from differences in adhesive 
specificities. Notably, many of the sequence differences in the Als NTDs localise to the pbc; 
a region now known to be critical to host adhesion. With the availability of high resolution 
crystal structures for the NTDs of several family members, this in turn raises the exciting 
possibility that we can rationalise binding specificity differences (and eventually, possibly 
functionality) within the Als family based on structural analysis of the pbcs. 
For the first time in the Als literature, this thesis begins to systematically analyse binding 
specificity differences in NT-Als1 and 3, and relate them to structural differences in the pbc. 
NT-Als1 and NT-Als3 were selected for comparison as the structures of their NTDs have 
been solved by crystallography by previous lab members (Dr. Hale and Dr. Lin), and both are 
of clinical relevance in C. albicans infection. Additionally, NT-Als1 and NT-Als3 are 84% 
identical at the sequence level, yet different preferences for cellular substrates have been 
demonstrated in the literature (Sheppard et al., 2004). To probe differences in specificities 
between NT-Als1 and 3, several mutations were systematically introduced into a model 
polyT peptide, designed to complement the pbc of either Als1 or Als3. Binding was assayed 
using a combination of DSF and MST, and the results rationalised based on co-crystal 
structures obtained with the peptides. 
5.2 Analysis of sequence differences in the pbc of NT-Als1 and 3 
Many sequence differences between NT-Als1 and 3 (see alignment in Appendix 2) are found 
in the A1B1 loop and βA2 strand that define the top and rear of the pbc respectively (figure 
5.1). Side chains from six of the observed eight substitutions point into the cavity and are thus 
likely to influence binding. Several of these substitutions are between smaller, aliphatic 
residues in NT-Als3 to bulkier or aromatic substituents in NT-Als1 (T28 of the A1B1 loop 
and T168 of the βA2 in Als3 are replaced with tyrosines in NT-Als1, whilst T20 of the A1B1 
loop is substituted by asparagine). The overall consequence of these substitutions is 
constriction of the NT-Als1 cavity relative to NT-Als3 (figure 5.1) at two points.   
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                      16                               28     59     167                        175                          291                          315 
Als1      SNAANYAFKGPGY FKY LYASRVMPS FTLRWTGYKN SDAGSNGIVIVA 
Als3      SNAATYNYKGPGT FKF LTDSRVIPS FTLRWTGYRN SDAGSNGIVIVA 
         ****.* :****  **: *  ***:** ********:* ************ 
             A1B1 loop                 βA2             βG2b               βG2’ 
      
Figure 5.1: A handful of sequence differences in the pbcs of Als1 and 3 changes the cavity properties. A) 
Sequence differences between Als1 and 3 (labelled and coloured red) localise primarily to the pbc; the βA2 
strand (orange) in domain N2 (grey) and A1B1 loop (cyan) of N1 (green/yellow). B) Surface representations of 
the structures show that substitution of T28 and T168 in Als3 with tyrosines in Als1 reduces the size of the Als1 
pbc relative to Als3. C) Sequence alignment for pbc regions, with differences highlighted red. 
A 
B 
C   
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Other cavity sequence differences are more subtle. K302 in Als1 is replaced with an arginine 
in Als3, thus conserving charge but increasing size and the number of potential hydrogen 
bond donors/acceptors, and F23 with a (more polar) tyrosine. An asparagine residue at 
position 22 in Als1 substituted to a smaller alanine residue in Als3 may compensate for the 
bulkier T28Y substitution in the A1B1 loop (located above residue 22) preventing 
overcrowding of the cavity. Remaining side chain substitutions in the βA1 strand (M173I and 
A169D) are orientated away from the cavity (Figure 5.1), and are thus likely to have little 
effect on ligand binding. The overall dielectric of the Als1 and 3 pbcs are predicted to be 
relatively similar. 
Comparison of the crystal structures of sNT-Als1 and sNT-Als3 in complex with polyT 
reveals that contacts formed to the peptide are highly conserved between the two proteins. 
However, residues that are conserved between Als1 and 3 in the βG2b and βA2 strands form 
hydrogen bonds to the peptide backbone, whilst residues that differ between the pbcs form 
direct contacts to the peptide side chains. This suggests that whilst conserved pbc residues 
recognise the peptide backbone, non-conserved residues are able to interact favourably with 
different sequences, and crucially, underlie specificity differences in the Als proteins. The 
sNT-Als1 and 3 polyT complexes will be compared in more detail with the Als-peptide co-
crystal structures obtained during this PhD in section 5.6. 
5.3 Structure-rationalised mutations in a model peptide 
Mutated peptides were based on polyT; previously demonstrated to bind to Als1 and 3 in 
Chapter 4 and the literature (Gaur, 2004; Gaur et al., 2002). All peptides were synthesised as 
heptamers; crystal structures demonstrate that for peptides bound in a linear conformation, a 
maximum of six residues are accommodated by the Als pbc and interactions are primarily 
formed to the first four residues from the C-terminus. It has been demonstrated that 
increasing peptide length beyond seven residues does not improve adherence to Als (Gaur, 
2004).  
Peptides used in this study are listed in Table 5.1, with residue positions labelled from the 
peptide C-terminus (P1). All peptides were synthesised by a collaborator (Dr. Soo Mei Chee, 
Tate lab, Imperial College London). Initially, focussing on steric differences between the 
cavities, tyrosine residues were introduced at different positions in the polyT peptide to 
determine how aromatics are accommodated by Als1 and 3 (Figure 5.2). Based on the results 
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obtained, a series of second generation peptides were designed investigating the effects of 
combined substitutions at P1, 2, 3 and 4. Basic aliphatic residues were included in addition to 
aromatics based on previous observations that the pbc of Als3 bound to R299 from it’s own 
C-terminus in the apo sNT Als3 crystal structure. A polyT peptide amidated at the C-
terminus was also synthesised as a negative control for the assay, as previous NMR 
experiments had demonstrated that this peptide did not bind to Als1 even upon addition of 50 
molar equivalents. 
Peptide  Primary sequence 
 NH3
+- T T T T T T T – COO- 
PolyTY1 NH3
+- T T T T T T Y – COO- 
PolyTY2 NH3
+- T T T T T Y T – COO- 
PolyTY3 NH3
+- T T T T Y T T – COO- 
PolyTY4 NH3
+- T T T Y T T T – COO- 
PolyTY5 NH3
+- T T Y T T T T – COO- 
Amidated  NH3
+- T T T T T T T – CONH2 
1st generation peptides 
Peptide  Primary sequence 
PolyTW2 NH3
+- T T T T T W T – COO- 
PolyTW3 NH3
+- T T T T W T T – COO- 
p10 NH3
+- T T T T H W T – COO- 
p18 NH3
+- T T T R H W T – COO- 
p25 NH3
+- T T T T  T W R – COO- 
2nd generation peptides 
Figure 5.2 and Table 5.1: Peptide sequences used in this study. Modifications to the model sequence are 
marked in bold. Positions in the peptide are numbered from the C-terminus. All peptides were synthesised by 
Dr. Soo Mei Chee (Tate lab, Imperial College London).   
All proteins used in this chapter were produced as outlined in earlier chapters. Briefly, sNT-
Als-299 constructs were used for crystallography and DSF assays, whilst Als1CBD lacking a 
histag was used for MST and DSF binding assays.  
 
P2 
P3 
P4 
P5 
P6 
NT (NH2) 
P1 
 CT (COO) 
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5.4 Differences in peptide binding affinities can be correlated with sequence 
differences in the pbc 
Binding of peptides to Als1 and 3 was initially probed via DSF using the sNT-299 constructs. 
DSF is used to indirectly probe protein unfolding in the presence of a fluorescent 
hydrophobic dye (Sypro-Orange); protein unfolding in a temperature gradient results in 
exposure of the hydrophobic core, binding of the dye and fluorescence enhancement. A 
protein Tm (estimated from the inflection point of the dye fluorescence curve) is defined as 
the temperature where native and denatured populations of a protein are equal. Increases in a 
measured Tm are indicative of increased stability, often observed in the presence of ligands as 
a result of binding. In the literature, assuming a 1:1 interaction and simple two-state 
approximation of the unfolding transition, it has been demonstrated that for structurally 
similar ligands that bind in the same mode and at identical sites, the magnitude of ∆Tm 
changes can be proportional to ligand affinity (Matulis et al., 2005; Senisterra et al., 2006; 
Vedadi et al., 2006). Changes in Als1 and 3 ∆Tms in the presence of first and second 
generation peptides relative to the ΔTm observed with the model polyT are shown in figure 
5.3. 
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Peptide 
Raw ∆Tm/oC 
Als1 Als3 
PolyT 
(TTTTTTT) 
4.5 ± 0.1 2.8 ± 0.1 
PY1 
(TTTTTTY) 
2.6 ± 0.1 2.8 ± 0.1 
PY2 
(TTTTTYT) 
6.0 ± 0.1 4.8 ± 0.1 
PY3 
(TTTTYTT) 
4.0 ± 0.2 5.8 ± 0.1 
PY4 
(TTTYTTT) 
3.1 ± 0.5 6.6 ± 0.2 
PY5 
(TTYTTTT) 
4.9 ± 0.1 2.1 ± 0.1 
T-NH2 0.8 ± 0.1 0.5± 0.1 
Peptide 
Raw ∆Tm/oC 
Als1 Als3 
PolyT 
(TTTTTTT) 
5.8 ± 0.8 2.8 ± 0.3 
PW2 
(TTTTTWT) 
9.2 ± 0.4 3.1 ± 0.2 
PW3 
(TTTTWTT) 
6.5 ± 0.2 3.2 ± 0.3 
p10 
(TTTTHWT) 
8.7 ± 0.5 4.0 ± 0.1 
p18 
(TTTRHWT) 
4.6 ± 0.3 5.0 ± 0.1 
p25 
(TTTTTWR) 
1.4 ± 0.4 6.5 ± 0.1 
-6.0
-4.0
-2.0
0.0
2.0
4.0
6.0
∆
T
m
/ o
C
 
∆Tm for 1st generation peptides relative to 
model polyT 
sNT-Als1297 sNT-Als3297
-6
-4
-2
0
2
4
6
 ∆
T
m
 / 
oC
 
∆Tm for 2nd generation peptides relative 
to model polyT 
NT-Als1297 NT-Als3297
0
0.2
0.4
0.6
0.8
1
30 35 40 45 50 55
Temperature [°C] 
0
0.2
0.4
0.6
0.8
1
40 45 50 55 60
Temperature [°C] 
 sNT-Als1299                                                                       sNT-Als3299 
PW2         PW3         p10         p18             p25 Apo protein    
PolyT 
PY4 
PY2 
PY1       PY2        PY3         PY4       PY5       TNH2 
N
or
m
al
is
ed
 fl
uo
re
sc
en
ce
 
A 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
C 
115 
 
Figure 5.3 and Table 5.2 (overleaf) DSF demonstrates differences in peptide substrate sequence 
preferences for sNTAls1299 and sNTAls3299. A) ∆Tms for Als1 (green) and Als3 (yellow) with first generation 
peptides and B) with second generation peptides. ∆Tms shown graphically are relative to the ∆Tm for the model 
polyT peptide (∆Tmpeptide-∆TmpolyT). Raw ∆Tm values (Tmpeptide-Tm Als) are also tabulated. C) Shifts in 
DSF curves for a subset of peptides with Als1 and 3 are displayed. The presence of an aromatic at P1 and P4 in 
the peptide reduces Als1 Tms and increases those for Als3. 
Peptide binding affinities for Als1 were also measured via MST using the NT-Als1CBD 
construct determined to be optimal for binding studies (Chapter 4). NTAls1CBD was titrated 
against the peptides listed in Table 5.3 conjugated to a FAM group (carboxyfluorescein) via 
their N-termini (Figure 5.4). In parallel, independent KD measurements for both peptide 
series were obtained via fluorescence polarisation (FP) performed by collaborators Dr. Chee 
and Runzhong Fu, Tate lab, Imperial College.  
 
Unfortunately, repeated attempts to clone an analogous construct in Als3 failed during the 
timescale of this project, preventing affinity measurements. Discussion of binding 
preferences in Als3 will thus be limited to DSF results with the sNT construct. However, 
correlation between trends in Tm values and KDs measured for Als1 suggest that this is a valid 
approach. 
 
As hypothesised, sNTAls1 and Als3 exhibited clear differences in peptide binding, where an 
increase in Als3 Tm relative to the model peptide was observed for a wider range of 
sequences than in Als1. DSF data for Als3 suggest that relative to polyT, aromatic residues in 
P2, 3, and 4 of the peptide favour binding (yielding positive ∆Tm shifts), and aromatics are 
tolerated at P1. An increase in Tm shift was observed for peptides p10 and p18 relative to 
PolyTW2, suggesting that basic residues at P1, 3 and 4 further promote binding. (These 
peptides contain a histidine at P3 and an arginine at P4 (p18) in addition to a tryptophan in 
P2). The combination of an arginine at P1 and tryptophan at P2 yields the largest Tm shift 
(4oC relative to polyT).  
Conversely in Als1, introduction of a tyrosine at P1 and P4 from the peptide C-terminus 
increased the KD for polyT binding from the nanomolar to micromolar range (as measured by 
MST with the Als1CBD construct), correlating with reductions in the sNT-Als1 Tm. The 
presence of aromatics (tryptophan or tyrosine) in P3 did not appear to significantly affect KD 
or Tm, however the presence of a histidine residue in these positions was unfavourable, 
leading for a reduction in Tm and increase in KD for the p10 and p18 peptides relative to the 
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model polyT or W2. Analogously to Als3, the presence of an aromatic at P2 appeared to 
promote binding, resulting in a 2-3 fold increase in affinity for a tyrosine, and 8 fold for 
tryptophan. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 and Table 5.3: Affinity differences for peptides binding to NT-Als1CBD as characterised by 
DSF, MST and FP. MST data are displayed graphically, and were collected using peptides labelled with an N-
terminal FAM group, at 30% laser power in 50mM tris buffer, 150mM NaCl, 0.05% Tween20, pH 7.4. Graphs 
and tabulated values are the average of three readings, with the exception of PolyTY4, where two readings were 
obtained. KDs could not be derived for the PY3, PW2 and PW3 peptides due to severe ligand dependent 
photobleaching of the FAM group under all experimental conditions trialled. FP measurements were obtained in 
50mM sodium phosphate, 150mM NaCl, pH 8.0. 
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Als1CBD (titrant) concentration/ μM  
PolyT
polyTY1
PolyTY2
PolyTY4
Peptide KD (μM) MST KD (μM) FP ∆Tm (oC) DSF 
 (T T T T T T T) 0.23 ± 0.20 3.8 ± 0.3 4.5 ± 0.1 
PY1 ( T T T T T T Y) 21 ± 1.4 66.2 ± 5.7 2.6 ± 0.1 
PY2 ( T T T T T Y T) 0.15 ± 0.11 1.8 ± 0.11 6.0 ± 0.1 
PY3 ( T T T T Y T T) No estimate 1.8 ± 0.07 4.0 ± 0.2 
PY4 ( T T T Y T T T) 44 ± 2.0 33.1 ± 0.2 3.1 ± 0.5 
PW2 ( T T T T T W T) No estimate 0.45 ± 0.1 9.2 ± 0.4 
PW3 ( T T T T W T T) No estimate 5.3 ± 0.2 6.5 ± 0.2 
p10  ( T T T T H W T) 0.03 ± 0.005 9.9 ± 2.0 8.7 ± 0.5 
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These changes in binding preferences correlate well with structural differences identified in 
the pbcs of NT-Als1 and 3. In both the Als1 and 3 sNT-Als polyT crystal structures, the 
register of the peptides is set by the salt-bridge formed between the peptide C-terminus and 
K59 of the Als. Residues P1 and P4 align with two constrictions in the Als1 cavity, defined 
by Y28 in the A1B1 loop at the base of the pbc and Y168 in the βA2 strand respectively 
(figure 5.5). Substitution of P1 and P4 with tyrosines, arginines (and certainly tryptophans) is 
thus predicted to be sterically unfavourable. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5: Differences in Als affinities for P1 and P4 substituted peptides correlate with cavity size 
differences caused by aliphatic-aromatic substitutions in the pbcs. The peptide hydrogen bond register with 
Als strands βA2 and βG2b is set by the C-terminus-K59 salt bridge at the at the base of the pbc. In Als1, Y28 
and Y168 align with peptide positions P1 and P4, correlating with reduced binding affinities observed (Figure 
5.4). The presence of threonines at analogous positions in Als3 makes the cavity wider. 
 
Als3                                                                    Als1 
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At equivalent positions in Als3, T28 creates a small pocket at the base of the pbc aligning 
with P1, and the presence of a threonine at 168 creates a large water-filled expansion in the 
cavity (Argimon et al., 2007) aligning with P4. Aromatics or bulky residues are thus tolerated 
at these positions in Als3.  
Of note, for sNTAls3 Tm improvements were most marked following basic arginine 
substitutions at P1 and P4 combined with a tryptophan substitution at P2 (peptides p18 and 
p25). Conversely, for Als1 introduction of a bulky arginine residue at P1 or P4 was sufficient 
to abolish improvements in affinity observed for peptides containing a tryptophan in the 
second position (see FP KD values for p18 and p25 peptides relative to the W2 peptide). In 
Als3, D169 has the potential to form salt bridges with basic substrate residues within the 
cavity- interactions that are not feasible in Als1 due to an alanine substitution at the 
corresponding position. These results correlate with observations made during development 
of binding constructs, where truncation of the proteins to basic residue R299 induced strong 
intra-molecular complementation in sNT-Als3, but not sNT-Als1.  
 
The presence of a tyrosine or tryptophan in P2 appeared to favour binding substantially for 
both Als1 and 3. Accommodation of an aromatic residue at P2 is possibly favoured by the 
presence of a large hydrophobic pocket defined by a cluster of valine residues (V172, V178, 
V206) and a hydrophobic sequence 206-208 in the F2 strand/loop (Figure 5.6). It is also 
feasible that residue Y298 at the base of the pocket could form π-π interactions with an 
aromatic at this position in the peptide to further stabilise the interaction.  
Figure 5.6: The pbcs of Als1 and 3 have pockets optimal for binding of hydrophobic residues at P2. 
 
Introduction of aromatic or a basic residue at P3 does not appear to significantly alter binding 
in Als1, whilst substitution of a tyrosine or histidine at P3 increased the Tm for Als3. This 
difference may again result from the T28Y substitution in the A1B1 loop above P3 that 
Als1                                                                   Als3 
119 
 
increases the size of the pocket relative to Als1, and residue D169 below, which could 
feasibly form hydrogen bonds with the histidine side chain. 
 
It should be noted that there are some discrepancies between the FP and MST data for 
Als1CBD peptide binding. FP tends to overestimate the KD values relative to MST; perhaps 
due to flexibility in the FAM- labelled N-terminus of the peptide that extrudes from the Als 
cavity. FP measures a reduction in the rotation of polarised light by ligands in the bound state 
relative to the free form; this change is less pronounced when the label is located in a highly 
flexible region (Lea and Simeonov, 2011). MST data could also not be obtained for several of 
the peptides due to ligand dependent photobleaching of the fluorophore; KD values for these 
peptides should be determined via an indirect competitive binding assay. However, both 
methods demonstrate the same overall trend in affinity changes with the peptide series.  
5.5 Crystallisation of Als1 and 3 peptide complexes 
To analyse contacts made between the pbc and mutated peptides that could underlie 
differences in Als binding preferences/ affinities, sNTAls1299 and sNTAls3299 were co-
crystallised with the first generation peptides listed in Table 5.1 (PolyTY1, 2, 3 and 4). 
Peptides p18 and p25 from the second series were further selected for co-crystallisation with 
Als3, yielding the greatest stabilisation of the protein in DSF.  
Optimisation screens were designed around conditions previously identified for co-
crystallisation of sNTAls1 and 3 with polyT (Dr. Hale and Dr. Lin). Complexes produced 
crystals exhibiting characteristic hexagonal plate morphologies for sNTAls3 and rods for 
sNTAls1, pictured in Figure 5.7. sNT-Als3 crystals were large (~200μm by 100μm by 25μm) 
and robust, and datasets were obtained for all peptides listed in Table 5.4. Despite scaling up 
crystallisation drops, sNT-Als1 crystals were typically small and grew as clusters of 
monocrystals, meaning that a dataset could only be collected for the Als1-Y4 complex.  
On average, reflections in sNTAls3-peptide diffraction patterns extended to as far as 1.2Å or 
1.5Å resolution, and 2.4Å for Als1. For the majority of datasets, CC1/2 values exceeded 0.5 
even in the highest resolution bins, and all of the data were used in processing. This is based 
on the current consensus in the literature that CC1/2 is a more reliable metric for estimating 
resolution limits than residuals/ R statistics (Evans, 2006). However, the resolution for 
datasets Als3+Y1, 2 and 3 was cut back during processing to obtain over 93-95% overall 
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completeness (and I/σ(I) of >1.5-2 for the outer shell). Processing statistics for the datasets 
are listed in Table 5.4. 
 
Figure 5.7: sNTAls3 (upper panels) and sNTAls1 (lower panels) peptide complexes exhibit characteristic 
“flake” and “rod” crystal forms. Crystals are as follows: A) sNTAls3+ p25 peptide, B) sNTAls3+p18 peptide, 
C) sNTAls3+PolyTY3 peptide, all obtained in 25-75mM (NH4)2OAc, 5-30% PEG w/v 400, 20-30% w/v PEG 
4000 and 100mM sodium acetate buffer  pH 4.6-5.6. Lower panel: D) Als1+ PolyTY2, E) Als1+PolyTY4, both 
in 25% w/v PEG 8K, 80mM (NH4)2SO4, 30% v/v ethylene glycol, 150mM ADA pH6. Scale bars shown 
correspond to 100μm with the exception of panel A. A dataset could not be obtained for theAls1- PolyTY2 
crystal, due to size limitations. 
Consistent with previous polyT-Als crystals, Als3 peptide complexes crystallised in 
spacegroup P 1 21 1, with a single complex in the asymmetric unit and ~45% solvent content. 
Als1 peptide complexes crystallised with 2 molecules in the asymmetric unit and in 
spacegroup P 21 21 21.  
Datasets were phased via molecular replacement using the apo sNT-Als structures as search 
models in Phaser MR (Mccoy et al., 2007). An unambiguous solution was obtained in each 
case with good connectivity of resultant maps, favourable translation and rotation z scores, 
and log likelihood gain (Table 5.6). Resulting Fo-Fc difference maps demonstrated clear 
density within the pbc corresponding to the peptide and coordinating water network, where 
the peptide sequence was clearly defined prior to refinement (Figure 5.8).
A                                                           B                                                 C                           
   D                                                                      E 
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 Als3- 
PolyTY1 
Als3- 
PolyTY2 
Als3- 
PolyTY3 
Als3- 
PolyTY4 
Als3- 
p18 
Als1- 
PolyTY4 
Diffraction source (DIAMOND) I04-1 I04-1 I04-1 I03 I04 I04-1 
Wavelength (Å) 0.91742 0.91742 0.91742 0.97999 0.97949 0.91741 
Detector Pilatus 2M  Pilatus 2M  Pilatus 2M  Pilatus 3 6M Pilatus 6M-F Pilatus 2M  
Crystal to detector distance (mm) 175.62 206.76 207.03 188.6 363.26 237.39 
Rotation range per image (o) 0.1 0.1 0.1 0.1 0.2 0.1 
Total rotation range (o) 200.00 200.00 200.00 200.00 200.00 200.00 
Exposure time per image (s) 0.05 0.05 0.05 0.05 0.2 0.05 
Space group P 1 21 1 P 1 21 1 P 1 21 1 P 1 21 1 P 1 21 1 P 21 21 21 
Cell dimensions (a, b, c) (Å) 47.19  58.57  
53.51 
49.19  58.41  
57.07 
49.51  58.16  
57.32 
49.38   58.32   
57.12    
49.60   58.08   
57.72 
47.96  63.20 
230.22 
(α, β, γ) (o) 90.00  110.6  
90.00 
90.00  114.22  
90.00 
90.00 114.63  
90.00 
90.00  114.39   
90.00 
90.00  114.39   
90.00 
90.00  90.00  
90.00 
Mosaicity (o) 0.204 0.142 0.142 0.099 0.144 0.197 
Resolution range (Å)  44.17-1.4 (1.44-
1.4) 
44.86-1.48 
(1.52-1.48) 
52.1-1.48 (1.52-
1.48) 
52.02-1.16 
(1.19-1.16) 
28.64-1.51 (1.55-
1.51) 
38.37- 2.37 
(2.43-2.37) 
% Completeness 92.0 (85.5) 96.2 (73.3) 95.7 (76.8) 99.6 (97.1) 96.4 (72.3) 99.8 (99.5) 
Multiplicity 4.0 (4.0) 3.7 (3.0) 3.6 (2.8) 3.5 (2.7) 3.4 (2.2) 7.3 (7.4) 
Total number of reflections 197160 (13384) 174739 (7819) 171885 (7885) 357569 (19697) 155155 (5430) 214723 (15887) 
Total number of unique reflections 49333 (3384) 47304 (2640) 47157 (2791) 101584 (7295) 45006    (2465) 29412 (2155) 
I/σI  19.0 (4.2) 24.1 (4.5) 20.7 (3.8) 15.8 (1.5) 17.5 (1.5) 9.2 (1.2) 
Rpim 0.023 (0.192) 0.017 (0.171) 0.018 (0.188) 0.021 (0.525) 0.024  (0.473) 0.097 (0.0965) 
CC1/2 0.999 (0.914) 1.000 (0.925) 0.999 (0.938) 0.999 (0.524) 0.999 (0.599) 0.996 (0.569) 
Overall B factor from Wilson plot (Å2) 11.10 12.63 13.52 16.41 16.32 12.46 
Table 5.4: Data processing statistics for 1st and 2nd generation peptides. Values for the highest resolution shell are included in parentheses. 
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Refinement was performed using iterative cycles of maximum likelihood refinement with the 
program Refmac5 (Murshudov et al., 1997) and manual model building in Coot (Emsley et 
al., 2010) until convergence of Rwork values. For the Als1-PolyTY4 structure, NCS global 
restraints were included in refinement. All residues were built into the final models with the 
exception of C-terminal R302 for Als3 complexes and several sidechains listed in Table 5.5, 
where density was absent or remained ambiguous following refinement. The majority of 
these side chains were lysine residues located in loop regions, where density is less well 
defined in general as a result of inherent flexibility. Refinement statistics for the final models 
are documented in table 5.6. Final Rwork values are good for all models (~1/10
th of the 
maximal resolution of the data) and Rfree values within a good range of Rwork, indicative of 
minimal model bias. Bond length and angle rms values are also within an acceptable range, 
as assessed by Molprobity (Chen et al., 2010) and Procheck (Laskowski et al., 1993a). A19 
was detected as a single Ramachandran outlier in the Als1-polyTY4 structure, although this 
has been observed in previous Als structures. Inspection of the map showed that this residue 
was a good fit to the density (Figure 5.9).  
Structure Als3-
polyTY1 
Als3- 
polyTY2 
Als3-
polyTY3 
Als3-
polyTY4 
Als3-p18 Als1- 
polyTY4 
Missing 
residues 
R302 
 
K106 (Cγ-
Cε) 
K148 (Nξ) 
R302 K106 (Cγ-
Cε) 
K148 (Cγ-
Cε) 
 
R309 (side 
chain) 
K106 (Cγ-
Cε) 
R302  
N20 
S43 
K299 
D147 (chain 
A and B) 
K148 (chain 
B) 
E129 (B) 
Table 5.5: Residues that could not be built into the Als peptide complex models. Density for the side chains 
of these residues was ambiguous or absent in 2Fo-Fc maps. 
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Figure 5.8: Examples of the quality of 2Fo-Fc (blue) and Fo-Fc (red and green) maps following molecular 
replacement. Maps shown correspond to those obtained for sNTAls3 with the p18 (above) and p25 (below) 
peptides. The peptide sequences (right) can be clearly built into the density. Images are exported from coot 
(Emsley et al, 2010), with 2Fo-Fc maps (blue) and  Fo-Fc difference maps (where red corresponds to negative 
peaks and green positive peaks) contoured at 1σ and 2.5σ respectively. 
 
 
 
 
 
 
Figure 5.9: The fit of A19 in the A1B1 loop of the Als1polyTY4 structure to a 2Fo-Fc map, viewed looking 
down ψ (NH-Ca) and ϕ (Ca-CO) respectively. Despite appearing as a Ramachandran outlier, the model is a 
good fit to the density in this region. 
W2 
R1 
K59 
W2 
K59 
H3 
T1 
A19 
N 
ψ 
A19 
N 
Cα Cα 
CO 
ϕ 
R1 W2 
T3 
T4 
T5 
T6 
 
T1 
W2 H3 
R4 
T5 
T6 
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 Als3- 
PolyTY1 
Als3- 
PolyTY2 
Als3- 
PolyTY3 
Als3- 
PolyTY4 
Als3- 
p18 
Als1- 
PolyTY4 
Number of molecules in AU 1 1 1 1 1 2 
Resolution range (Å) 44.17-1.4 44.86-1.48 52.108-1.48 52.02-1.16 52.34-1.51 57.56- 2.40 
Vm (Å3/Da) 2.22 2.22 2.22 2.22 2.23 2.58 
Solvent content (%) 44.5 44.5 44.7 44.6 44.95 52.44 
Total number of reflections used in refinement 46986 45080 44977 96437 42712 26879 
MR z-scores (translation, rotation) 25.1, 44.8 32.8, 58.6 81.6, 38.2 25.3, 13.4 73.4, 38.2 22.1, 29.0 
MR LLG score 2538  15256  15969  1894  11486  1192  
Percentage of reflections for Rfree (%) 4.89 4.96 4.815 5.00 5.07 4.89 
Rwork, Rfree  0.151, 0.184 0.154, 0.189 0.148 0.153, 0.182 0.139, 0.184 0.209, 0.259 
Overall FOM (Figure of merit) 0.888 0.904 0.8711 0.8936 0.8570 0.770 
DPI coordinate precision, DPIfree 0.075, 0.064 0.081, 0.069 0.075, 0.067 0.035, 0.036 0.078, 0.070 0.420, 0.270 
Atomic displacement model Anisotropic Anisotropic Anisotropic Anisotropic Anisotropic Isotropic 
Overall average B factor (Å2) 5.55 8.28 8.60 8.23 9.14 12.33 
NCS restraints x x x x x √ 
Number of atoms refined 2652 2579 2627 2688 5271 4921 
Number of solvent atoms 271 233 238 264 203 173 
Number of ligand atoms 0 0 0 0 0 4 (sulphates) 
Rms deviations Bond  lengths (Å) 0.0106 0.0113 0.0133 0.0134 0.0306 0.0134 
                         Angle distances (o) 1.499 1.510 1.572 1.6308 2.3911 1.6297 
                         Chiral volumes 0.8119 0.0948 0.0895 0.120 0.01643 0.0863 
Ramachandran plot Favoured (Allowed) (%) 89.6 (10.4) 89.2 (10.8) 89.7 (10.3) 88.5 (10.8) 89.2 (10.8) 97.2 (2.03) 
                                Disallowed                (%) 0 0 0 0.7 0 0.77 
Table 5.6: Molecular replacement and refinement statistics for the Als-peptide complexes. All refinement was performed using Refmac 5.8.0103 (Murshudov et al, 
2014). AU= asymmetric unit, MR= Molecular replacement, and DPI is the dispersion precision indicator for the working reflection and free reflection sets.
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5.6 Residues that differ between the pbcs of Als 1 and 3 form key contacts 
to peptide side chains in Als3 crystal structures 
Analysis of the Als1 and 3-peptide complex crystal structures suggests that peptides are 
bound in the pbc with minimum changes in the conformation of the peptide backbone, Als 
secondary structural elements and side chains (Figure 5.10).  
 
 
 
 
 
 
 
 
 
 
Figure 5.10: Overlays of the sNTAls1-YPolyT4 complex with Dr. Lisa Hale’s polyT complex (A) and 
NTAls3 peptide complexes (B). No major differences are observed between Als1 peptide complexes. Als3 
complexes overlay with 0.2-0.3Å RMSD, and differences in side chain positions are highlighted. The interaction 
formed between Als3 N22 and the side chain hydroxyl of a tyrosine in P1 of the peptide PolyTY1 (yellow) 
induces movement of the A1B1 loop relative to other Als3-peptide complexes, and changes the orientations of 
several side chains in the A1B1 loop.  
A 
 
 
 
 
 
 
 
 
B 
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With the exception of the Als3-PolyTY1 complex, where interaction of N22 with the P1 
tyrosine hydroxyl induces rearrangement of the A1B1 loop and a change in the side chain 
orientations of residues N22, Y21 and T20, complex pbcs superimpose with 0.2-0.3< RMSD 
between Cα atoms. Instead, other side chains in the peptides are primarily accommodated 
through rearrangements in the pbc water networks. 
In all crystal structures obtained for Als1 and 3, the majority of hydrophobic contacts and all 
of the hydrogen bonds made directly to the peptide backbone are conserved in terms of pbc 
residue number and identity (Figure 5.11a and b). Hydrogen bonds are primarily formed with 
the βG2b strand (via T296 and R294) and βA2 strand (residues S170 and V172) in a parallel 
arrangement, where the hydrogen bond register is established by coordination of the peptide 
C-terminus by K59. Of note, all of these residues are equivalent between Als1 and 3, (S170 
and T296 are highly conserved in other Als family members). Conserved hydrophobic 
contacts to the backbone are mediated by R171 (βA2), W295 and G297 (βG2b); residues that 
are also equivalent between Als1 and 3. These pbc residues form a basic “scaffold” for 
peptide recognition, in accordance with data from previous Als crystal structures (Salgado et 
al., 2011). 
Remaining residues in the βA2 strand, A1B1 loop and βF2 loop (defining the opposite face 
and lid of the cavity respectively) directly contact peptide side chains, or indirectly contact 
the peptide via intermediary water molecules. Crucially, the majority of these residues (168, 
169, 23, 22, 28) differ between Als1 and Als3, underlying differences in binding preferences 
observed.  
Analysis of Als3 crystallographic peptide complexes with the series 1 and 2 peptides reveals 
additional contacts are formed to the peptide side chains relative to the polyT complex (PDB 
code 4LEB), correlating with increases in Tm shifts. In complex with peptide polyTY4, T168 
of Als3 forms a hydrophobic interaction with the peptide tyrosine (Y4PolyTY4). Conversely in 
Als1, where introduction of a tyrosine at position 4 reduced binding affinity, no additional 
direct contacts to the peptide (from Y168 or other residues) were observed relative to Dr. 
Hale’s polyT complex structure (Figure 5.11). Analogously for the Als3 polyTY1 peptide 
complex, additional hydrogen bonds are formed between the side chain hydroxyls of Y23 and 
T28 of the A1B1 loop to Y1polyTY1. Although co-crystal complexes with Als1 could not be 
obtained for these peptides, substitution of Y23 with non-polar phenylalanine and T28 with a 
bulky tyrosine is likely to reduce hydrogen bonding potential (in the latter case due to steric 
127 
 
constraints considering hydrogen bond directionality). In the Als3 p18 complex, the ηNH of 
R1p18 forms a salt bridge with the side chain carboxylate of D169; absent in Als1 due to 
substitution with a non-polar residue (A169). All of these interactions could contribute 
enthalpically to binding (and affinity) in Als3, but not Als1. 
Conversely, for tyrosine and tryptophan residues in Position 2 of p18 and p25 (Y/Wp18/p25), 
peptides observed to bind favourably to Als1 and 3, additional bonds to the aromatics are 
provided by residues that are conserved between 1 and 3; the backbone amides of V268 and 
T269 of the F2 strand, and pi-bonding with Y298 from strand βG2b. 
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5.7 Als3 pbc water networks may underlie a narrower peptide binding 
affinity range 
Additional contacts formed to the series 1 and 2 peptide side chains in Als3 complexes could 
underlie increased binding affinities relative to polyT (inferred from positive ∆Tm shifts). 
However, it is interesting to note that in Als3 the overall number of hydrogen bonds formed 
to the peptide is relatively conserved between different structures. Whilst series 1 and 2 
peptides with bulkier or charged side chain substituents form an increased number of 
hydrogen bonds to the Als3 pbc directly, the number of water molecules participating in the 
pbc hydrogen bonded network is concomitantly reduced relative to the model polyT peptide 
(Table 5.7). This suggests that the wider cavity and extended water network of Als3 allows 
for the pbc hydrogen bonding potential to be satisfied whether substrate sequences are 
“complementary” to the pbc or suboptimal, without a significant loss in binding enthalpy.  
It must be noted that solvation properties of the Als1 and Als3 crystal structures are not 
directly comparable; obtained under different crystallisation conditions and at different 
resolution. (In particular, the lower resolution of Als1 data could lead to underestimation of 
the number of water molecules within Als1 models). However, comparison of Als1-polyT 
and Als1-polyTY4 complexes (obtained under the same conditions and at similar resolution) 
reveals that binding of PolyTY4 lead to a significant reduction in the number of water 
molecules in the pbc hydrogen bonded network relative to the model (Table 5.7 and Figures 
5.12/5.13). As no additional hydrogen bonds are made directly between the pbc and peptide, 
there is a substantial overall loss in hydrogen bonding, correlating with the observed 
reduction in binding affinity. 
Als-peptide interactions appear to be largely enthalpically driven (Chapter 4). It may thus be 
hypothesised that conservation of the hydrogen bonding network in Als3 with different 
peptides has two consequences. Whilst satisfaction of hydrogen bonding potential via cavity 
water molecules allows for binding of smaller, suboptimal substrates to expand Als3’s 
substrate binding repertoire,  the range in affinities observed for binding of different peptide 
sequences may be narrower (and perhaps weaker) relative to Als1, as there is little overall 
change in the number of bonds formed to the peptide. Conversely, in Als1, a hydrogen 
bonded water molecule network cannot compensate for binding of larger, suboptimal 
substrates, leading to a substantial loss in pbc hydrogen bonding and affinity (and possibly 
binding enthalpy). In Als3, binding of substrates via water molecules may also increase the 
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koff rates for interactions to reduce affinities, as the hydrogen bonding network is likely to be 
less rigid. KDs for binding of these peptides to Als3 are yet to be measured (with an Als3CBD 
construct), however differences in Tm shifts are observed over a fairly narrow range relative 
to Als1. In addition to deriving KDs for Als3, it would be interesting to test these hypothesises 
via ITC –based enthalpy measurements, and SPR-based kon and koff measurements with Als1 
and 3 and the series 1 and 2 peptides.  
Table 5.7 and Figure 5.12: Comparison of the water networks in Als1 and 3 peptide complexes.  In Als3, a 
reduction in the number of hydrogen bonds made directly from pbc residues to sub-optimal peptide sequences 
may be compensated by an expansion in the pbc water network. In Als1, the narrow cavity is less hydrated in 
the presence of bulkier peptides (figure below), and fewer waters are observed to form H bonds to the pbc 
(Ligplot diagrams overleaf).
 Als3 
polyT 
Als3 
polyT
Y1 
Als3 
polyT
Y2 
Als3 
polyT
Y3 
Als3 
polyT
Y4 
Als3 
p18 
Als1 
polyT 
Als1 
poly
TY4 
Water molecules in the pbc  36 24 26 21 25 19 17 4 
Water molecules in the 
peptide-pbc H- bonding 
network (as assessed by 
LigPlus) 
13 9 7 5 10 8 6 1 
Number of hydrogen bonds 
made directly from pbc 
residues to the peptide (as 
assessed by LigPlus) 
6 10 11 9 5 9 9 9 
Als1    
 
 
 
 
Als3                                                                                              
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5.7 Generation of Als1 pbc mutants: swapping specificities between Als1 
and Als3 
Following demonstration of differences in peptide substrate binding preferences between 
Als1 and 3 via DSF and KD measurements, we sought to “graft” specificities between the 
proteins via mutagenesis of the pbc. Contacts formed in crystal structures suggested that this 
could be achieved through substitution of a minimum number of pbc residues, namely 
Y168T, and Y28T (and to a lesser extent, Y23F). 
Work with Als1 single mutants was performed by a Masters student under my supervision, 
Oscar Leung, and will not be discussed here. Briefly, single mutants had demonstrated that 
Y28T and Y168T mutations were destabilising, reducing the protein Tm and inducing severe 
precipitation of the protein at temperatures above 4oC for Als1CBD-Y28T. The effects of 
both mutations appeared to be rescued by an A22N mutation, where the Tm of the double 
mutant was equivalent to the wild type protein, or increased for the Als1-CBD A22N/Y168T 
mutant. A series of double and triple mutants substituting these residues in Als1 to the 
corresponding Als3 residue were thus generated in NTAls1-CBD; mutant properties are 
summarised in the table below. Double and triple mutants listed showed no signs of 
precipitation, and all exhibited peak dispersion and linewidths comparable to those of wild 
type NT-Als1CBD in 1D 1H NMR spectra, indicating that perturbations to the protein fold 
were minimal (Figure 5.14). 
Mutant Tm (
oC) Other properties 
Als1-CBD wt 50 ± 0.2 ~20 mgl-1, no precipitation. 
Als1-CBD A22N/Y168T 53 ± 0.2 ~16mgl-1, slightly more aggregative 
and behaves more like Als3. 
Als1-CBD Y28T/A22N 50 ± 0.6 ~ mgml-1, minimal precipitation. 
Als1-CBD Y28T/A22N/Y168T 48 ± 0.4 ~14mgl-1, no precipitation, slightly 
more aggregative and behaves more 
like Als3. 
Figure 5.14 and Table 5.8: Properties of NT-Als1CBD pbc mutants. Excellent peak dispersion and linewidth 
shapes in the amide and ring-current shifted methyl regions of 1D NMR spectra demonstrate that mutants are 
folded. However, some differences in the properties of mutants were observed, with a tendency for Y168T 
mutations to behave more like wild-type Als3. The A22N mutation was introduced to stabilise the threonine to 
tyrosine mutations, based on combination of different mutations trialled by a Masters student, Oscar Leung. 
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 The DSF binding assay with the 1st generation peptides was thus repeated with the NT-
Als1CBD pbc mutants (figure 5.15, performed by Oscar Leung). Results for the triple mutant 
should be interpreted with caution due to the slightly reduced stability of the apo protein 
relative to the wild type (the ∆Tm shifts observed with peptides are consequently larger, 
possibly due to increased stabilisation upon peptide binding). Predictably, mutation of Y168T 
appeared to improve the Tm of Als1 with the Y4 peptide, correlating with an increase in 
cavity size at this position in Als3 structures. Analogously, the Y28T mutation appeared to 
improve affinity for the Y1 peptide, also observed to form a hydrogen bond to the tyrosine 
side chain hydroxyl in the sNTAls3 crystal structure. Conversely, mutation of A22 to N, 
observed to make relatively few contacts in Als3-peptide crystal structures, did not appear to 
significantly alter ∆Tms with peptides, and positive ∆Tm shifts in the presence of the Y2 
peptide were retained. For the triple mutant, the trend in Tm shifts closely resembles those of 
wild type sNT-Als3 for all peptides (section 5.5). This reinforces the importance of sequence 
differences in the pbcs of Als1 and 3 in determining peptide binding specificities, and 
suggests that following further substitutions in the pbc, it may be possible to convert the 
specificity of Als1 to that of Als3.  
NT-Als1CBD                                              
NT-Als1CBD Y168T/Y28T/A22N 
NTAls1CBD Y28T/Y168T     A22N/Y168T 
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  ∆Tm/ oC for peptide 
 
Als1CBD mutant PolyT Y1 Y2 Y3 Y4 NH3 
NT-Als1CBDwt 5.4± 0.3 4.3 ± 0.1 11.5± 0.2 7.8± 0.8 5.0± 0.3 -1.2 ± 0.1 
A22N/Y168T 3.3 ± 0.4 3.3 ± 0.1 8.7 ± 0.1 5.3 ± 0.3 3.4 ± 0.3 -1.7 ± 0.3 
T28Y/Y168T 6.1 ± 0.1 7.4 ± 0.1 5.7 ± 0.3 8.0 ± 0.2 6.5 ± 0.2 0.0 ± 0.2 
A22N/T28Y/Y168T 6.1 ± 0.1 7.6 ± 0.1 12.5 ± 0.1 8.0 ± 0.1 7.3 ± 0.2 0.6 ± 0.3 
sNTAls3 2.8 ± 0.1 2.8 ± 0.1 4.8 ± 0.1 5.8 ± 0.2 6.6 ± 0.1 0.5 ± 0.1 
Figure 5.15 and Table 5.9: ∆Tms of NT-Als1CBD mutants for the 1st generation peptides relative to the 
polyT model, obtained via DSF. Mutation of pbc residues, Y28T and Y168T appears to confer the binding 
properties of Als3 on Als1. Values shown graphically are relative to ∆Tm shifts observed for the peptides minus 
the ∆Tm shift for the model polyT peptide. Raw ∆Tm values tabulated are relative to the Tm for the apo protein. 
5.8 Conclusions and future perspectives 
This is the first study attempting to relate structural differences in the Als proteins to 
sequence based substrate preferences; using measurements of affinity constants and X-ray 
crystallography to explore how different peptide sequences are accommodated within the Als 
pbcs.  
However, further work is required. Crucially, NT-Als3 should be cloned and expressed with a 
CBD domain for binding assays, thus permitting quantitative measures of KDs for 
comparison with Als1 (at best, DSF only allows for identification of trends in binding). In 
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Als1CBDwt A22N/Y168T A22N/Y28T/Y168T sNTAls3 T28Y/Y168T
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addition to sterics, it may be interesting to further investigate the effects of charge on peptide 
binding. Furthermore, differences in binding specificities here have been characterised in a 
model peptide system, where sequences have been manipulated based on contacts observed 
in Als crystal structures. It may thus be argued that the differences in specificities 
documented are a good starting point to predict sequence binding preferences in biological 
peptide substrates. To this end, the high-throughput FP assay developed by a collaborator 
(Dr. Chee, Tate lab, Imperial College) will be used to assay binding to a library of peptides 
derived from the C-termini of extracellular matrix proteins, including those that have been 
documented to bind to Als3.  
The data presented here suggest that Als3 is able to accommodate a wider range of peptide 
sequences than Als1, correlating with observations in the literature (Klotz et al., 2004; 
Sheppard et al., 2004). This is largely due to differences in the Als3 pbc that result in an 
overall increase in cavity size- allowing for accommodation of bulky aromatics or aliphatics 
at P1 and P4, whilst these substitutions are not tolerated in Als1. Additionally, increased 
hydration of the larger Als3 pbc could arguably lead to greater malleability in hydrogen 
bonded water networks, further increasing the potential for broad sequence recognition. 
However, Tm shifts observed with Als3 are generally quite low, and affinities measured with 
the wild type polyT peptide in Chapter 4 were consistently lower than those for Als1. It has 
been documented that there is often a trade-off observed between binding specificities and 
affinities. It is thus possible that whilst Als3 recognises a broader range of sequences, 
interaction affinities for substrate binding tend to be lower than for Als1, which may bind to a 
narrower range of biological ligands with increased affinity. Of note, many other members of 
the Als family exhibit substitutions at similar positions in the pbc; suggesting that there may 
be an affinity and specificity “scale” within the Als family based on properties/size of the pbc 
(Figure 5.16). For example, Als5 is almost 100% identical to Als1 in the A1B1 loop, but 
shares many of the same residues as Als3 in the βA1 strand, suggesting the protein’s 
properties may be intermediary to those of Als1 and 3. Indeed, it is possible that this scale 
extends to homologous adhesins from other Candida or Saccharomyces species. Homology 
modelling of alpha-agglutinin-1, an Als homologue and mating factor from S. cerevisiae that 
binds highly specifically to the a-agglutinin surface glycopeptide ligand with an estimated 
2nM affinity (Zhao et al., 2001), reveals a cavity significantly smaller than that of Als1.  
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Figure 5.16: A potential specificity/ affinity scale for the Als (and possibly other C. albicans adhesins).  
Furthermore, it would be interesting to determine whether the broader binding repertoire of 
Als3 can be related to its increased role in virulence relative to other members of the Als 
family (Hoyer, 2011). For example, it has been demonstrated that in epithelial monolayes, 
there is a direct correlation between cellular damage and C. albicans binding mediated by 
Als3 (Phan et al., 2007b; Zhao et al., 2004).  Als3 alone also appears to bind to ligands that 
may correlate with the protein’s unique functions in infection; gp96 binding has been linked 
to trafficking of C. albicans to the brain in a mouse model (Liu and Filler, 2011), whilst 
recognition of E-cadherin is crucial to Als3’s role as a cellular invasin (Phan et al., 2007b). 
Do these unique biological functions simply reflect Als3’s broader ligand binding repertoire 
and a larger pbc, or are they due to other structural features of the protein? To this end, it may 
be interesting to determine whether pbc-Als1 specificity mutants can acquire Als3 
functionality in in vitro assays, or following incorporation of these mutations into full length 
Als1 at the C. albicans cell surface. 
Finally, the peptides identified from this model system could be useful in design of 
antimicrobials that specifically target C. albicans. Fragment-based screening previously 
attempted in our lab has not been successful in identifying drug candidates against Als1, 
possibly due to the large size of the Als cavities (Dr. Perez Dorado, unpublished data). 
However, some of the peptides identified in this assay bind to Als1 with nM affinity, which 
could feasibly be improved with further engineering of the sequence/ conjugation to other 
chemical moieties. Whilst there are limitations to use of peptides as drug candidates (Otvos et 
al., 2007), antimicrobial peptides have been used successfully in prevention of microbial 
colonisation and biofilm formation on hospital surfaces. 
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 Chapter Six: Structural characterisation of 
effector protein BEC1054 
 
Chapter summary 
BEC1054 is a 10.9kDa protein derived from a class of effectors from the fungus Blumeria 
graminis, an obligate pathogen of H. vulgare. Secreted into the plant host during infection, 
BEC1054 has been demonstrated to be critical to infection maintenance and prevention of the 
hypersensitive response, however the precise role of the protein is unknown. Following 
BEC1054 cloning and optimisation of the purification protocol to produce the protein 
natively, BEC1054 was characterised via solution NMR and the structure solved to 1.9Å 
resolution by X-ray crystallography via iodide-SAD phasing. Higher resolution structures (up 
to 1.14Å) were also obtained through molecular replacement of native datasets using the 
SAD-phased structure. The BEC1054 structure comprises a canonical RNAse fold that 
concurs with structural predictions. The crystal structure reveals clear separation of positive 
and negative charges on the protein surface, in addition to a relatively hydrophobic concave 
surface that could be important in substrate interactions.  
Structural characterisation of BEC1054 could lead to further insights into the protein’s 
function within the plant cell, and is a precedent for structural characterisation of other 
RNAse like BECs from the same effector family. 
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6.1 Background 
Following sequencing of the B. graminis genome, structural modelling of identified CSEP 
proteins revealed that RNAse type folds were considerably overrepresented relative to other 
folds (Pedersen et al., 2012). 75 RNAse type proteins lacking the catalytic residues for 
endonucleolytic activity were identified from a total of 491 CSEPs, predominantly 
concentrated within MCL families 2 (27 of 32 members) and 3 (11 of 20 members). The 
remaining 16 proteins with predicted RNAse fold homology were distributed across the other 
CSEP families. Of these CSEPs, BEC1054 from family 21 was identified as critical to 
infection in the plant, and was thus selected for structural and functional analysis. The I-
TASSER and Phyre2 threading and homology modelling protein structure prediction 
software were consistent in assigning BEC1054 a T1 RNAse type fold (Figure 6.1), although 
lacking the N-terminal β-hairpin and two C-terminal strands typically present in other 
members of the RNAse T1 family.  
 
 
 
 
 
 
Figure 6.1: Phyre (cyan) and I-TASSER (blue) models of BEC1054, compared to T1 RNAse (grey). Both 
servers predict that BEC1054 has an RNAse type fold that overlays well with members of the T1-RNAse 
families, although lacking the N-terminal hairpin and two C-terminal strands (boxed).  
6.2 Refolded BEC1054 yields crystals with suboptimal diffraction 
properties 
BEC 1054 was initially produced according to a protocol developed by the Spanu lab (Dr. 
Dana Gheorghe). The full length protein lacking the 21 amino acid signal sequence 
(corresponding to residues 1-97 of the mature protein), was expressed as an N-terminal his-
tagged fusion from a pET53 vector lacking the strepII tag in BL21 (DE3) cells. BEC-NTH 
was solubilised from inclusion bodies under denaturing conditions (outlined in materials and 
methods), and progressively refolded via dialysis through a series of decreasing urea 
concentrations (8M-0M). Following removal of precipitates via centrifugation, the protein 
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was subjected to affinity chromatography and size exclusion chromatography as outlined in 
methods. Yields from purifications were typically high (~15mgl-1 of unlabelled protein) , and 
size exclusion profiles also suggested that samples were homogenous, yielding a small void 
and narrow symmetrical elution peak at a volume of ~90ml (Figure 6.2). This corresponds to 
a molecular weight of ~13kDa (Figure 6.2); the predicted molecular weight of BEC1054 
(10.9) plus the 2.5kDa non-cleavable tag (MAHHHHHHVTSLYKKAGSEFAL). SDS-
PAGE analysis of peak fractions suggested that the protein contained no visible impurities. 
 
 
Figure 6.2: Purification and refolding of BEC1054-NTH. (A) BEC1054 (marked with an arrow) was 
resolubilised from inclusion bodies in 8M urea in 20mM Tris pH 7.9, 300mM NaCl and 0.1% Tween, and then 
progressively refolded via dialysis in the same buffer containing decreasing concentrations of urea. (B) Size 
exclusion and SDS-PAGE analysis of peak fractions indicated that purified samples were pure and homogenous. 
The solution properties of BEC1054-NTH were characterised by NMR (Figure 6.3). A 1H 1D 
spectrum demonstrated that the protein was folded; spectra exhibited good dispersion in 
regions corresponding to amide protons (8-10ppm) and ring-current shifted methyls 
(<0.5ppm), indicating exposure to a wide range of defined chemical environments. 
Linewidths were also narrow, indicative of good tumbling and minimal aggregation. A small 
peak at 1ppm suggests that disordered regions within the protein are minimal. 
1. Mark12 marker 
2. Cells post-induction 
3. Cell lysate 
4. Supernatant post-centrifugation 
5. Solubilised pellet 
6. Supernatant post refold 
7. Pellet post refold 
8. IMAC flow through 
9. IMAC wash 
10. IMAC eluate 
Void 
BEC1054-NTH 
A                                                                                                   B 
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A 2D 1H 15N NMR spectrum of the protein also exhibited excellent dispersion in both 1H and 
15N dimensions, with minimal peak overlap or signs of aggregation (no peaks are clustered in 
the centre of the spectrum). Peaks corresponding to side chain gln/asn amides are clearly 
identifiable, in addition to a tryptophan Nε1-H1 peak (Figure 6.3). The spectrum contained 
~125 peaks; roughly equal to the predicted value of ~123. This value was calculated based on 
97 residues from BEC1054 plus an additional ~14 from the tag, taking into account peak 
absences from 3 proline residues and predicted peak doublets from 6 asparagine and 
glutamine side chain amides. However, closer inspection of the spectrum indicated that 
several peaks (~10) were symmetrical in nature, but differing in the 1H and 15N frequencies. 
It was hypothesised that symmetrical peak doublets corresponded to a single BEC1054 
residue undergoing conformational exchange in the slow regime of the NMR timescale. 
Consequently, although the total number of peaks was equivalent to the predicted value, 
peaks corresponding to other residues in the protein may have been absent. Peak doubling 
will be discussed further in Chapter 7.  
With the exception of the peak doubling phenomenon, NMR data suggested that BEC1054 
samples were of sufficient quality and homogeneity for crystallisation. Following buffer 
screening and precipitation tests to identify optimal crystallisation conditions, BEC1054 was 
subjected to broad screen crystallisation trials (Hampton research) at 20oC, at 15mgml-1 in 
50mM sodium acetate, 150mM NaCl, pH 4. Optimisation screens based on two initial hits 
(outlined in Figure 6.4) yielded two crystal forms; elongated square bipyramids (~30µm by 
10µm) and cuboidal plates (~50µm by 50µm). Whilst the former did not diffract, for plate 
crystals diffraction was observed to ~2.4 Å. However, crystals were macroscopically 
twinned; a pathology that was inherent in the anisotropic mosaicity of diffraction images 
(Figure 6.4b). Caused by a divergence in Bragg angle at specific crystal rotation angles; 
anisotropic mosaicity is often a symptom of misaligned related lattice planes grown from a 
single nucleation point. This pathology was observed across different crystals frozen with a 
range of cryoprotectants (and in the absence of ice rings), further suggesting that this was a 
problem related to the crystal form rather than ineffectual cryoprotection. High estimated 
mosaicity of the data (~1.6) prevented indexing and integration, despite collection of data 
with fine slicing (Δφ=0.1o) and use of 3d spot profiling in Xia2.  
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Figure 6.4 and Table 6.1: Initial and optimised hits from BEC1054-NTH crystallisation trials. 
Optimisation screens outlined in the table were set up around an initial condition marked in bold. (A) Crystals 
obtained in 0.4M sodium citrate, 0.1M bis-tris propane, pH 7.0, and (B) crystals grown in 0.4M (NH4)2SO4, 
20% PEG 4000, 0.1M sodium acetate, pH 4.6. (C) Diffraction images obtained from a crystal in (B) are shown 
where φ=0 and φ=90o; where φ=90o reflections are highly mosaic. (Spots in the yellow box are shown inset). 
Further optimisation screens set up at 4oC in an attempt to slow the kinetics of crystal growth 
failed to produce single crystals, and streak seeding at lower precipitant concentrations to 
reduce nucleation was also unsuccessful. However, screening with detergents identified n-
tetradecyl-D-maltoside as an additive that successfully reduced plate overlap (Figure 6.5). 
Detergents have been documented to reduce multiple lattice pathologies of crystals of some 
soluble proteins (Guan et al., 2001; Mcpherson et al., 1986), possibly through minimising 
non-specific aggregative interactions and growth of multiple crystals from single nucleation 
Initial condition for optimisation Crystal properties Diffraction properties 
0.5 -1.5M (0.7)M  sodium citrate, 
0.1M bis-tris propance, pH 7.0-
9.0 
Elongated square 
bipyramids, singular 
(panel A). 
No diffraction following crystal 
optimisation 
0.025M-0.5M (0.1)M (NH4)2SO4, 
5-40% (25%) PEG 4000, 0.1M 
sodium acetate/citrate, pH 3.0-
6.0 pH 4.6 
 
Larger cuboids, 
multiple lattice 
pathology (panels B 
and C). 
High mosaicity, reflection smearing, 
datasets could not be processed. 
A                                                                                  B 
C 
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points. Mosaicity was considerably reduced relative to previous crystals, and a single dataset 
obtained at 3Å resolution could be indexed and integrated via XDS (Kabsch, 2010) and 
SCALA (Evans, 2006) from the Xia2 program (Winter, 2010). However, resolution was 
concomitantly reduced, and overall completeness and I/σ(I) of the data were poor as radiation 
damage to the crystal prevented collection of data beyond a rotation of 360o (the theoretical 
minimum to obtain complete native data with two fold redundancy for a crystal of P1 
symmetry.)  
 
Figure 6.5: Improvements in the multiple lattice pathology of BEC1054-NTH crystals with detergents. (A) 
Crystals obtained in 0.1M sodium acetate, pH 5.0, 30% PEG 4000, 0.4 M (NH4)2SO4. (B) Crystals grown under 
the same condition with the addition of n-tetradecyl-D-maltoside and (C) with dodecyltrimethylammonium 
chloride detergents (both at at 1x CMC). Crystals in (B) were still composed of overlapping plates, but 
diffraction mosaicity improved (lower panels, recorded at ϕ=0 and ϕ=90). A dataset obtained could be indexed 
and integrated (Table 6.2). 
Additionally, despite no obvious differences between the 1H 1D NMR spectra of different 
BEC1054-NTH samples, the quality of crystals and resulting diffraction data were highly 
variable between protein batches. Attributed to inconsistencies in the refolding protocol, the 
decision was made to attempt to produce BEC1054 natively. 
                                                                                                    
A                                                   B                                                C 
~3.5Å ~3.5Å 
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Diffraction source DIAMOND IO4 
Wavelength (Å) 1.77 
Rotation range per image (o) 0.1 
Total rotation range (o) 300 
Exposure time per image (s) 0.5 
Space group P1 
Cell dimensions (a, b, c) (Å) 57.40   76.10   84.13       
(α, β, γ) (o) 101.34   90.05  103.39 
Mosaicity (o) 0.323 
Resolution range (Å)  55.77-3.00 (3.08-3.00) 
% Completeness 87.3 (86.3) 
Total number of reflections 36565 (2480) 
Total number of unique 
reflections 
23677 (1698) 
I/σ(I)   (1.5) 
Rpim 0.089 (0.408) 
CC1/2 0.99 (0.97) 
Overall B factor from Wilson 
plot (Å) 
60.19 
Table 6.2: Data collection statistics for a low resolution dataset obtained from a BEC-NTH crystal grown 
with n-tetradecyl-D-maltoside detergent. Numbers in parentheses correspond to values for the outer 
resolution shell. 
6.3 Natively expressing BEC1054 improves the structural properties of the 
protein 
The BEC1054 sequence was cloned into a pNIC vector using the LIC method, thus 
facilitating screening of fusions with various tags to improve solubility. Expression of BEC-
NTHpNIC, BEC-NTHtrx (Thioredoxin)pNIC and BEC-NTHgb1pNIC was trialled in E. coli Bl21 
(DE3) and T7 SHuffle Express cells (NEB). Expression of BEC1054 as a thioredoxin fusion 
in SHuffle cells at 18oC overnight yielded substantial amounts of soluble protein. BEC1054-
trx was purified via affinity chromatography, and the tag removed via cleavage with TEV 
protease and a second round of affinity chromatography prior to gel filtration. Size exclusion 
profiles were comparable to that of the refolded protein, and SDS-PAGE analysis of peak 
fractions showed samples were highly pure. Whilst Figure 6.6 highlights the presence of a 
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possible degradation product in the main size exclusion peak, mass spectrometry was used to 
confirm the molecular weight of BEC1054 (10.9kDa). 
 
 
 
 
 
 
 
 
 
 
Figure 6.6: Native purification of BEC1054 as a Thioredoxin fusion. (A) Post purification via Ni-NTA 
affinity chromatography, the BEC-trx fusion protein (corresponding to a molecular weight of ~25kDa), was 
cleaved by TEV protease to yield BEC1054. (B) Gel filtration of cleaved BEC1054 revealed that samples were 
pure and homogenous.  
The protein was analysed via NMR, and resultant spectra compared with refolded BEC1054. 
Whilst the majority of peak linewidths and dispersion were comparable, several features of 
the spectrum were indicative of an improved sample (Figure 6.7). Resonances corresponding 
to tryptophan amides are more clearly resolved in 1D and 2D spectra and several peaks in the 
ring current shifted methyl region are sharper in linewidth in the 1D, possibly indicative of a 
more stable hydrophobic core. At equal contour levels, 122 peaks were observed in the 2D 
HSQC relative to the 125 for refolded BEC1054, despite the loss of ~14 residues from the 
tag. This suggested that although slow exchange had not been alleviated by production of the 
protein under native conditions, an increased number of resonances could be detected for 
structured BEC1054 residues. It is probable that expression of BEC1054 in SHuffle cells with 
a thioredoxin tag was optimal for disulphide formation; thioredoxin has been demonstrated to 
catalyse oxidative shuffling of disulphides (Berndt et al., 2008). Additionally, controlled 
expression at lower temperatures can facilitate folding.  
1. Mark12 marker 
2. Cells pre-induction 
3. Cells post-induction 
4. Lysate 
5. Supernatant 
6. Pellet 
7. Wash1 
8. Wash2 
9. Eluate (BEC-fusion) 
10. Empty 
11. Cleaved BEC1054 
A                                                                                          B 
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Production of BEC1054 under native conditions vastly improved the crystallisation properties 
of the protein. Crystals were larger and lacked multiple layers, forming from fewer nucleation 
sites in the drop. Such characteristics were suggestive of more controlled crystal growth or an 
improvement in lattice contacts; possibly resulting from a reduction in detritus/aggregates 
that had formed in refolded samples (Figure 6.8). Crystal reproducibility also improved. High 
quality native diffraction data was obtained, with a substantial reduction in reflection overlap 
(panel 6.8). Indexing and integration of reflections was performed in Xia2 (Winter, 2010), 
where spacegroup and unit cell dimensions were estimated in Pointless (Evans, 2006) and 
data were scaled using Scala (Evans, 2006). Processing statistics are outlined in Table 6.3, 
where maximal resolution was selected to afford >90-95% completeness of data and on the 
basis of CC1/2 values. Multiple crystal morphologies were obtained: reflecting differences in 
unit cell dimensions and space group.  
 
Figure 6.8: Macroscopic improvements in BEC1054 crystals and diffraction for natively produced 
protein. Reflections are less mosaic, stronger, and extend to higher resolution. All crystals were grown in 0.2-
0.4M (NH4)2SO4, 10-20% PEG 4000, 0.1M sodium acetate, pH 4.6, where for crystals (A) and (C) the mother 
liquor was supplemented with N-dodecylmaltoside and trimethylamine N-oxide respectively (obtained from an 
additive screen (Molecular Dimensions)).  
 
~1.5Å ~1.1Å ~1.3Å 
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Crystal Crystal A Crystal B Crystal C 
Diffraction source I04 I04 I04 
Wavelength (Å) 0.92 0.92 0.92 
Detector Pilatus 6M-F Pilatus 6M-F Pilatus 6M-F 
Crystal to detector distance (mm) 174.19 158.38 158.48 
Rotation range per image (o) 0.5 0.5 0.5 
Total rotation range (o) 360 360 360 
Exposure time per image (s) 0.20 0.20 0.20 
Space group P62 2 2 P62 2 2 C2 2 2 
Cell dimensions (a, b, c) (Å) 60.5 60.52 
78.28 
60.33 60.33 
78.08 
49.86 53.39 
66.62 
(α, β, γ) (o) 90.00 90.00 
120.00 
90.00 90.00 
120.00 
90.00 90.00 
90.00 
Mosaicity (o) 0.419 0.193 0.114 
Resolution range (Å)  52.41-1.30  
(1.34-1.30) 
52.25-1.26 
(1.29-1.26) 
33.31-1.24 
(1.27-1.24) 
% Completeness 99.5 (96.5) 99.9 (99.3) 98.7 (89.3) 
Total number of reflections 670160 
(25064) 
853485 
(46170) 
318773 
(14571) 
Multiplicity 31.5 (16.9) 36.6 (27.9) 12.7 (8.9) 
Total number of unique reflections 21286 (1483) 23331 (1656) 25198 (1639) 
I/σ(I)  23.4 (5.0) 74.2 (17.5) 36.1 (6.3) 
Rpim 0.017 (0.163) 0.006 (0.04) 0.017 (0.164) 
CC1/2 0.998 (0.996) 1.00 (0.902) 1.00 (0.958) 
Overall B factor from Wilson plot 
(Å) 
12.77 8.935 7.59 
Table 6.3: Processing statistics for the BEC1054 native datasets. Values in parentheses correspond to those 
for the high resolution sheels. 
6.4 Phasing the crystal structure of BEC1054 via iodide SAD 
Initial attempts to phase the native BEC1054 datasets via molecular replacement in Phaser 
(Mccoy et al., 2007) with an F1 RNAse search model (20 % identity over 70% coverage) 
failed, despite the high degree of predicted fold similarity between the proteins. Additional 
search models used included a Phyre model based on the F1 RNAse, and a polyalanine model 
of the F1RNAse generated with Chainsaw (Stein, 2008). In all cases, LLG and translation z 
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function scores were below levels accepted for solution, and the resultant electron density 
maps uninterpretable. 
Several strategies were thus considered for phasing the data experimentally, through 
incorporation of anomalous scatterers via crystal soaks or incorporation of selenium into 
BEC1054 protein samples. Due to the absence of any structured methionines within the 
BEC1054 protein, attempts were made to incorporate selenium via labelling of cysteine 
residues (Salgado et al., 2011). However, yields of selenocysteine labelled BEC were 
extremely poor, and no crystals were obtained under the same conditions as for native BEC. 
The low pH of the BEC1054 crystallisation conditions and presence of high amounts of 
acetate rendered the crystals unsuitable for soaks with many heavy metals. As an alternative, 
phasing was attempted via halide SAD; a strategy that has been successful with a range of 
different protein crystal samples (Dauter et al., 2000; Dauter and Dauter, 1999; Dauter et al., 
2001). Briefly, crystals were fished from the crystallisation drops and transferred to a drop of 
mother liquor supplemented with 0.5M-1M NaI or CsBr solution for 30 seconds. Datasets 
were collected for two of the halide-soaked crystals at a single wavelength corresponding to 
the f’’ peak at the k edge of the elements determined from a fluorescence scan (0.920Å for 
bromide) for SAD phasing.  
Only datasets obtained from crystals soaked with NaI at >1M had sufficient anomalous signal 
for phasing; an RCRanom of >1 even in the outer resolution shell (1.9Å). Images were 
collected over 180o at 1o oscillations to allow for six fold redundancy of reflections 
considering the twelve-fold symmetry of the crystal’s space group, and the need to collect 
both Bijvoet pairs. Data processing statistics are outlined in Table 6.4.   
Following processing, the BEC dataset was submitted to SHELX and autoSHARP suites for 
localisation of anomalously scattering halide atom sites using direct methods (Global 
Phasing). Initial peaks in Fourier difference maps identified 3 iodide sites- confirmed by 
SHARP. Heavy atom phases from the heavy atom substructure were used in calculation of 
the protein phases in Sharp via SAD, to produce phase corrected electron density maps where 
enantiomeric ambiguity was solved using density modification and solvent flattening using 
SOLOMON (Abrahams and Leslie, 1996). A model was subsequently built by ARP-wARP 
(Langer et al., 2008), and refined using iterative cycles of manual and automated refinement 
in Coot (Emsley et al., 2010) and Refmac5 (Murshudov et al., 1997) respectively. 
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Diffraction source I04-1 
Wavelength (Å) 0.9200 
Detector Pilatus 2M (289x254 mm2) 
Crystal to detector distance (mm) 155.776 
Rotation range per image (o) 1.0 
Total rotation range (o) 180 
Exposure time per image (s) 0.15 
Space group P62 2 2 
Cell dimensions (a, b, c) (Å) 60.04   60.04   77.75 
(α, β, γ) (o) 90.00, 90.00, 120.00 
Mosaicity (o) 0.317 
Resolution range (Å)  52.00-1.90 (1.95-1.90) 
% Completeness 100.0 (99.8) 
Multiplicity 18.4 (10.7) 
Total number of reflections 128596 (5333) 
Total number of unique reflections 6985 (498) 
I/σ(I)  39.7 (11.0) 
Rpim 0.016 (0.072) 
CC1/2 anom 0.782 (0.541) 
I/ σ(I)anom  1.95 (1.01) 
% Anomalous completeness 99.9 (99.0) 
Anomalous multiplicity 10.2 (5.70) 
Overall B factor from Wilson plot (Å) 14.96 
Table 6.4: Statistics for processing of anomalous BEC data from NaI soaked crystals. Values in 
parentheses are for the highest resolution shell. Data were processed in Xia2 with a final maximal resolution 
value selected to afford >95% completeness of data and a value of I/σ(I)>1.5 in the outer shell. Native BEC 
crystals produced under conditions outlined in Figure 6.8 were soaked in 1M NaI solution for 30s. 
The asymmetric unit contained 1 molecule of BEC, and 3 iodides. All residues have been 
built with the exception of BEC’s C-terminal glycine and the side chain of R76. Refinement 
statistics are outlined in Table 6.5. Iodide ions were identified in hydrophobic patches at the 
protein surface (in close proximity to Y4 and W6) or coordinated by arginine residues R14 
and R17, or R25 (b and c of panel 6.10).  
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 Figure 6.9: Electron density maps in the BEC1054 structures. A) Iodide positions in the BEC1054 structure, 
with details inset (B+C) (An extra iodide shown comes from a symmetry related molecule). D) The quality of 
2Fo-Fc electron density maps obtained in a BEC structure obtained from molecular replacement of the dataset 
obtained from crystal B. 
Following structure solution, the BEC1054 PDB output file was also used as a model for 
molecular replacement in Phaser to solve higher resolution native datasets obtained. In each 
case, a single unambiguous solution was obtained, with favourable LLG values, translation 
and rotation z-function scores (Table 6.5). The model was refined followed iterative rounds 
of model building in Coot and maximum likelihood refinement in Refmac5 (Murshudov, 
2011), where B-factors were fit anisotropically in refinement of models built for the native 
datasets (deemed to be acceptable following results of a Hamilton R-ratio test). Final 
refinement statistics were good for all models; outlined in Table 6.5. Side chains and residues 
that could not be built into Fo-Fc or 2Fo-Fc maps are outlined in Table 6.6. Validation of all 
BEC1054 structures with the programs Molprobity (Chen et al., 2010), procheck (Laskowski 
et al., 1993a), and tools in Coot indicate that structures have minimal deviations in bond 
length and angles, with no outliers in the Ramachandran plot. However, it should be noted 
that the number of residues with psi and phi conformations in the “allowed” rather than 
“favoured” region of the plot is relatively high for the iodide-phased structure. No difference 
A                                                                      B 
C                                                                      
D                                                                      
R14                                                                    
R17                                                                    
R25                                                                    
R17                                                                 
Y4, W6                                                                  
   R25                                  
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was observed in the topology or positions of secondary structural elements for all BEC 
structures calculated from native crystals relative to the SAD-phased structure. 
 SAD-Iodide 
phased BEC1054 
A10 native E4 native B6 native 
Number molecules in AU 1 1 1 1 
Resolution range (Å) 52.0-1.90 52.41-1.30 52.25-1.70 33.3-1.24 
Vm (Å3/Da) 1.86 1.90 1.88 2.03 
Solvent content (%) 33.76 35.25 34.70 39.56 
MR z-scores (translation, rotation 
functions) 
Not applicable 32.0, 11.5 32.1, 11.8 14.4, 30.41 
MR LLG Not applicable 1439 1437 457 
Total number of reflections used in 
refinement 
6626 20158 9264 23977 
Percentage of reflections for Rfree (%) 4.77 5.15 5.10 4.76 
Rwork, Rfree  0.189, 0.237 0.139, 0.178 0.134, 0.175 0.138, 0.151 
Overall FOM 0.863 0.890 0.903 0.922 
CC1/2 (Fo-Fc), CC1/2free 0.938, 0.897 0.976, 0.966 0.966, 0.946 0.973, 0.958 
Average DPI, DPIfree 0.182, 0.162 0.048, 0.048 0.168, 0.092 0.041, 0.036 
Atomic displacement model Isotropic, no TLS Anisotropic Anisotropic Anisotropic 
Overall average B factor (Å2) 12.02 10.40 10.93 15.30 
Non crystallographic symmetry restraints x x x x 
Number of protein atoms 760 758 760 760 
Number of ligand atoms 3 (Iodides) 0 0 1 (TMO) 
Number of water atoms 89 86 84 93 
Rms deviations Bond  lengths (Å) 0.0223 0.0304 0.0324 0.044 
                           Angle distances (o) 2.0057 2.3901 2.475 1.670 
                           Chiral volumes 0.1342 0.1377 0.1336 0.1479 
Ramachandran plot  Favoured (Allowed) 
(%)                                  
80.5 (19.5) 86.7 (12) 95.74 (4.26) 91.6 (8.4) 
                                Disallowed (%) 0 0 0 0 
Table 6.5: Refinement statistics for the BEC1054 crystal structures. AU=Asymmetric unit, MR=Molecular 
replacement, DPI= Dispersive positional error. TMO= Tri-methylamine-N-Oxide. 
 SAD phased A10 E4 B6 
Missing atoms R76 side chain 
G97 residue 
K75 side chain 
R76  side chain 
E96 side chain 
R91 side chain 
G97 residue 
R76 side chain 
G97 residue 
K68 
E96 
G97 residue 
Table 6.6: Missing atoms from the BEC1054 structural models. 
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6.5 The crystal structures of BEC1054 
BEC1054 has a canonical (α+β) RNAse fold characteristic of the T1 family (Figure 6.10). 
The core of the protein is composed of a four stranded anti-parallel β-sheet, comprising 
strands β3 (residues35-37), β4(50-55), β5(69-73), and β6(80-84).  Alpha-helix α1 (residues 
12-24) lies perpendicular to the convex face of the central β-sheet; a highly hydrophobic 
interface maintained by contacts between a strip of apolar residues on one face of the helix 
(V15, A18, V19 and L21) and others lining the convex face of the β-sheet (F53 from β5, Y79 
and I71 from β6, and L80 and V82 from β7). Loop β3-β4 also contains 1.5 turns of a 310 
helix (α2). A second smaller antiparallel β-sheet is located at the periphery of the protein, 
comprising an N-terminal hairpin formed from strand β1 (residues Y3-C6) and β2 (T9-P12), 
and C-terminal strand β7 (T93-V95). A single disulphide between C6 of strand β1and C92 of 
the β6-7 loop links the N and C-termini of the protein; this disulphide is universally 
conserved throughout the RNAse T1 family.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.10: The structure (A) 
and topology of BEC1054 (B). The 
topology diagram was generated 
using assignments from the DSSP 
program (Kabsch and Sander, 
1983). 
 
  
  
 
180o, y axis 
A 
 
 
 
 
 
 
 
B 
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Charge is clearly segregated at the surface of BEC1054 (Figure 6.11). A large band of 
negative charge outlines the top of the convex face of BEC; contributed by the peripheral β-
sheet and loop β5-6 (regions highly enriched in glutamate and aspartates). The solvent 
exposed face of helix 1 is predominantly cationic, and two smaller regions of positive charge 
are located at the solvent exposed face of the core β-sheet; formed by R26 and K27 of loop 
H1-β3, and R14 and R17.  The concave face of BEC1054 is surprisingly hydrophobic for a 
solvent exposed surface; defined by the main β-sheet and extended loop regions β6-7 and β4-
5. Specifically, the edges of the β sheet are lined with aromatic residues (F38, F44, Y70, Y79 
and F85). 
 
 
Figure 6.11: Surface 
electrostatics (A) and 
distribution of 
aromatics (B) in 
BEC1054. Positive and 
negative charge are 
clearly segregated at the 
surface of BEC1054, 
with many aromatics 
(orange) localising to a 
hydrophobic concave 
surface of the protein. 
A 
 
 
 
 
 
 
 
 
 
 
B -                                               +                    
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6.6 Conclusions and perspectives; can structural homologues provide 
insights into the function of BEC1054? 
The crystal structure of BEC1054 concurs relatively well with the predicted homology 
model, exhibiting a T1- RNAse type fold. Following submission of the BEC1054 structure to 
the Dali server (Holm and Rosenstrom, 2010), the only “non-spurious” structural homologues 
identified were members of the T1 RNAse family, or fungal ribotoxins (Table 6.7).   
 
 
Table 6.7: Top unique structures obtained from a Dali search with the BEC1054 PDB coordinates 
identifies T1 RNAses (top half) and fungal ribotoxins (bottom half). z scores of above 2 are considered to be 
“non-spurious”. %LAli corresponds to the number of structurally equivalent residues. 
 
Derived from fungi or bacteria, T1 RNAses are guanyl-specific RNAses with roles ranging 
from cellular RNA turnover to phosphate scavenging, nitrogen storage and microbial defence 
(Irie, 1999). Analogously to BEC1054, they are composed of a core four-stranded β sheet 
packed against a perpendicular α-helix, and short N-terminal hairpin. The active site of the  
 Dali z score RMSD (Å) % Identity %LAli pI Species 
BEC 1054 x x x x 5.6 B. graminis 
RNAse MS (PDB 
1rds-A) 
9.9 2.6 17 100 3.9 Aspergillus 
satoi 
RNAse Po1 (PDB 
3wr2-C) 
9.5 2.0 20 100 8.3 Pleurotus 
ostreatus 
RNAse T1 (PDB 
1rn1-C) 
9.4 2.5 19 100 4.1 Aspergillus 
oryzae 
RNAse  F1 (PDB 
1fus-A) 
9.2 2.5 24 100 4.4 Fusarium 
moniliforme 
RNAse SA 
(PDB) 
3.6 3.9 13 66 5.7 Streptomyces 
aureofaciens 
RNAse SA3 
(PDB) 
3.4 3.7 10 69 4.5 Ralstonia 
solanaceurum 
Restrictocin 
(PDB) 
7.9 2.8 11 62 9.3 Aspergillus 
restrictus 
Alpha-sarcin 
(PDB) 
7.7 2.9 11 67 9.2 Aspergillus 
giganteus 
Hirsutellin A 
(PDB) 
6.6 3.3 16 66 9.3 Hirsutella 
thompsonii 
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RNAse is located on the opposite face of the β-sheet (Figure 6.12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.12: The surface and secondary structure characteristics of BEC1054 (centre) compared to those 
of Fusarium monoliforme F1 RNAse (left) and restrictocin (right), a fungal ribotoxin from Aspergillus 
fumigatus.  RNAse F1 (PDB code 1FUT) and restrictocin (PDB code 1JBR) surfaces are shown with substrate 
analogues used for crystallisation (2’GMP and a 31 nucleotide SRL analogue respectively).  
 
Fungal ribotoxins are also guanyl-specific RNAses, but are highly specific to recognition of 
the GAGA tetraloop of the SRL (sarcin ricin loop) ribosomal RNA 28S sequence; conserved 
across the kingdoms of life (Endo and Wool, 1982; Schindler and Davies, 1977; Wool et al., 
1992). Cleavage occurs within the GAGA tetraloop between nucleotides G4325 and A4326 
(rat 28S numbering) (Macbeth and Wool, 1999; Yang et al., 2001). Unfolding of the tetraloop 
is required for docking of G4325 and A4326 within the active site and alignment of the 
scissile bond; mediated by recognition of an adjacent bulged-G motif (base G4319) in the 
SRL termed the “ identity element”  (Yang et al., 2001) (Figure 6.13). Fungal ribotoxins thus 
comprise the core T1 RNAse fold and active site, but have evolved additional peripheral 
SSEs for contacting the ribosome and conferring specificity for the SRL (Figure 6.13). 
Extended loop regions with highly basic insertions, (β2-3, β3-4 and β4-5) contact the SRL 
F1 RNAse                                   BEC1054                                  Restrictocin      
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identity element and ribosomal protein L9, and an extended N-terminal β-hairpin is proposed 
to interact with phospholipid membranes to mediate cell entry (Garcia-Mayoral et al., 2005). 
 
The secondary structural elements (SSEs) of BEC1054 and crystal structures of the T1 
RNAses or ribotoxins superimpose with between 1.0Å- 1.5Å RMSD between Cαs. SSEs are 
conserved in terms of topology despite relatively low sequence identities (Figure 6.13), 
although T1 RNAses lack the 310-helix present in BEC and ribotoxins. Loop regions in 
ribotoxins are significantly longer than in T1 RNAses and BEC1054; defining a deeper 
binding surface for accommodation of the tertiary structure of the SRL (relative to single 
stranded RNA bound by T1 RNAses).  
 
Although overall sequence conservation between BEC1054 and the T1 RNAses or ribotoxins 
is low (Table 6.7), regions of high sequence conservation localise to the concave face of 
BEC1054 and loops α1-β3 and β4-β5 (Figure 6.13 lower panel), corresponding to the RNA 
binding site of these proteins. Whilst BEC1054 lacks the conserved catalytic triad for RNAse 
activity (E58 corresponds to a deletion in strand β4, His92 is substituted by serine and R77 
by lysine), many residues that form hydrophobic contacts or π-stacking interactions with the 
guanosine base in T1 RNAse or ribotoxin crystal structures are conserved, such as F94, T37 
and F38 (corresponding to residues F100, T41 and Y42 in RNAse F1 and T52 and F51 in 
restrictocin) (Vassylyev et al., 1993; Yang et al., 2001). Residues that form hydrogen bonds to 
the phosphate backbone are also conserved; including Y34 (Y38 in RNAse T1, W50 in 
restrictocin) and K70 (R77).  However, none of the hydrogen bonds formed between the 
RNAses and the guanosine base (Y42, N43, N44, and N98) are conserved in BEC1054, 
suggesting that although BEC1054 may have the capacity for RNA (or nucleic acid) binding, 
the protein lacks the active site geometry requisite for strict guanosine specificity. 
Mutagenesis studies have demonstrated that these residues are critical to guanosine 
specificity in T1 RNAses (Steyaert et al., 1994; Steyaert et al., 1991). Notably, these residues 
are not strictly conserved in ribotoxins (F51, T52 and N53 in restrictocin), where substrate 
specificity is primarily dictated by the tertiary structure of the RNA rather than primary 
sequence. 
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Figure 6.13: Residue conservation between BEC1054 and the T1 RNAse and ribotoxin families  maps to the RNA binding site. (A) Crystal structures of F1 RNAse, 
BEC1054 and restrictocin. Dark blue residues are relatively conserved between all three structures, and interact with the sugar or phosphate backbone of RNA substrates  in 
restrictocin and F1RNAse. Magenta residues form specific contacts to the guanosine base, and are not conserved in BEC1054.  Residues requisite for recognition of the SRL 
identity element in restrictocin are red, in addition to residues K26 and R25 in BEC1054 (this region is overlaid in (D)). (B) Overlay of the F1RNAse and restrictocin active 
site, illustrating specific recognition of the guanosine base geometry by residues that are absent in BEC1054. (C) Sequence conservation with T1 RNases and ribotoxins is 
mapped onto the BEC1054 structure, using conservation scores calculated by the ConSurf program from MSAs of the T1 RNAse and fungal ribotoxin families. Conserved 
residues are coloured blue and variable sequences are yellow, and a guanyl substrate analogue is superimposed on the putative RNA binding site. 
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In the context of preliminary data from collaborators suggesting BEC1054 may associate 
with ribosomes and a hypothesised association with the SRL (Spanu lab, unpublished data), it 
is of interest that fungal ribotoxins were identified as structural homologues by Dali. 
However, BEC1054 lacks many of the sequence or structural motifs present in ribotoxins that 
mediate specific ribosomal contacts. Loop regions β2-3, β3-4 and β4-5 are considerably 
shorter in BEC1054, and less enriched in basic residues (Figure 6.13). Specifically, BEC1054 
lacks a conserved stretch of lysine residues (K110, K111 and K113 in loop β4-5 in  
restrictocin) which mutagenesis studies have shown to be essential for recognition of the SRL 
identity element (Garcia-Mayoral et al., 2005). It is feasible that R25 and K26 within the α1-
β3 loop of BEC1054, which is close to K110-K113 in structural overlays if not in sequence, 
could play a similar role in contacting the identity element (Figure 6.13). Cationic residues 
are absent from this region of the structure in the T1 RNAse family.  
Furthermore, proposed ribosomal targeting sequences that are conserved amongst fungal 
ribotoxins (Table 6.8) are absent in BEC1054. These sequences are highly homologous to 
motifs from other ribosomal associated proteins that bind within the region of the SRL. 
BEC1054 does contain a sequence motif TNKRGSY that has some similarity to a targeting 
sequence from eukaryotic elongation factors EF-1, 2 and 3; absent from members of the T1 
RNAse family. However, this is located in strand, a distinct region of the structure from the 
N-terminal β hairpin as in ribotoxins.  
 
Consensus ribosomal targeting 
sequence from  ribotoxins 
Position in 
ribotoxin 
Consensus ribosomal targeting sequence from  
ribosome associated proteins 
KFDSKK(P/F)K Loop β4-5 
Ribosomal protein S12 
KYG(A/T)K(K/R)(P/F)K 
TNK(W/F/Y)E(D/T)K 
N-terminal β 
hairpin 
Eukaryotic elongation factors EF-1, 2 and 3 
TNK(W/Y/F)x(E/N/D/)K 
   
Table 6.8: Ribosomal recognition sequences identified in other ribotoxins. (Kao and Davies, 1995, 1999). 
 
If BEC1054 can associate with ribosomes, a lack of sequence conservation in elements 
known to be critical to ribotoxin activity suggests that the protein has either diverged 
evolutionarily to such an extent that similarities cannot be detected, or perhaps (more likely), 
that association with the ribosome is mediated by other structural features. Of note, ribosomal 
recognition by host plant ribosome inactivating proteins is mediated by entirely different 
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structural features. A strictly conserved tryptophan within the active site contacts the SRL 
(W241 in maize RIP), whilst two conserved tyrosine residues (Y94 and Y130 from maize 
RIP) form π-π stacking interactions with base A4324 of the SRL (Nga-SzeMak et al., 2007, 
Peumans et al.2001). Remaining structural elements that contact the ribosome are quite 
variable between plant RIPs, reflecting differences in the ribosomal proteins that are 
recognised. 
 
Analogously to T1 RNAses and ribotoxins, BEC1054 exhibits clear segregation of anionic 
and cationic charge at the protein surface; a feature common to nucleic acid binding proteins 
(Figure 6.14). In all of these proteins, positive charge maps to the putative RNA binding site 
at the concave face of the protein; to the base of loop α1-β3, strand β3 and loop β4-β5.  
 
Figure 6.14: The surface charge distribution in BEC1054 appears to be intermediary to that of T1 
RNAses and fungal ribotoxins.  All proteins exhibit charge separation where positive charge is located to a 
putative RNAse binding site, (Vedadi et al., 2006) but the overall surface charge of BEC1054 is intermediary to 
that of T1 RNAses (acidic) and ribotoxins (highly basic). Proteins in upper and lower panels are related by a 
180o rotation about the y axis, where the orientation is shown in a small cartoon figure inset.
F1 RNAse                             BEC1054                                                 Restrictocin  
RNAse F1                                   BEC1054                                                    Restrictocin 
  180o, y 180o, y -                                 +                    
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The overall pI of BEC1054 and distribution of surface charge appears to be intermediary to 
those of fungal ribotoxins and the T1 RNAse family (Tables 6.7 and Figure 6.14). In the T1 
RNAse family, the protein surface is predominantly anionic, reflected in the acidic pIs of 
these proteins. Anionic residues cluster to other faces of the protein; primarily to the base of 
α1 and loops β3-β4 and alongside one edge of the β-sheet. Negative charge is also localised 
to a similar region of BEC1054, contributed by the peripheral β-sheet and loop β4-β5. In T1 
RNAses, acidic regions have been proposed to induce repulsion of the phosphate backbone, 
preventing docking of an RNA substrate in an incorrect orientation (Sugio et al., 1985). 
Conversely, fungal ribotoxins exhibit a very high density of surface cationic residues (Figure 
6.14). In RNAses, basic pIs appear to correlate with increased levels of cytotoxicity, as a 
direct consequence of increased cellular entry (Ilinskaya et al, 2002, Futami et al, 2001). It 
has been proposed that cationic surface residues interact with anionic phospholipid 
membranes to promote membrane aggregation and fusion in endocytotic uptake (Gasset et 
al., 1990; Yang and Moffat, 1996). The mechanism of B. graminis effector entry into the 
plant cell is currently debated in the literature, although a highly conserved N-terminal YxC 
motif within the CSEP family is proposed to be important for host vesicular trafficking 
(Spanu et al., 2010, Godfrey et al., 2010). However, it is possible that the cationic face of 
helix 1 in BEC1054 initiates non-specific binding of the effector to host vesicle membrane 
surfaces prior to entry, in a fashion analogous to ribotoxins and other (extracellular) T1 
RNAses (RNAse Pol1). 
Structural similarities identified between BEC1054 and T1 RNAses/ ribotoxins coupled with 
conservation in non-catalytic active site residues suggest that the protein could have a role in 
nucleic acid binding within the host cell. However, structural similarities between BEC1054 
and ribotoxins are perhaps less convincing. Sequence conservation with BEC1011 (another 
member of family 21 shown to be critical to infection in HIGs assays) (Pliego et al., 2013), 
within the putative RNA binding site suggests that these proteins could have a modular role 
in RNA binding, where conserved residues for RNA recognition are under purifying 
evolutionary selection but additional residues have evolved to confer specificity for different 
substrate sequences. Alternatively, it is possible that these proteins are paralogues that 
recognise the same target, and have diverged under strong evolutionary pressures to escape 
recognition by host R proteins (Chapter 1.3.1). 
Furthermore, it cannot be discounted that BEC1054 has a biological role that is not linked to 
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RNA binding activity. Notably, residue conservation in the putative BEC1054 binding site is 
very low for remaining five members of CSEP family 21, in the context of highly divergent 
sequences (Figure 6.15). The concave nature of the BEC1054 surface (Figure 6.12) coupled 
with the unusually high hydrophobicity of this region renders this an ideal interface for a 
protein-protein interaction. The RNAse fold is very thermodynamically stable (Klink and 
Raines, 2000; Klink et al., 2000), and perhaps an optimal scaffold for evolution of fungal 
effectors with different functionalities; attested to by the prevalence of predicted RNAse folds 
within the B. graminis effectorome (Pedersen et al., 2012).  
 
 
 
 
 
 
 
 
 
Figure 6.15: Conservation in sequence within CSEP family 21 reveals that putative RNA binding residues 
are poorly conserved. Sequence conservation (calculated using the Consurf server) is mapped onto the 
BEC1054 structure, shown in two orientations. Highly conserved residues are coloured blue and poorly 
conserved are yellow. 
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Chapter Seven: NMR-based interaction analyses 
of BEC1054; testing the RIP inhibitor hypothesis 
 
Chapter summary 
BEC1054 exhibits an RNAse- type fold, where many of the residues from a putative binding 
site are conserved with those present in the fungal T1 RNAse family and fungal ribotoxins. 
The structure of BEC1054 was further probed by NMR, and resonances in the HSQC 
spectrum assigned to corresponding residues in the BEC1054 protein sequence. Structural 
features of BEC1054 in solution concur with those present in the crystal structure, however 
NMR data suggest that the protein may be relatively dynamic in solution, with several 
regions undergoing conformational exchange that can be detected on the NMR timescale.  
Further titrations with nucleic acid sequences (including total RNA and ribosomal SRL DNA 
and RNA sequences) suggest that BEC can bind to nucleic acids with weak affinity, with 
CSPs mapping to the putative RNA binding interaction site. Additionally, preliminary NMR 
titrations performed with polysomes could be indicative of a weak interaction. However, 
ribosome binding experiments are inconclusive, whilst low affinity measurements for the 
nucleic acid sequences tested suggests that these ligands are not optimal. Further experiments 
will be required to test the hypothesis that BEC1054 binds to the host ribosome SRL to 
outcompete interactions with host RIPs induced as part of the hypersensitive defence 
response (Spanu lab). However, the BEC1054 backbone assignment will be invaluable for 
determining the interaction surface of BEC1054 and any binding partners identified in the 
future. 
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7.1 Background 
The crystal structure of BEC1054 confirmed that the protein exhibits an RNAse type fold, 
where many of the residues from a putative RNA binding site are conserved with the T1 
RNAse family and ribotoxins. Furthermore, previous DSF experiments performed by the 
Spanu lab (Helen Pennington, unpublished data) suggested that BEC1054 may be capable of 
interacting with RNA. NMR chemical shift perturbation (CSP) analysis upon titration of a 
protein with a ligand can be a powerful technique for characterising interactions; providing a 
means for calculating KDs in the mM-μM range, and for identifying a ligand binding site in a 
structure following assignment of peak resonances in the HSQC. The latter requires 
correlating the 1H15N amide HSQC resonances with the 13C chemical shifts of atoms from the 
same residue in the protein backbone via 3D experiments. Previous 2D NMR spectral 
characterisation of BEC1054 had suggested that samples were amenable for 3D NMR 
analysis.  
To further investigate the Spanu lab’s hypothesis that BEC1054 can interact with the SRL 
from the 28S rRNA, the BEC1054 HSQC was assigned, and binding experiments performed 
with BEC1054 and total plant cell RNA and SRL oligonucleotides. In addition, binding to 
ribosomes was tested via preliminary NMR experiments performed with commercially 
available Promega wheat germ translation extracts (containing plant ribosomes), and 
polysomes extracted from barley in this laboratory. 
7.2 Preliminary analysis of BEC1054 by NMR and peak doubling  
Previous characterisation of natively produced BEC1054 by 1D 1H and 2D 1H-15N NMR 
(Chapter 6.3) had demonstrated that samples were folded, exhibiting good peak dispersion in 
spectral regions corresponding to amides, tryptophan side chains and ring-current shifted 
methyls/methylenes, all with narrow linewidths (Figure 6.7). However, the spectrum contains 
122 peaks, an excess for a protein of 97 amino acids containing 3 prolines. Closer inspection 
of the spectrum (Figure 7.1) revealed that several peaks were reflected by 180o and translated 
in the nitrogen and proton frequencies respectively, exhibiting differences in peak intensity 
although equivalent in shape. This could be indicative of conformational exchange on the ms-
s timescale (in the range of slow exchange on the NMR timescale). In this regime, kex for 
interconversion of the residue conformers is >10x the difference in linewidth between the two 
resonances (δv) (measured in Hz), and the conformers exist for a sufficient period of time for 
separate resonances to be observed, with peak intensities proportional to their relative 
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conformational exchange at higher pH (Figure 7.4, red), and those that are in fast exchange at 
lower pH (Figure 7.4, blue).  
Conformational exchange for residues in the region of the peripheral β-sheet (strands β2 and 
β7) and strand β6 of the main sheet could feasibly arise from differences in the alignment of 
C-terminal strand (β7), as the chemical shifts of proton and nitrogen nuclei are highly 
sensitive to changes in hydrogen bonding patterns. Whilst in the BEC1054 crystal structure 
β7 forms hydrogen bonds to the N-terminal β- hairpin, in many crystal structures of T1 
RNAses the C-terminal strand either aligns with the central β-sheet, or appears to be 
unstructured (Vassylyev et al., 1993). Indeed, B factors for residues in the β7 strand of the 
BEC1054 crystal structure are significantly higher than those of other strands, often 
indicative of increased flexibility (Figure 7.4d). Displacement of strand β7 would induce 
disruption of hydrogen bonds formed to residues Y3 and D5 in β1 of the BEC1054 crystal 
structure; however, only W4 is observed to undergo exchange in NMR. Arguably, movement 
of strand β7 from above to below the plane of the tryptophan indole could induce changes in 
the chemical shift of W4. Alignment of strand β7 with the core β-sheet could also underlie 
chemical shift changes observed in alternating amides in the β6 strand; characteristic of 
alternating hydrogen bond patterns in β-sheets (Figure 7.4). However, amides observed to 
undergo exchange currently form hydrogen bonds to strand β5 (inset), suggesting that a shift 
in strand register would be required.  
Whilst in silico docking studies (Clus Pro 2.0 server) (Comeau et al., 2004) suggested that 
peak doubling could potentially result from transient dimerization of BEC1054 (Figure 7.5), 
several factors suggest that this is unlikely. Many residues mapping to the proposed interface 
do not exhibit conformational exchange in spectra, no significant linewidth broadening is 
observed, and proximity of repulsive charges in the proposed interface is likely to be 
energetically unfavourable. There is also no evidence for BEC1054 dimerisation in vitro.  
Experimental conditions that minimised peak doubling were selected for acquiring 3D 
spectra; initially with the aim of solving the structure of BEC1054 via NMR. (NMR structure 
determination relies on long-range restraints derived from assignment of NOEs; a process 
that is complicated by conformational exchange). A pH of 7.4 and a temperature of 308K 
were thus selected for 3D experiments, as a physiologically relevant condition that minimised 
peak doubling.  
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Figure 7.4: Residues undergoing conformational exchange in BEC1054 may relate to changes in the 
position of the β7 strand. (A) Residues in fast exchange at lower pH (blue) map to regions around strand β7 in 
the BEC crystal structures. In members of the T1 RNAse family, the position of strand β7 (boxed) differs from 
that in the BEC1054 structure, suggesting that flexibility in this region could account for chemical exchange in 
BEC NMR data. T1 RNAse residues corresponding to those undergoing exchange in BEC1054 are coloured 
blue and labelled (BEC1054 numbering in brackets). (C) Changes in b-sheet hydrogen bonding could also 
correlate with observations that alternating residues are in exchange. (D) High B factors for this strand in the 
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BEC1054 crystal structure (marked with an asterisk on the graph) further suggest that this region is 
conformationally flexible. (RNASe T1 PDB codes 110X and 1RNT). 
 
 
 
 
 
 
 
 
Figure 7.5: Possible transient dimerization of BEC1054 could account for peak doubling. (A) Several 
residues undergoing chemical exchange form interactions at the modelled interface (R17 salt bridge, E96 base 
stacking). (B) However, electrostatic repulsion at the modelled interface is likely to render the interaction 
energetically unfavourable. Docking performed using the ClusPro 2.0 server (ref, date). 
7.3 The backbone assignment of BEC1054 provides insights into dynamic 
regions that may have a role in ligand binding 
The backbone assignment of BEC1054 was performed with a double labelled sample 
(15N13C) and a standard suite of NMR experiments (Sattler et al., 1999).  
Briefly, an HSQC correlates the chemical shifts of covalently bonded 1H and 15N (or 13C) 
nuclei, yielding a spectrum with a cross peak for every amide bond within a protein. Amide 
resonances can be further correlated with the chemical shifts of carbon nuclei via addition of 
a third C13 dimension to the correlation experiment. (Practically, 13C resonances can thus be 
viewed as “strips” in a third dimension extracted from root amide resonances in a 2D HSQC, 
Figure 7.6a). For the BEC1054 backbone assignment, 13C’ carbonyl chemical shifts were 
obtained from 3D HNCO and HN(CA)CO experiments, and HNCACB and CBCA(CO)NH 
experiments were used to obtain 13C Cα and Cβ chemical shifts. In these experiments, nuclei 
are correlated as magnetisation is transferred via J coupling.  
 
A                                               B 
-                                 + 
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CBCA(CO)NH                                                                 HNCACB 
Figure 7.6: Overview of the backbone 
assignment process. (A) The C13 
dimension can be viewed as “strips” 
extracted in a third dimension from the 
2D HSQC. (B) Magnetisation transfer 
scheme for CBCA(CO)NH and 
HNCACB experiments, where 15N and 
1HN resonances are correlated with Cα 
and Cβ 13C resonances for the (i-1) and 
(i and i-1) residues respectively. 
Magnetisation is transferred via nuclei in 
grey, but signals are only recorded from 
nuclei in red. (C) Sequential alignment 
of resonances assigned as Cα and Cβ(i/i-
1) from different strips of the BEC1054 
spectra allows for assignment of 
resonances to the sequence. 
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In a CBCA(CO)NH experiment, transfer of magnetisation occurs from Hα and Hβ protons to 
Cα and Cβ carbons via an INEPT pulse sequence, and subsequently to the 13C’ carbonyl of 
the same residue and amide N of the next residue via 90o pulses. Magnetisation is finally 
transferred to the amide proton of the next residue for detection via a retro-INEPT sequence. 
As the chemical shifts are allowed to evolve on 13 Cα and Cβ (during t1) and 15N (during t2), 
spectra correlate the 15 N and 1H of the current amide, in addition to the preceding or inter (i-
1) Cα and Cβ resonances (Figure 7.6b).  Conversely, in an HNCACB experiment, where 
magnetisation is also transferred to the Cα and Cβ, the C’ carbonyl may be bypassed, thus 
yielding resonances for both residue i and i-1 (intra and inter). By comparing the data from 
these experiments (Figure 7.6a and c), one can assign resonances as inter or intra, and as 
belonging to a Cα or Cβ (exhibiting a 180o phase difference in the HNCACB spectrum). 
Following assignment of inter and intra-residue Cα and Cβ chemical shifts, sequential 
connectivities can be established by aligning peaks in the HNCACB and CBCA(CO)NH 
spectra from different HSQC root amide resonances (Figure 7.6c). Using the known protein 
sequence, stretches of connecting resonances are assigned specific residue identities 
according to the characteristic shifts observed for Cα and Cβ atoms in different amino acids.  
The inter- and intra- carbonyl residues are assigned using the same principle; where an 
HN(CA)CO experiment yields only inter C’ chemical shifts, and the HNCO yields both inter- 
and intra-residue carbonyl resonances. In assignment of the BEC1054 HSQC, carbonyl 
resonances derived from these experiments were used to resolve ambiguities in assignments 
due to overlap of Cα and Cβ resonances. 
Following peak picking in the BEC1054 HSQC, assignment of inter- and intra- C13 
resonances and residue connectivities, chemical shift values were assigned to specific 
residues using a combination of automated assignment with the program MARS (Jung and 
Zweckstetter, 2004) and manual inspection. Excluding prolines, the backbone of BEC1054 
was assigned to 92.7% (89/96 residues) (Figure 7.7).  
The BEC1054 HSQC contains 4 unassigned clear peaks (marked with a green asterisk in 
Figure 7.7), and 3 small unassigned peaks that could correspond to noise in the spectrum or 
alternate conformations of other residues. None of these peaks yielded data in the 13C 
dimension. Absences of resonances in the carbon dimension could result from conformational 
flexibility in side chains (lacking a defined chemical shift), or from chemical exchange on the 
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Lβ6-7 and Lβ3-4 between “open” and “closed” conformations. The majority of T1 RNAse 
structures have been obtained in complex with ligands, and it is thus possible that 
conformational flexibility in these loop regions of BEC1054 has a role in ligand binding. 
 
Figure 7.8: Unassigned residues map to loop regions of the BEC1054 structure (labelled red). Whilst in the 
BEC1054 structure these loop regions are in an “open” conformation, in other T1 RNAses they are in a “closed” 
conformation, suggesting that flexibility and dynamics in these regions may underlie losses in NMR signal. 
Following assignment of the BEC1054 backbone, chemical shifts for the amide proton, amide 
nitrogen, Cα and Cβ were input to the TALOS (Shen et al., 2009) and CSI (Hafsa and 
Wishart, 2014) secondary structural prediction programs. The Cα and Cβ resonances are 
particularly sensitive to dihedral angles and exhibit characteristic shifts when present in 
helical, β-sheet or loop regions. TALOS predicts secondary structure based on dihedral 
angles, whilst CSI calculates secondary structures directly from the chemical shifts. Whilst 
both SSE predictions concur relatively well with the crystal structure (Figure 7.9), both 
programs fail to predict the presence of the 310 helix and CSI does not predict the presence of 
strand β2 and β7 forming the peripheral β-sheet. This could provide support for the 
hypothesis that this strand may alternate between a disordered conformation and 
T1 RNAse                                                                                                                            BEC1054 
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complementing the core or peripheral β-sheets, accounting for the chemical exchange 
observed for residues in this region of the protein.   
 
Figure 7.9: TALOS and CSI secondary structure predictions from BEC1054 chemical shifts compared to 
the crystal structure. SSEs that are present in the crystal structure but are not predicted from the NMR data by 
the TALOS or CSI programs are boxed in red and labelled. 
7.4 BEC1054 interacts with nucleic acid 
In order to test the hypothesis that BEC1054 is an RNA binding protein, BEC1054 was 
titrated with total RNA extracted from a plant cell (RNA provided by Helen Pennington, 
Spanu lab). Free amine groups in BEC1054 were labelled with a fluorophore (Nanotemper 
MO-L003 kit), and titrated against unlabelled RNA at a maximal concentration of 1μg.  
 
 
 
 
 
Figure 7.10: BEC1054 
interacts with total RNA 
from barley (A). Results are 
the average of two separate 
measurements so standard 
deviations are not shown. (B) 
No binding was observed for 
negative controls, when BSA 
was titrated against total RNA, 
or BEC1054 was titrated 
against BSA. 
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Experiments indicated that BEC1054 bound to total RNA (Figure 7.10), whilst no binding 
was observed in control experiments performed with BEC1054 titrated against BSA, and 
labelled BSA titrated against total RNA. Unfortunately, the interaction could not be 
investigated by NMR as insufficient amounts of total RNA were produced from extractions. 
Whilst the inhomogenous nature of total RNA prevented estimation of a precise KD for the 
interaction, binding curves suggested that a KD could lie within the low micromolar range. To 
determine whether BEC1054 could specifically recognise an RNA SRL sequence in line with 
the Spanu lab hypothesis, BEC1054 was also titrated against a single-stranded (ss) SRL RNA 
sequence produced via in vitro transcription (Figure 7.11). The transcript was designed and 
synthesised by Helen Pennington (Spanu lab), based on a model SRL sequence from rat 28S 
rRNA as the barley 28S rRNA has not been curated. However, this region is typically highly 
conserved amongst eukaryotes.  
 
Figure 7.11: Predicted secondary structures of ssRNA (A) and ssDNA (B) SRL sequences. Structures 
predicted using the mFold server, (Zuker, 2003). Structures are compared with the predicted structure for an 
SRL oligo crystallised with fungal ribotoxin restrictocin in (C) (Yang et al., 2001). 
Labelled BEC1054 was titrated against unlabelled in vitro transcribed RNA in MST 
experiments (at a maximal RNA concentration of 1mM). The interaction was weak, and 
whilst a KD could not be accurately estimated as saturation of the protein was not reached, it 
is likely to lie in the range of 0.8-1.2mM. However, no binding was observed under 
comparable conditions with a ss RNA sequence analogous to that of the T7 promoter, 
selected as a non-ribosomal negative control (Figure 7.12). This suggests that whilst the SRL 
RNA sequence is non-optimal for BEC1054, the protein does exhibit some sequence 
specificity in nucleic acid binding. 
A                                               B                                                    C 
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The SRL interaction was also probed by NMR. However, limitations in the yield of in vitro 
transcription reactions meant that BEC1054 could only be titrated with up to 8 molar 
equivalents of SRL RNA; with an estimated KD in the mM range this amount is insufficient 
to produce a significant fraction of complex. Following addition of the RNA, peak shifts 
smaller than half a line width were observed in the spectrum, and could not be considered to 
be indicative of any significant interaction (data not shown).  
To obtain significant yields for titrations, a DNA oligonucleotide of the same sequence was 
purchased. Whilst it cannot be ruled out that the structure formed by this oligonucleotide 
upon dissolution differs from that of the RNA SRL, the mFold program predicts formation of 
a similar structure (Figure 7.11). MST experiments suggested that the BEC1054 KD was 
comparable to that of the ssRNA SRL oligo; however saturation could not be reached even 
upon titration with a highest concentration of 5mM, preventing accurate estimation of the KD 
(Figure 7.12). To ensure that labelling of BEC1054 lysines with a fluorophore was not 
interfering with the interaction, unlabelled BEC1054 was also titrated against an SRL 
oligonucleotide labelled with an N-terminal Cy-5 (IDT Technologies). However, binding 
curves were suggestive of a KD value within the same range (Figure 7.12).  
NMR titrations performed with the single-stranded SRL DNA oligonucleotide exhibited a 
subset of small CSPs (below a linewidth) upon addition of >8molar equivalents. In fast 
exchange and appearing to saturate at ~30-50molar equivalents, these CSPs were in 
agreement with a low affinity KD (high μM to low mM range). Additionally, many of the 
peaks that shift are identical to those that produce very minor shifts upon addition of up to 8 
molar equivalents of the SRL RNA oligonucleotide. pH was carefully controlled after the 
addition of each equivalent to ensure that CSPs were not an artefact of pH. 
CSPs were mapped onto the crystal structure of BEC1054, and largely localise to the putative 
RNA binding site on the concave face of the β-strand (Figure 7.12b). Residues showing 
significant shifts include T37, F38, (β3), I39, (β3-β4 loop) V50 (β4), Y79 (β5-β6 loop) and 
E96 (β7). Residues T37 and F38 correspond to residues T41 and Y42 that form hydrophobic 
interaction to nucleotides in crystal structures of T1 RNase, whilst Y79 could also have a role 
in base stacking with the SRL. Intriguingly, R25 also exhibits CSPs upon titration; in a 
similar region of the structure to residues K110, K111 and K113 in restrictocin that have been 
demonstrated to contact the SRL crystal structures (Chapter 6.6).  
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sequences. No significant binding was observed to a “random” control RNA sequence derived from the T7 
promoter. (D) MST measurements using a labelled ssDNASRL and unlabelled BEC1054 yield a similar KD 
within a similar range. Curves are the average of two measurements. 
However, it must also be noted that some small shifts are observed on the opposite face of 
BEC1054 (Figure 7.12b, lower picture). Distal shifts could result from conformational 
change, interaction with the phosphate backbone to facilitate correct positioning of the 
nucleotide within the binding site (Sugio et al., 1995), or may be indicative of non-specific 
association with the oligonucleotide. 
7.5 BEC interactions with polysomes  
Previous pull down experiments performed by the Spanu lab had indicated that BEC1054 
could be associating with ribosomes (Chapter 1.3.7). To test this further, additional in vitro 
binding assays were performed with plant ribosomes. Preliminary experiments were 
performed with commercially available wheat germ extract (Promega) (the experiments 
performed in A. thaliana transformed with BEC1054 suggested that the biological activity of 
this protein was not species specific). However to obtain a purer sample, polysomes were also 
extracted from H. vulgare plants via a sucrose cushion sedimentation protocol adapted from 
(Hari, 1980). These experiments were performed with a student under my supervision, 
Michal Pryzdacz. SDS-PAGE analysis of polysome extractions demonstrated that protein 
banding profiles were highly similar to those present in the commercial wheat germ extract 
(Figure 7.13). Additionally, A260/A280 values measured for samples were all in the range 1.8-
1.9, correlating with predicted values for ribosome extraction. However, yields were always 
relatively low for NMR, even when preparations were scaled up. 
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 Initially, plans were made to incubate purified polysomes with recombinant BEC1054 and 
perform a sucrose cushion pulldown, detecting for the presence of BEC1054 within the 
supernatant and pellet with an anti-BEC1054 antibody. In the eventuality that other cellular 
factors may be required for the interaction, a parallel sucrose pull down experiment was 
performed where polysomes were extracted from a transgenic H. vulgare plant expressing 
BEC1054. Unfortunately, the detection limit of the BEC1054 antibody was found to be at 
~0.5ng of protein, and sensitivity of the antibody was thus below the limit required for 
detection of BEC1054 in cell lysate samples extracted from the plant.  
Interactions were further probed by NMR. As an initial crude experiment, wheat germ extract 
or H. vulgare purified polysomes were incubated with BEC1054, and changes to the 
spectrum and BEC1054’s relaxation properties monitored in a one-point HSQC titration. 
Ribosomes are typically “invisible” species in NMR; tumbling very slowly as a ~3.2MDa 
complex (eukaryotes) and thus exhibiting very rapid T2 relaxation times (the time required 
for transverse magnetisation to relax back to the z axis). In many proteins that interact 
strongly with ribosomes, titration of an N15 labelled sample with ribosomes can thus induce 
peak disappearance, as the signal to noise ratio (SNR) drops to below detectable levels 
(Blombach et al., 2014; Sette et al., 1999).  In an attempt to increase the BEC1054: ribosome 
ratio, an HSQC experiment was performed with a BEC1054 sample at 30μM (the minimal 
protein concentration required to obtain an HSQC in ~6 hours with adequate SNR), and 
repeated at the same concentration following dissolution in Promega wheat germ extract, or 
1. NEB-Broad range marker (2-212kDa) 
2. Barley-extracted polysomes (1/10 dilution) 
3. Barley extracted polysomes (1/100 dilution) 
4. Promega wheat germ extract (L4380) (neat) 
5. Promega wheat germ extract (1/10 dilution) 
1     2      3     4      5    
Figure 7.13: SDS-PAGEgel of barley polysome 
preparations. Gel banding  patterns are comparable to 
those observed in commercially available wheat germ 
extract purchased from Promega, although it is possible 
that a few higher molecular weight bands are missing. 
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obtained in a preliminary titration performed with the Promega commercial wheat germ 
extract (data not shown). This could be indicative of a weak interaction with ribosomes (and 
fast exchange), where an average of the bound and free state resonance intensities are 
observed. Although reductions in peak intensities appear to be global, and do not map 
convincingly to any specific region of BEC1054, this may be expected upon binding of a 
much larger molecular species such as a ribosome (which is likely to reduce T2 relaxation 
rates for the entire protein). However, it is also possible that reductions in peak intensities 
result from reduced tumbling rates as a consequence of molecular crowding, due to the high 
protein concentrations and crude nature of the polysome extract. 
To probe changes in relaxation more quantitatively, CPMG experiments were performed with 
BEC1054 alone and BEC1054 in the presence of polysomes to estimate differences in T2 
values. The 2D CPMG experiment correlates the chemical shifts of protons with covalently 
bonded N15 nuclei using the basic HSQC pulse sequence, but through use of a 180 spin-echo 
pulse train prior to acquisition, precession differences in nuclei arising from chemical shift 
differences or inhomogeneities in the magnetic field are refocussed. Signal differences 
recorded for backbone nuclei in a protein are thus directly related to T2 relaxation times, 
which can be fit from signal decays following use of different delay times.  
 
Figure 7.15: CPMG analysis of BEC1054 and polysomes. T2 relaxation times are substantially reduced in the 
presence of polysomes, indicative of reduced tumbling rates. Experiment performed in ribosomal buffer (see 
methods) in the presence and absence of polysomes extracted from H. vulgare. 
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Figure 7.15 demonstrates that BEC1054 T2 relaxation times were roughly halved in the 
presence of polysomes, indicative of more rapid relaxation that could be correlated with 
reduced tumbling rates of BEC1054. Again, reductions in T2 values do not appear to map to 
a specific region of the BEC1054 structure.  
7.6 Collaborator’s results suggest a potential inhibitory role for BEC1054 
against ribosome inactivating proteins (RIPs) 
Recent experiments performed in planta by collaborators (Helen Pennington, Spanu lab) have 
provided evidence that BEC1054 could be counteracting the activity of RIPs in the host 
hypersensitive response. In plants, one of the RIPs expressed in response to jasmonate 
signalling pathways induced as part of the host hypersensitive response (Section 1.3.6) 
includes jasmonate-induced protein 60 (JIP60).  JIP60 mediated cleavage of the SRL in host 
ribosomes has been shown to occur upstream of cell death in planta (Reinbothe et al, 1994 
Dunaeva et al., date), and concurring with this,  Pennington et al. observed that infiltration of 
Nicotiana benthamiana leaves with JIP60 lead to rapid cell death of the leaf (Pennington et 
al., 2015, in preparation). However, when plant leaves were coinfiltrated with JIP60 and 
BEC1054, the phenotype of leaves was no different to that of untransformed healthy wild-
type plants. This suggests that BEC1054 is able to inhibit JIP60 activity, or interfere with the 
signalling events downstream of JIP60 activity to prevent host cell apoptosis.  
Comparison of total RNA profiles from wild type N. benthamiana plants and a transgenic 
line expressing BEC1054 under conditions mimicking a hypersensitive response may provide 
support for direct inhibition of JIP60/host RIP activity (Pennington et al. manuscript in 
preparation). Following treatment of wild type leaves with Methyl-jasmonate (to induce 
expression of RIPs such as JIP60) and analysis of total RNA extracted from the plant with a 
Bioanalyzer electrophoresis system (Agilent), Pennington et al. observed the distinct loss of a 
peak in the UV absorbance spectrum (recorded at 260nm) within the region that typically 
corresponds to rRNA. It is thus possible that this corresponds to loss of the major peak 
corresponding to intact 28S rRNA following cleavage of the SRL. Conversely, RNA profiles 
obtained from transgenic BEC1054 plants following treatment with methyl-jasmonate were 
no different to those from a healthy, wild-type plant. This strongly suggests that BEC1054 
could be protecting host RNA from degradation. Experiments are ongoing to try and identify 
the sequence of the RNA fragment. 
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7.7 Conclusions and perspectives 
Whilst the Spanu lab’s experiments have provided some evidence for a role for BEC1054 in 
inhibition of host RIPs in the hypersensitive response, results presented here provide limited 
support for the hypothesis that BEC interacts directly with the SRL of host ribosomes. 
Preliminary experiments suggest that BEC1054 has the capacity to bind nucleic acid, 
exhibiting some sequence specificity. In particular, experiments performed with total RNA 
extracted from a plant cell yielded promising results. However, evidence for binding to a 
specific SRL sequence was less conclusive; the very weak nature of the interaction 
suggesting that this is not an optimal ligand for BEC1054. Nucleic acid binding proteins 
typically exhibit relatively high affinity (and varying specificities) for their ligands. It has 
been demonstrated that ribotoxin-SRL interactions are highly dependent on the tertiary 
structure of the SRL (specifically the bulged-G loop and S-turn); and it is possible that other 
ribosomal proteins are required for correct presentation of the SRL. Analogously, for many 
ribosomal binding proteins, interaction affinity for rRNA appears to be higher in the context 
of scaffold proteins. However, binding of other fungal ribotoxins to isolated SRL 
oligonucleotides has been observed in vitro with interaction KDs in the nM range (Yang et al., 
2001), and restrictocin has been crystallised with an SRL oligonucleotide of a similar 
sequence (sequence shown in Figure 7.11). Additionally, the interaction surface of BEC1054 
is likely to be small, perhaps arguing against an interaction with ribosomal proteins in the 
vicinity the SRL in addition to the proposed bulged-G loop. As noted in Chapter 6, structural 
elements in ribotoxins critical to recognition of the SRL are poorly conserved in BEC1054. 
However, BEC1054 does contain several tyrosine and tryptophan residues along the concave 
face of the protein, and may thus contact the SRL or surrounding regions of the ribosome 
using similar structural features to those observed in plant RIPs (Pneumas et al., 2001). 
Preliminary NMR experiments performed with ribosomal samples were relatively crude in 
terms of methodology and sample preparation, but have suggested that BEC1054 could be 
interacting with ribosomes. Crucially, it should be ruled out that changes in T2 relaxation 
times and diminished NMR signals are not the result of molecular crowding within the 
sample, via titration of an unrelated non-ribosomal associating protein with ribosomes as a 
control experiment. Further measures may also be required to test the integrity of polysome 
preparations; such as polysomal profiling via UV spectrometry, in vitro translation tests or 
mass spectrometry. It would also be beneficial to work with purer samples, and sucrose 
gradient separation should be performed with polysomal extracts to isolate individual 
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ribosomes and subunits. Performing gradient separations of ribosomes with a transgenic 
BEC1054 H. vulgare line and detecting for BEC1054 with an antibody would be particularly 
advantageous in determining whether BEC1054 has the ability to associate with ribosomes. 
Analogously, the same experiment should be performed in vitro with recombinant BEC1054, 
where positive detection signals cannot occur as a result of basal translation of the protein 
within the transgenic plant.  However, this will require optimisation of Western blotting 
protocols to achieve antibody detection of BEC1054 at picogram levels.  
Furthermore, it would be particularly interesting to perform pull-downs with ribosomes 
extracted from leaves exposed to conditions that mimic infection in the host plant. It has been 
demonstrated that in uninfected plant hosts, some host ribosomal inactivating proteins are 
only able to cleave the ribosomal SRL following exogenous treatment of leaves with methyl-
jasmonate, a phytohormone produced in response to stress or infection (Reinbothe, 1994)  
(Chaudhry et al., 1994). It is currently debated whether jasmonate hormones induce post-
translational processing of ribosomal inactivating proteins to an active form, or whether 
marking of the host ribosomes (e.g. through remodelling of ribosomal associated proteins) 
allows for SRL cleavage (Chaudhry et al., 1994; Reinbothe et al., 1997). It is thus possible 
that BEC1054 only associates with the ribosome under specific infection conditions, and 
ribosome extractions from transgenic plant tissue treated with methyl jasmonates may be 
informative. Several experiments performed by collaborators in the Spanu lab during this 
PhD have provided evidence that BEC1054 could be associating with ribosomes. Yeast two 
hybrid assays performed with protein sequences derived from pull-downs performed with 
BEC1054 and plant cell lysate (see Chapter 1.3.7) have provided evidence for a weak 
interaction between BEC1054 and Eef1G (but not Eef1A). Furthermore, split YFP-assays 
performed with BEC1054 have demonstrated a potential interaction with ribosomal 
elongation factors Eef1A and Eef1G, both elongation factors that localise to the ribosomal A 
site in translation, in close proximity to the SRL (Pennington et al., manuscript in 
preparation) (Figure 7.16). In these experiments, it is possible that positive results are not 
obtained through a direct interaction, but an indirect association via ribosomal elements in 
close proximity. Unfortunately, protein constructs corresponding to these translation 
elongation factors could not be produced within the timescale of this project to test for a 
direct interaction with BEC1054.  
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Further experiments should be performed to determine whether BEC1054 exhibits 
preferential binding to single-stranded or double-stranded nucleic acid. The proposal for 
modular roles of BECs in specific recognition of a range of host sequences could also 
correlate with the overrepresentation of RNAse type folds within the B. graminis genome, 
although the lack of sequence conservation in the putative RNA binding site in other CSEPs 
would argue against this. Techniques such as SELEX (or systematic evolution of ligands by 
exponential enrichment) (Tuerk and Gold, 1990) could provide insights into nucleic acid 
sequences bound preferentially by BEC1054. In SELEX, nucleic acid aptamers that have the 
capacity to bind a target protein are selected from a randomly generated library via affinity 
chromatography. Stringency conditions are increased in subsequent rounds to isolate higher 
affinity ligands. However, this comes with a caveat that such sequences may be of little 
biological relevance, and it has been observed that high affinity ligands do not always reflect 
enhanced substrate specificity (Carothers et al., 2006). 
Finally, Y2H and split YFP assays have also identified several protein putative interactors 
from barley that are not linked to the ribosome, including malate dehydrogenase, glutathione-
S-transferase and PR5 (Pennington et al., manuscript in preparation). The latter is a defence 
protein produced by the plant with an unknown function in immunity. It is possible that PR5 
recognises BEC1054 to initiate an ETI (effector triggered-immune) response in the plant, or 
that BEC1054 binds to PR5 to subvert an immune response. However, it is difficult to 
speculate about the role of a potential interaction in the absence of a known biological 
function for PR5.  
Results obtained by collaborators have provided some promising evidence for the role of 
BEC1054 as an inhibitor of RIPs in the host hypersensitive response, and further in vitro 
experiments will be performed with BEC1054 to test this hypothesis. If proved to be correct, 
this will be an unprecedented mode of immune evasion in a plant host. Currently, 
characterisation of the structure of BEC1054 by crystallography and NMR has provided a 
precedent for the study of other CSEPs from B. graminis, a model organism for studying 
infection in biotrophic phytopathogens. 
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Appendix 1: S75 calibration curve for protein molecular weight 
estimates 
 
 
 
Ve= -34.7log10(Mw)+118.9 
Mw=10(118.9-Ve)/34.7 
Conalbumin (Mw=75kDa) Ve1=55.0ml 
Ovalbumin (Mw=44kDa) Ve2=60.9ml 
RNAse A (Mw=75kDa) Ve3=80.9ml 
Apoproteinin (Mw=6.5kDa) Ve4=91.6ml 
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Appendix 2: A note on KD determination using different 
techniques 
In Chapter 4 of this thesis, several different methods were employed for determination of a 
KD for the interaction between NT-Als proteins and a heptathreonine peptide. This appendix 
will briefly describe how KDs are derived from each assay, and the relative merits/ limitations 
for each. 
A biological interaction can be described as the (reversible) association between a 
macromolecule (or protein, P) and a ligand (L) to form a complex [PL]: [𝑃𝑃] + [𝐿𝐿] ↔ [PL]                                                                                                                     (1) 
where the dissociation constant, defined as the concentration of ligand required to half equal 
populations of protein and complex, is obtained via equation 2. 
𝐾𝐾𝐾𝐾 = [𝑃𝑃][𝐿𝐿][𝑃𝑃𝐿𝐿] = 𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘 = 1𝐾𝐾𝐾𝐾                                                                                                          (2) 
Expressions for P and L can be found from the total concentrations (Xtot) of protein and 
ligand using the law of mass conservation: [𝑃𝑃] = [𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] − [𝑃𝑃𝐿𝐿]  and  [𝐿𝐿] = [𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃] − [𝑃𝑃𝐿𝐿]                                                                     (3) 
which can be substituted into equation 2 and rearranged to yield an expression for PL: 
𝐾𝐾𝐾𝐾 = ([𝑃𝑃𝑃𝑃𝑘𝑘𝑃𝑃]−[𝑃𝑃𝐿𝐿])([𝐿𝐿𝑃𝑃𝑘𝑘𝑃𝑃]−[𝑃𝑃𝐿𝐿])[𝑃𝑃𝐿𝐿]                               [𝑃𝑃𝐿𝐿]2 − ([𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃] + [𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] + 𝐾𝐾𝐾𝐾)[𝑃𝑃𝐿𝐿] + [𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃][𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃] = 0                                                 (4) 
Equation 4 is a quadratic of the form 𝑎𝑎𝑥𝑥2 − 𝑏𝑏𝑥𝑥 + 𝑐𝑐 = 0 which can be solved using the 
quadratic formula (5) where x=[PL], a= 1, b=−([𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃] + [𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] + 𝐾𝐾𝐾𝐾), c=[𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃][𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃] to 
yield equation (6). 
𝑥𝑥 = −𝑏𝑏±√𝑏𝑏2−4𝑎𝑎𝑎𝑎
2𝑎𝑎
                                                                                                                   (5) 
[𝑃𝑃𝐿𝐿] = ([𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃] + [𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] + 𝐾𝐾𝐾𝐾) ± �([𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃] + [𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] + 𝐾𝐾𝐾𝐾)2 − 4([𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃][𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃])2  
Equation 6 forms the basis for fitting of a KD for many binding techniques. 
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KD determination via CSPs in NMR 
In NMR, resonance frequencies of nuclei are highly sensitive to changes in their chemical 
environment. Binding of a ligand to a protein thus produces chemical shift perturbations 
(CSPs) in nuclei that directly interact or experience conformational changes as a result of 
binding, which can be monitored in HSQCs as a function of the titrant concentration, and 
used to fit a KD.  
 
Figure 2.1: Ligand binding exchange regimes on the NMR timescale. VA and VB correspond to resonances 
for the free and ligand-bound states of the protein respectively. The difference between the Koff  rate for an 
interaction and δVA-VB determines whether peak shifts are in fast, slow or intermediate exchange. Slow 
exchange results in a disappearance of a peak corresponding to the unbound form and appearance of another 
peak at the resonance frequency of the bound form, whilst fast exchange result in a shift in a single peaks 
position (representing an average of free and bound populations) until the bound resonance frequency is reached 
upon saturation. Chemical shift differences between free and bound states typically lie within the range of 100-
300Hz for 15N and proton nuclei, thus for fast exchange, koff >3000Hz (s
-1) and assuming a diffusion controlled 
kon, this means that interactions with a KD > ~3μM tend to be fast exchange. 
However, this method is generally limited to KD determination in the μM to mM range. The 
nature of peak shifts and the KD fitting process is governed by the exchange regime on the 
NMR timescale between the free and bound states. Assuming a simple two state binding 
mechanism and diffusion controlled kon rate, the exchange regime is dependent on the koff for 
an interaction relative to the difference in resonance frequency (Δυ, in Hz) between the two 
states. Where the koff for an interaction is significantly (up to 10x) below Δυ, shifts are in 
slow exchange, and free and bound states exist for sufficient time such that separate peaks at 
corresponding resonances are observed, with volumes proportional to their populations. 
Conversely, for reactions where the koff  rate is significantly above Δυ, a single peak at a 
population-weighted average of the resonances is observed. Assuming typical peak shifts 
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(∆υ) for 1H and 15N nuclei and a diffusion controlled kon, KDs in the nM-low μM range (ie 
relatively strong interactions) typically give rise to slow exchange, as koff≈ 10
9.KD. For slow 
exchange data, a KD must be fitted from changes in peak intensities/volumes, but the lack of 
curvature in resultant binding isotherms and the need to acquire measurements at protein 
concentrations orders of magnitude above the KD can make this difficult. Fast exchange data, 
typically observed for weaker affinities in the μM to mM range, are readily fit to a KD 
through measuring concentration dependent shifts in peak resonances. For fast exchange data, 
the ratio of protein: protein complex is proportional to the weighted chemical shift change 
observed relative to the unbound state at the nth point in the titration (∆𝛿𝛿𝛿𝛿),  
∆𝛿𝛿𝛿𝛿
∆𝛿𝛿𝛿𝛿𝑎𝑎𝑥𝑥
= [𝑃𝑃𝐿𝐿][𝑃𝑃]  
and ∆𝛿𝛿𝛿𝛿 = ∆𝛿𝛿𝛿𝛿𝑎𝑎𝑥𝑥 �[𝑃𝑃𝐿𝐿][𝑃𝑃] � 
where ∆𝛿𝛿𝛿𝛿𝑎𝑎𝑥𝑥 denotes the difference between chemical shift values for the unbound and 
saturated states. Substituting this expression into equation 6 yields the following: 
∆𝛿𝛿𝛿𝛿 =  ∆𝛿𝛿𝛿𝛿𝑎𝑎𝑥𝑥 �{(𝛿𝛿[𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃] + [𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] + 𝐾𝐾𝐷𝐷) − (𝛿𝛿[𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃] + [𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] + 𝐾𝐾𝐷𝐷)2 − 4[𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃][𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃]}1/2�2𝛿𝛿[𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃]  
where [P]n and [L]n denote the protein and ligand concentrations at the nth titration point. A 
KD and ∆𝛿𝛿𝛿𝛿𝑎𝑎𝑥𝑥 are readily fit to this equation. 
For the intermediate exchange regime, where koff~ Δυ, peaks typically broaden beyond 
detection and a KD cannot be estimated.  
        
Figure 4.2: Fitting of CSPs in fast exchange and slow exchange on the NMR timescale. For interactions 
with KDs in the μM to mM range, CSPs upon titration with a ligand are followed a single peak at the population 
weighted average of the free and bound state resonances (fast exchange, a). For KDs in the nM-low μM range, 
titration results in disappearance of the free state resonance, and appearance of a peak corresponding to the 
A                                                 B                                                              C 
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complex (b, slow exchange). Intensity and resonance frequency changes are plotted for slow and fast exchange 
data respectively as a function of ligand concentration to fit a KD (c). 
KD determination via isothermal titration calorimetry 
Conversely, KD estimation via ITC (isothermal titration calorimetry) experiments is more 
accurate for higher affinity interactions (nM-low μM range). The experiment indirectly 
measures the heat exchange for a chemical reaction through measuring the power required to 
maintain a constant temperature between a reference cell containing buffer, and a reaction 
cell containing a solution of a macromolecule (P) as a ligand (L) is titrated in. The power 
difference measured for each injection point is integrated over time to yield the change in 
heat energy (∆Q) for the reaction per mole of injectant (kJmol-1), which is plotted against 
molar ratio (ligand:protein) to yield a binding isotherm.  
At constant volume and pressure, it follows (from the first principle of thermodynamics) that 
the molar heat evolved is equal to the molar enthalpy: 
∆𝐻𝐻° =  𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑𝑃𝑃𝐿𝐿
 
where dv denotes the change in the number of moles. As 𝑑𝑑𝑑𝑑𝑃𝑃𝐿𝐿 = [𝑃𝑃𝐿𝐿] × 𝑉𝑉𝑎𝑎𝑐𝑐𝑐𝑐𝑐𝑐 it follows that: 
𝑑𝑑𝑑𝑑 = ∆𝐻𝐻°𝑑𝑑𝑑𝑑𝑃𝑃𝐿𝐿 = ∆𝐻𝐻°𝑉𝑉𝑎𝑎𝑐𝑐𝑐𝑐𝑐𝑐𝑑𝑑[𝑃𝑃𝐿𝐿]  and  1𝑉𝑉𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 × 𝑑𝑑𝑑𝑑𝑑𝑑[𝐿𝐿𝑃𝑃𝑘𝑘𝑃𝑃] = ∆𝐻𝐻° 𝑑𝑑[𝑃𝑃𝐿𝐿]𝑑𝑑[𝐿𝐿𝑃𝑃𝑘𝑘𝑃𝑃]                          
In an ITC experiment, [PL] is a variable changing as a function of [Ltot] titrated into the cell. 
Thus taking the first derivative of binding equation 5 for d[L] we (should!) obtain: 
𝑑𝑑[𝑃𝑃𝐿𝐿]
𝑑𝑑[𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃] = 12 + 2 − (1 + [𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃]𝛿𝛿[𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] + 1𝛿𝛿𝐾𝐾𝑎𝑎[𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃])2 ��1 + [𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃][𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] + 1𝐾𝐾𝐾𝐾[𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] �2 − 4 [𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃][𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃]�1/2 
𝑑𝑑[𝑃𝑃𝐿𝐿]
𝑑𝑑[𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃] = 12�1 + [𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃]𝛿𝛿[𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] + 1𝛿𝛿𝐾𝐾𝐾𝐾[𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] −��1 + [𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃]𝛿𝛿[𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] + 1𝛿𝛿𝐾𝐾𝐾𝐾[𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃]�2 − 4 [𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃]𝛿𝛿[𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃]� 
which is multiplied by equation x to obtain: 
𝑑𝑑 = 𝑘𝑘[𝑃𝑃𝑃𝑃𝑘𝑘𝑃𝑃]∆𝐻𝐻𝑉𝑉𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
2
�1 + [𝐿𝐿𝑃𝑃𝑘𝑘𝑃𝑃]
𝑘𝑘[𝑃𝑃𝑃𝑃𝑘𝑘𝑃𝑃] + 1𝑘𝑘𝐾𝐾𝐾𝐾[𝑃𝑃𝑃𝑃𝑘𝑘𝑃𝑃] −��1 + [𝐿𝐿𝑃𝑃𝑘𝑘𝑃𝑃]𝑘𝑘[𝑃𝑃𝑃𝑃𝑘𝑘𝑃𝑃] + 1𝑘𝑘𝐾𝐾𝐾𝐾[𝑃𝑃𝑃𝑃𝑘𝑘𝑃𝑃]�2 − 4 [𝐿𝐿𝑃𝑃𝑘𝑘𝑃𝑃]𝑘𝑘[𝑃𝑃𝑃𝑃𝑘𝑘𝑃𝑃]�  
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For a simple 1 site binding model, data are fit to this equation via non-linear least-squares 
methods, with modulation of of ΔH (change in enthalpy), KA (association constant) and n. 
This subsequently allows for calculation of a KD and ΔS (entropy change), from the 
relationship: 
𝐾𝐾𝐷𝐷 =  1𝐾𝐾𝐾𝐾                         𝑎𝑎𝛿𝛿𝑑𝑑                          ∆𝐺𝐺° = −𝑅𝑅𝑅𝑅𝑅𝑅𝛿𝛿𝐾𝐾𝐾𝐾 = ∆𝐻𝐻° − 𝑅𝑅∆𝑆𝑆° 
However, accurate fitting requires sufficient curvature in the thermogram; a function of the 
macromolecule concentration and KD. Assessed as Brandt’s c value (c= [Mcell] x KD x n), 
values of between 1-100 are generally considered to be acceptable for fitting, with 10-50 
optimal. Although theoretically ITC should be suitable for KD determination within the x-x 
range, in practice reactions with very tight KDs require very low macromolecule 
concentrations within the cell, and can be limited by low heats of injection. Conversely, weak 
interactions may require very high macromolecule concentrations, often limited by protein 
solubility/ aggregation. 
 
Figure 4.3: Fitting a KD from ITC. Changes in power levels required to keep a constant temperature between a 
reference cell and sample cell are monitored as a ligand is titrated in (a). Injection heats are integrated and 
plotted as a function of time/injection number for calculation of KD, binding stoichiometry and ∆H (b). Graph 
(c) demonstrates the effect that Brandt’s c value has on isotherm curvature (c=[Mtot] x n x 1/KD). 
 
 
A  
 
 
B   
C   
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KD determination via Microscale Thermophoresis (MST) 
Microscale thermophoresis (MST) has been estimated to accurately calculate KD values over 
a wider range (nM-mM). The technique uses an infra-red laser to generate a temperature 
gradient in a sample, inducing thermophoretic diffusion of molecules which is dependent on 
molecular properties such as mass, charge, hydration shell and conformation. Once the laser 
is switched off, ordinary mass diffusion balances the thermophoretic movement to yield a 
steady state concentration. The distribution of molecules in the sample can be monitored 
through fluorescent labelling of a molecule, and quantifying the fluorescence emitted. In 
binding assays, a fluorescently labelled molecule (at a constant concentration) is titrated 
against an unlabelled binding partner. Differences in the thermophoretic properties of the 
complex relative to free labelled molecule lead to differences in normalised steady state 
fluorescence readings across the titration series, quantified as Fnorm: 
𝐹𝐹𝑘𝑘𝑘𝑘𝑛𝑛𝑛𝑛 =  𝐹𝐹1𝐹𝐹0 
where F1 is equal to the steady state fluorescence, and F0 the initial fluorescence (pre-
switching on the laser). Fnorm is a superposition of the unbound and bound fluorescent 
molecules, where FB denotes the fraction bound: 
𝐹𝐹𝑘𝑘𝑘𝑘𝑛𝑛𝑛𝑛 = (1 − [𝐹𝐹𝐹𝐹])𝐹𝐹𝑘𝑘𝑘𝑘𝑛𝑛𝑛𝑛,𝑢𝑢𝑘𝑘𝑏𝑏𝑘𝑘𝑢𝑢𝑘𝑘𝑑𝑑 + [𝐹𝐹𝐹𝐹]𝐹𝐹𝑘𝑘𝑘𝑘𝑛𝑛𝑛𝑛,𝑏𝑏𝑘𝑘𝑢𝑢𝑘𝑘𝑑𝑑  
and so interaction affinity can be characterised from the change in Fnorm as a function of 
titrant concentration. ΔFnorm values (Fnorm- Fnorm for the unbound state, estimated from a 
titration curve) can be fit to equation 6 to obtain a KD via least squares minimisation. 
𝐹𝐹𝐹𝐹 = [𝑃𝑃𝐿𝐿][𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] = ([𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃] + [𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] + 𝐾𝐾𝐾𝐾) ± �([𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃] + [𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃] + 𝐾𝐾𝐾𝐾)2 − 4([𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃][𝐿𝐿𝑃𝑃𝑃𝑃𝑃𝑃])2[𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃]  
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 Figure 4.4: Fitting a KD from MST. (a)Heating a capillary containing sample with an infra-red laser leads to 
thermophoretic diffusion of the sample (central panel, where the heated spot is represented as a red circle), 
balanced by standard diffusion in the steady state once the laser is switched off . (b) By labelling a molecule 
with a fluorescent probe, the changes in diffusion of the molecule can be monitored via changes in fluorescence 
(where F0= the fluorescence pre switching on the laser and heating of the sample, and F1= the fluorescence 
measured post-heating and diffusion of the sample). Titration with a binding partner results in changes in 
thermophoresis according to the population of bound molecules , measured as a change in F1. This can be fitted 
to the concentration of the binding partner to derive a KD (c). 
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Appendix 3: NT-Als1 and 3 sequence alignment 
 
                                                10                       20                      30                      40                      50                      60 
Als1      KTITGVFDSF NSLTWSNAAN YAFKGPGYPT WNAVLGWSLD GTSANPGDTF TLNMPCVFKY 
Als3      KTITGVFNSF NSLTWSNAAT YNYKGPGTPT WNAVLGWSLD GTSASPGDTF TLNMPCVFKF 
          *******:** *********. * :**** ** ********** ****.***** *********: 
                      A1                      B1                C1      C1* 
                           
                  70         80         90        100        110        120                      
Als1      TTSQTSVDLT ADGVKYATCQ FYSGEEFTTF STLTCTVNDA LKSSIKAFGT VTLPIAFNVG 
Als3      TTSQTSVDLT AHGVKYATCQ FQAGEEFMTF STLTCTVSNT LTPSIKALGT VTLPLAFNVG 
          ********** *.******** * :**** ** *******.:: *. ****:** ****:***** 
                 C1’        C1’’            C1’’’              E1 
 
                 130        140        150        160        170        180                      
Als1      GTGSSTDLED SKCFTAGTNT VTFNDGDKDI SIDVEFEKST VDPSGYLYAS RVMPSLNKVT 
Als3      GTGSSVDLED SKCFTAGTNT VTFNDGGKKI SINVDFERSN VDPKGYLTDS RVIPSLNKVS 
          *****.**** ********** ****** *.* **:*:**:*. ***.***  * **:******: 
                 α1             F1         G1                  A2        B2 
 
                 190        200        210        220        230        240                      
Als1      TLFVAPQCEN GYTSGTMGFS SSNGDVAIDC SNIHIGITKG LNDWNYPVSS ESFSYTKTCT 
Als3      TLFVAPQCAN GYTSGTMGFA NTYGDVQIDC SNIHVGITKG LNDWNYPVSS ESFSYTKTCS 
          ******** * *********: .: *** *** ****:***** ********** *********: 
          B2              C2         D2a       D2b                     C2’ 
 
                 250        260        270       280       290    296   300      
Als1      SNGIQIKYQN VPAGYRPFID AYISATDVNQ YTLAYTNDY TCAGSRSQS KPFTLR WTG  
Als3      SNGIFITYKN VPAGYRPFVD AYISATDVNS YTLSYANEY TCAGGYWQR APFTLR WTG  
          **** *.*:* ********:* *********. ***:*:*:  ** ***.    ***** ****  
              C2’’            E2            F2a     F2b   G2a      G2b 
 
                 310   315      
Als1      YKNSDAGSNG IVIVA 
Als3      YRNSDAGSNG IVIVA 
          *:******** ***** 
                                       G2’ 
 
*Changes in the numbering result from insertions in NT-Als sequences in other members of the Als family, as 
indicated in Salgado et al., 2011. The numbering indicated in this alignment is used throughout Chapters 3, 4 
and 5 of the main text. 
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Peak pH 3.0 pH 3.5 pH 4.6 pH 6.5 pH 7.0 pH 7.4 283 300 303 308 310 
A2 Slow Towards 
intermediate 
Slow- ~equal  Slow δn Slow δn Slow δn Fast Fast Fast slow Fast 
W4 Fast Fast Fast Slow  Slow Fast/ poor 
signal 
Fast Fast Fast Fast Fast 
C6 Fast Fast Fast broad 
δv 
Tending to 
intermediate 
Slow/ 
Intermediate 
Slow/ 
Intermediate 
Fast Fast Fast Fast Fast 
G8 Fast broad 
δv 
Fast Slow- 
overlap 
Slow- 
overlap 
Slow- 
overlap 
Slow- 
overlap 
Slow δn Slow δn Slow δn Intermediate Fast 
R14 Slow δn Slow δn Slow δn Slow δn Slow δn Slow δn Slow δn Slow δn Slow δn Intermediate Fast 
R17 Slow 
~equal 
Slow ~equal Slow δn Slow ~equal Fast Fast Fast Fast Slow Slow Fast 
A19 Slow δn Slow δn Slow δn Slow δn Fast Fast Slow δn Slow δn Slow δn Slow δn Slow δn 
L72 Fast Fast Slow δn Slow ~equal Slow  Slow  Slow δn Slow δn Slow δn Slow δn Fast 
L80 Slow 
overlap 
Slow overlap Slow overlap Fast Fast Fast Slow 
overlap 
Slow 
overlap 
Slow 
overlap 
Slow 
overlap 
Slow 
overlap 
F83 Slow 
overlap 
Slow overlap Slow overlap Slow overlap Slow 
overlap 
Slow 
overlap 
Slow 
overlap 
Slow 
overlap 
Slow 
overlap 
Slow 
overlap 
Fast 
C92 Fast  Fast Slow Slow Fast Fast      
F94 Slow 
~equal 
Slow ~equal Slow δn Slow δn Slow δn Slow δn Slow Slow Slow Slow Fast 
E92 Slow δn Slow δn Slow δn Slow δn Slow δn Fast Slow Slow Slow Slow Fast 
Table 4: Changes in BEC1054 peak exchange regimes with pH and temperature. pH titrations were performed at 308K in buffers described in figure 7.1 Temperature 
titrations were performed in 20mM sodium acetate, 150mM NaCl, pH 4.6. All spectra were recorded at 600MHz on an Avance II spectrometer with TCI cryoprobe. δn 
denotes a noticebale difference in doubling peak intensities (and thus in the populations of the two conformational states.)
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Appendix 5: BEC1054 sequence 
 
 
    signal sequence                                           1                               10                                20                              30                            40 
mrpfqllsal aifinleavea    aaywdcdgte ipernvraav vlafnyrkes fhgypatfii  
                             50                                60                                      70                          80                               90                    97 
gstfsgvgev rqfpvedsda nwqggavkyy iltnkrgsyl evfssvgsgn kctfveg 
Cleavage site 
 
